Saratoga Investment
SAR
#7777
Rank
$0.36 B
Marketcap
$22.67
Share price
-0.74%
Change (1 day)
-2.70%
Change (1 year)

Saratoga Investment - 10-Q quarterly report FY


Text size:
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended May 31, 2017

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 001-33376

 

 

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

 

 

 

Maryland 20-8700615

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

535 Madison Avenue

New York, New York

 10022
(Address of principal executive office) (Zip Code)

(212) 906-7800

(Registrant’s telephone number, including area code)

Not applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ☐    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (check one):

 

Large Accelerated Filer   Accelerated Filer 
Non-Accelerated Filer   Smaller Reporting Company 
   Emerging Growth Company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of July 12, 2017 was 5,967,273.

 

 

 


Table of Contents

TABLE OF CONTENTS

 

 

 

     Page 

PART I.

 FINANCIAL INFORMATION   3 
Item 1. Consolidated Financial Statements   3 
 Consolidated Statements of Assets and Liabilities as of May 31, 2017 (unaudited) and February 28, 2017   3 
 Consolidated Statements of Operations for the three months ended May 31, 2017 and May 31, 2016 (unaudited)   4 
 Consolidated Schedules of Investments as of May 31, 2017 (unaudited) and February 28, 2017   5 
 Consolidated Statements of Changes in Net Assets for the three months ended May 31, 2017 and May 31, 2016 (unaudited)   7 
 Consolidated Statements of Cash Flows for the three months ended May 31, 2017 and May 31, 2016 (unaudited)   8 
 Notes to Consolidated Financial Statements as of May 31, 2017 (unaudited)   9 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   35 
Item 3. Quantitative and Qualitative Disclosures About Market Risk   59 
Item 4. Controls and Procedures   60 
PART II. OTHER INFORMATION   61 
Item 1. Legal Proceedings   61 
Item 1A. Risk Factors   61 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   61 
Item 3. Defaults Upon Senior Securities   61 
Item 4. Mine Safety Disclosures   61 
Item 5. Other Information   61 
Item 6. Exhibits   62 
Signatures    64 

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

 

   As of 
   May 31, 2017  February 28, 2017 
   (unaudited)    

ASSETS

   

Investments at fair value

   

Non-control/Non-affiliate investments (amortized cost of $291,471,679 and $251,198,896, respectively)

  $  278,767,064  $  242,531,514 

Control investments (cost of $48,625,339 and $49,283,536, respectively)

   50,922,884   50,129,799 
  

 

 

  

 

 

 

Total investments at fair value (amortized cost of $340,097,018 and $300,482,432, respectively)

   329,689,948   292,661,313 

Cash and cash equivalents

   1,246,815   9,306,543 

Cash and cash equivalents, reserve accounts

   26,526,889   12,781,425 

Interest receivable (net of reserve of $817,374 and $157,560, respectively)

   3,652,935   3,294,450 

Management and incentive fee receivable

   276,484   171,106 

Other assets

   278,376   183,346 

Receivable from unsettled trades

   253,041   253,041 
  

 

 

  

 

 

 

Total assets

  $361,924,488  $318,651,224 
  

 

 

  

 

 

 

LIABILITIES

   

Revolving credit facility

  $24,500,000  $—   

Deferred debt financing costs, revolving credit facility

   (760,150  (437,183

SBA debentures payable

   134,660,000   112,660,000 

Deferred debt financing costs, SBA debentures payable

   (2,924,288  (2,508,280

Notes payable

   74,450,500   74,450,500 

Deferred debt financing costs, notes payable

   (2,578,509  (2,689,511

Base management and incentive fees payable

   3,992,960   5,814,692 

Accounts payable and accrued expenses

   773,025   852,987 

Interest and debt fees payable

   1,805,492   2,764,237 

Directors fees payable

   51,500   51,500 

Due to manager

   345,305   397,505 
  

 

 

  

 

 

 

Total liabilities

  $234,315,835  $191,356,447 
  

 

 

  

 

 

 

Commitments and contingencies (See Note 7)

   

NET ASSETS

   

Common stock, par value $.001, 100,000,000 common shares authorized, 5,884,475 and 5,794,600 common shares issued and outstanding, respectively

  $5,884  $5,795 

Capital in excess of par value

   192,449,147   190,483,931 

Distribution in excess of net investment income

   (26,898,415  (27,737,348

Accumulated net realized loss from investments and derivatives

   (27,540,893  (27,636,482

Accumulated net unrealized depreciation on investments and derivatives

   (10,407,070  (7,821,119
  

 

 

  

 

 

 

Total net assets

   127,608,653   127,294,777 
  

 

 

  

 

 

 

Total liabilities and net assets

  $361,924,488  $318,651,224 
  

 

 

  

 

 

 

NET ASSET VALUE PER SHARE

  $21.69  $21.97 
  

 

 

  

 

 

 

See accompanying notes to consolidated financial statements.

 

3


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)

 

   For the three months ended
May 31, 2017
  For the three months ended
May 31, 2016
 

INVESTMENT INCOME

   

Interest from investments

   

Non-control/Non-affiliate investments

  $5,920,433  $6,620,113 

Payment-in-kind interest income from Non-control/Non-affiliate investments

   223,273   129,090 

Control investments

   1,335,386   532,126 

Payment-in-kind interest income from Control investments

   262,109   —   
  

 

 

  

 

 

 

Total interest income

   7,741,201   7,281,329 

Interest from cash and cash equivalents

   7,081   3,786 

Management fee income

   375,681   373,684 

Incentive fee income

   105,295   —   

Other income

   478,190   249,596 
  

 

 

  

 

 

 

Total investment income

   8,707,448   7,908,395 
  

 

 

  

 

 

 

OPERATING EXPENSES

   

Interest and debt financing expenses

   2,523,606   2,368,056 

Base management fees

   1,391,027   1,227,157 

Professional fees

   384,331   359,299 

Administrator expenses

   375,000   325,000 

Incentive management fees

   176,096   728,280 

Insurance

   66,165   70,658 

Directors fees and expenses

   51,000   66,000 

General & administrative

   197,243   212,209 

Other expense

   38,531   13,187 
  

 

 

  

 

 

 

Total operating expenses

   5,202,999   5,369,846 
  

 

 

  

 

 

 

NET INVESTMENT INCOME

   3,504,449   2,538,549 
  

 

 

  

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

   

Net realized gain from investments

   95,589   6,102,905 

Net unrealized depreciation on investments

   (2,585,951  (5,353,867
  

 

 

  

 

 

 

Net gain (loss) on investments

   (2,490,362  749,038 
  

 

 

  

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $1,014,087  $3,287,587 
  

 

 

  

 

 

 

WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS PER COMMON SHARE

  $0.17  $0.57 

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED

   5,861,654   5,737,496 

See accompanying notes to consolidated financial statements.

 

4


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

May 31, 2017

(unaudited)

 

Company

 

Industry

 

Investment Interest Rate/
Maturity

 Principal/
Number of
Shares
  Cost  Fair Value (c)  % of
Net Assets
 

Non-control/Non-affiliated investments - 218.5% (b)

 

   

Apex Holdings Software Technologies, LLC

 Business Services First Lien Term Loan
(L+8.00%), 9.21% Cash, 9/21/2021
 $18,000,000  $17,864,592  $18,000,000   14.1

Avionte Holdings, LLC (g)

 Business Services Common Stock  100,000   100,000   257,000   0.2

BMC Software, Inc. (d)

 Business Services Syndicated Loan (L+4.00%), 5.21% Cash, 9/10/2022 $4,883,493   4,835,787   4,905,468   3.8

CLEO Communications Holding, LLC

 Business Services First Lien Term Loan (L+7.00%), 8.21% Cash/2.00% PIK, 3/31/2022 $13,000,000   12,872,436   12,870,000   10.1

CLEO Communications Holding, LLC (j)

 Business Services Delayed Draw Term Loan (L+7.00%), 8.21% Cash/2.00% PIK, 3/31/2022 $—     —     —     0.0

Courion Corporation

 Business Services Second Lien Term Loan (L+10.00%), 11.21% Cash, 6/1/2021 $15,000,000   14,885,014   14,229,000   11.1

Emily Street Enterprises, L.L.C.

 Business Services Senior Secured Note (L+8.50%), 10.00% Cash, 1/23/2020 $3,300,000   3,287,284   3,321,450   2.6

Emily Street Enterprises, L.L.C. (g)

 Business Services Warrant Membership Interests Expires 12/28/2022  49,318   400,000   426,600   0.3

Erwin, Inc.

 Business Services Second Lien Term Loan (L+11.50%), 12.71% Cash/1.00% PIK, 8/28/2021 $13,143,616   13,036,964   13,143,616   10.3

FranConnect LLC (d)

 Business Services First Lien Term Loan (L+7.00%), 8.50% Cash, 5/26/2022 $14,500,000   14,427,500   14,427,500   11.3

GreyHeller LLC

 Business Services First Lien Term Loan (L+11.00%), 12.21% Cash, 11/16/2021 $7,000,000   6,935,808   7,000,000   5.5

GreyHeller LLC (j)

 Business Services Delayed Draw Term Loan B (L+11.00%), 12.21% Cash, 11/16/2021 $—     —     —     0.0

GreyHeller LLC (g)

 Business Services Common Stock  850,000   850,000   850,000   0.7

Help/Systems Holdings, Inc.(Help/Systems, LLC)

 Business Services First Lien Term Loan (L+5.25%), 6.46% Cash, 10/8/2021 $5,932,462   5,847,487   5,937,208   4.7

Help/Systems Holdings, Inc.(Help/Systems, LLC)

 Business Services Second Lien Term Loan (L+9.50%), 10.71% Cash, 10/8/2022 $3,000,000   2,925,229   2,928,900   2.3

Identity Automation Systems

 Business Services Convertible Promissory Note 13.50% (6.75% Cash/6.75% PIK), 8/18/2018 $621,695   621,695   621,695   0.5

Identity Automation Systems (g)

 Business Services Common Stock Class A Units  232,616   232,616   514,298   0.4

Identity Automation Systems

 Business Services First Lien Term Loan (L+9.25%), 10.46% Cash/1.75% PIK, 12/18/2020 $10,324,839   10,261,369   10,324,839   8.1

Knowland Technology Holdings, L.L.C.

 Business Services First Lien Term Loan (L+8.75%), 9.96% Cash, 7/20/2021 $16,888,730   16,833,572   16,888,731   13.2

Microsystems Company

 Business Services Second Lien Term Loan (L+10.00%), 11.21% Cash, 7/1/2022 $8,000,000   7,929,936   8,000,000   6.3

National Waste Partners (d)

 Business Services First Lien Term Loan 10.00% Cash, 2/13/2022 $9,000,000   8,910,000   8,910,000   7.0

Vector Controls Holding Co., LLC (d)

 Business Services First Lien Term Loan 14.00% (12.00% Cash/2.00% PIK), 3/6/2018 $8,711,174   8,679,449   8,711,174   6.8

Vector Controls Holding Co., LLC (d), (g)

 Business Services Warrants to Purchase Limited Liability Company Interests, Expires 5/31/2025  343   —     328,008   0.3
    

 

 

  

 

 

  

 

 

 
  Total Business Services   151,736,738   152,595,487   119.6
    

 

 

  

 

 

  

 

 

 

Targus Holdings, Inc. (d), (g)

 Consumer Products Common Stock  210,456   1,791,242   24,957   0.0

Targus Holdings, Inc. (d)

 Consumer Products Second Lien Term Loan A-2 15.00% PIK, 12/31/2019 $243,206   243,206   243,206   0.2

Targus Holdings, Inc. (d)

 Consumer Products Second Lien Term Loan B 15.00% PIK, 12/31/2019 $729,230   729,230   729,230   0.6
    

 

 

  

 

 

  

 

 

 
  Total Consumer Products   2,763,678   997,393   0.8
    

 

 

  

 

 

  

 

 

 

My Alarm Center, LLC (g)

 Consumer Services Second Lien Term Loan (L+11.00%), 12.21% Cash, 7/9/2019 $10,343,750   10,329,743   2,695,581   2.1

PrePaid Legal Services, Inc. (d)

 Consumer Services First Lien Term Loan (L+5.25%), 6.50% Cash, 7/1/2019 $2,558,573   2,546,279   2,564,458   2.0

PrePaid Legal Services, Inc. (d)

 Consumer Services Second Lien Term Loan (L+9.00%), 10.25% Cash, 7/1/2020 $11,000,000   10,968,443   10,957,100   8.6
    

 

 

  

 

 

  

 

 

 
  Total Consumer Services   23,844,465   16,217,139   12.7
    

 

 

  

 

 

  

 

 

 

C2 Educational Systems

 Education First Lien Term Loan (L+8.50%), 10.00% Cash, 5/31/2020 $16,000,000   15,840,181   15,840,000   12.4

M/C Acquisition Corp., L.L.C. (d), (g)

 Education Class A Common Stock  544,761   30,241   —     0.0

M/C Acquisition Corp., L.L.C. (d), (g)

 Education First Lien Term Loan 1.00% Cash, 3/31/2018 $ 2,321,073   1,193,790   6,320   0.0

Texas Teachers of Tomorrow, LLC (g), (h)

 Education Common Stock  750,000   750,000   878,603   0.7

Texas Teachers of Tomorrow, LLC

 Education Second Lien Term Loan (L+8.00%), 9.21% Cash, 6/2/2021 $10,000,000   9,922,434   10,000,000   7.8
    

 

 

  

 

 

  

 

 

 
  Total Education   27,736,646   26,724,923   20.9
    

 

 

  

 

 

  

 

 

 

TM Restaurant Group L.L.C. (g)

 Food and Beverage First Lien Term Loan 14.50% PIK, 7/17/2017 $9,358,694   9,349,470   8,279,637   6.5

TM Restaurant Group L.L.C. (g), (i)

 Food and Beverage Revolver 14.50% PIK, 7/17/2017 $413,954   413,954   366,225   0.3
    

 

 

  

 

 

  

 

 

 
  Total Food and Beverage   9,763,424   8,645,862   6.8
    

 

 

  

 

 

  

 

 

 

Censis Technologies, Inc.

 Healthcare Services First Lien Term Loan B (L+10.00%), 11.21% Cash, 7/24/2019 $10,950,000   10,840,545   10,879,920   8.5

Censis Technologies, Inc. (g), (h)

 Healthcare Services Limited Partner Interests  999   999,000   907,701   0.7

ComForCare Health Care

 Healthcare Services First Lien Term Loan (L+8.50%), 9.71% Cash, 1/31/2022 $10,500,000   10,400,434   10,500,000   8.2

Roscoe Medical, Inc. (d), (g)

 Healthcare Services Common Stock  5,081   508,077   585,152   0.5

Roscoe Medical, Inc.

 Healthcare Services Second Lien Term Loan 11.25% Cash, 9/26/2019 $4,200,000   4,159,694   4,186,560   3.3

Ohio Medical, LLC (g)

 Healthcare Services Common Stock  5,000   500,000   218,050   0.2

Ohio Medical, LLC

 Healthcare Services Senior Subordinated Note 12.00% Cash, 7/15/2021 $7,300,000   7,241,526   6,395,530   5.0

Zest Holdings, LLC (d)

 Healthcare Services Syndicated Loan (L+4.25%), 5.46% Cash, 8/16/2023 $4,136,911   4,056,579   4,162,973   3.3
    

 

 

  

 

 

  

 

 

 
  Total Healthcare Services   38,705,855   37,835,886   29.7
    

 

 

  

 

 

  

 

 

 

HMN Holdco, LLC

 Media First Lien Term Loan 12.00% Cash/2.00% PIK, 7/8/2021 $8,343,607   8,267,744   8,593,916   6.7

HMN Holdco, LLC

 Media Delayed Draw First Lien Term Loan 12.00% Cash, 7/8/2021 $4,800,000   4,754,553   4,824,000   3.8

HMN Holdco, LLC (g)

 Media Class A Series, Expires 1/16/2025  4,264   61,647   263,131   0.2

HMN Holdco, LLC (g)

 Media Class A Warrant, Expires 1/16/2025  30,320   438,353   1,481,132   1.2

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests (Common), Expires 5/16/2024  57,872   —     2,530,743   2.0

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests (Preferred), Expires 5/16/2024  8,139   —     413,217   0.3
    

 

 

  

 

 

  

 

 

 
  Total Media   13,522,297   18,106,139   14.2
    

 

 

  

 

 

  

 

 

 

Elyria Foundry Company, L.L.C. (d), (g)

 Metals Common Stock  35,000   9,217,564   1,458,100   1.1

Elyria Foundry Company, L.L.C. (d)

 Metals Second Lien Term Loan 15.00% PIK, 8/10/2022 $437,500   437,500   437,500   0.4
    

 

 

  

 

 

  

 

 

 
  Total Metals   9,655,064   1,895,600   1.5
    

 

 

  

 

 

  

 

 

 

Mercury Network, LLC

 Real Estate Second Lien Term Loan (L+10.50%), 11.71% Cash, 3/17/2022 $12,988,202   12,885,683   13,118,084   10.2

Mercury Network, LLC (g)

 Real Estate Common Stock  580,559   857,829   2,630,551   2.1
    

 

 

  

 

 

  

 

 

 
  Total Real Estate   13,743,512   15,748,635   12.3
    

 

 

  

 

 

  

 

 

 

Sub Total Non-control/Non-affiliated investments

   291,471,679   278,767,064   218.5
    

 

 

  

 

 

  

 

 

 

Control investments - 39.9% (b)

     

Easy Ice, LLC (f)

 Business Services Preferred Equity 10.00% PIK  5,080,000   8,124,444   8,131,921   6.4

Easy Ice, LLC (d), (f)

 Business Services First Lien Term Loan (L+10.25%), 11.31% Cash, 1/15/2020 $26,680,000   26,480,450   26,680,000   20.9
    

 

 

  

 

 

  

 

 

 
  Total Business Services   34,604,894   34,811,921   27.3
    

 

 

  

 

 

  

 

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (d), (e), (f)

 Structured Finance Securities Other/Structured Finance Securities 22.56%, 10/20/2025 $30,000,000   9,520,445   11,563,263   9.0

Saratoga Investment Corp. Class F Note (a), (d), (f)

 Structured Finance Securities Other/Structured Finance Securities (L+8.50%), 9.71%, 10/20/2025 $4,500,000   4,500,000   4,547,700   3.6
    

 

 

  

 

 

  

 

 

 
  Total Structured Finance Securities   14,020,445   16,110,963   12.6
    

 

 

  

 

 

  

 

 

 

Sub Total Control investments

     48,625,339   50,922,884   39.9
    

 

 

  

 

 

  

 

 

 

TOTAL INVESTMENTS - 258.4% (b)

  $340,097,018  $329,689,948   258.4
    

 

 

  

 

 

  

 

 

 
      Principal  Cost  Fair Value  % of
Net Assets
 

Cash and cash equivalents and cash and cash equivalents, reserve accounts - 21.8% (b)

    

U.S. Bank Money Market (k)

   $27,773,704  $27,773,704  $27,773,704   21.8
   

 

 

  

 

 

  

 

 

  

 

 

 

Total cash and cash equivalents and cash and cash equivalents, reserve accounts

 $27,773,704  $27,773,704  $27,773,704   21.8
   

 

 

  

 

 

  

 

 

  

 

 

 

 

(a)Represents a non-qualifying investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 4.9% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b)Percentages are based on net assets of $127,608,653 as of May 31, 2017.
(c)Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d)These securities are either fully or partially pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 22.56% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f)As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

Company

  Purchases   Redemptions   Sales
(Cost)
   Interest
Income
   Management
and Incentive
Fee Income
   Net Realized
Gains
(Losses)
   Change in
Unrealized
Appreciation
(Depreciation)
 

Easy Ice, LLC

  $—     $—     $—     $1,037,917   $—     $—     $(8,811

Saratoga Investment Corp. CLO 2013-1, Ltd.

  $—     $—     $—     $453,586   $480,976   $—     $1,411,943 

Saratoga Investment Corp. Class F Note

  $—     $—     $—     $105,992   $—     $—     $48,150 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(g)Non-income producing at May 31, 2017.
(h)Includes securities issued by an affiliate of the company.
(i)The investment has an unfunded commitment as of May 31, 2017 (see Note 7 to the consolidated financial statements).
(j)The entire commitment was unfunded at May 31, 2017. As such, no interest is being earned on this investment.
(k)Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s Consolidated Statements of Assets and Liabilities as of May 31, 2017.

 

5


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2017

 

Company

 

Industry

 

Investment Interest Rate/
Maturity

 Principal/
Number
of Shares
  Cost  Fair Value (c)  % of
Net Assets
 

Non-control/Non-affiliated investments - 190.5% (b)

    

Apex Holdings Software Technologies, LLC

 Business Services First Lien Term Loan (L+8.00%), 9.05% Cash, 9/21/2021 $18,000,000  $17,857,818  $17,843,400   14.0

Avionte Holdings, LLC (g)

 Business Services Common Stock  100,000   100,000   251,000   0.2

BMC Software, Inc. (d)

 Business Services Syndicated Loan (L+4.00%), 5.05% Cash, 9/10/2020 $5,611,666   5,582,551   5,639,163   4.4

Courion Corporation

 Business Services Second Lien Term Loan (L+10.00%), 11.05% Cash, 6/1/2021 $15,000,000   14,879,353   14,230,500   11.2

Emily Street Enterprises, L.L.C.

 Business Services Senior Secured Note (L+8.50%), 10.00% Cash, 1/23/2020 $3,300,000   3,282,213   3,316,500   2.6

Emily Street Enterprises, L.L.C. (g)

 Business Services Warrant Membership Interests Expires 12/28/2022  49,318   400,000   394,544   0.3

Erwin, Inc.

 Business Services Second Lien Term Loan (L+11.50%), 12.55% (11.50% Cash/1.00% PIK), 8/28/2021 $13,111,929   13,000,581   13,111,929   10.2

GreyHeller LLC

 Business Services First Lien Term Loan (L+11.00%), 12.05% Cash, 11/16/2021 $7,000,000   6,933,141   6,930,000   5.4

GreyHeller LLC (i), (j)

 Business Services Delayed Draw Term Loan B (L+11.00%), 12.05% Cash, 11/16/2021 $—     —     —     0.0

GreyHeller LLC (g)

 Business Services Common Stock  850,000   850,000   850,000   0.7

Help/Systems Holdings, Inc.(Help/Systems, LLC)

 Business Services First Lien Term Loan (L+5.25%), 6.30% Cash, 10/8/2021 $5,947,481   5,857,960   5,947,481   4.7

Help/Systems Holdings, Inc.(Help/Systems, LLC)

 Business Services Second Lien Term Loan (L+9.50%), 10.55% Cash, 10/8/2022 $3,000,000   2,922,606   2,926,800   2.3

Identity Automation Systems

 Business Services Convertible Promissory Note 13.50% (6.75% Cash/6.75% PIK), 8/18/2018  611,517   611,517   611,517   0.5

Identity Automation Systems (g)

 Business Services Common Stock Class A Units  232,616   232,616   386,143   0.3

Identity Automation Systems

 Business Services First Lien Term Loan (L+9.25%), 10.30% (9.25% Cash/1.75% PIK) 12/18/2020 $10,293,791   10,223,741   10,293,791   8.1

Knowland Technology Holdings, L.L.C.

 Business Services First Lien Term Loan (L+8.75%), 9.80% Cash, 7/20/2021 $17,777,730   17,692,307   17,777,730   14.0

Microsystems Company

 Business Services Second Lien Term Loan (L+10.00%), 11.05% Cash, 7/1/2022 $8,000,000   7,927,489   7,964,800   6.3

National Waste Partners

 Business Services First Lien Term Loan 10.00% Cash, 2/13/2022 $9,000,000   8,910,000   8,910,000   7.0

Vector Controls Holding Co., LLC (d)

 Business Services First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018 $8,819,270   8,778,186   8,819,270   6.9

Vector Controls Holding Co., LLC (d), (g)

 Business Services Warrants to Purchase Limited Liability Company Interests, Expires 5/31/2025  343   —     327,200   0.3
    

 

 

  

 

 

  

 

 

 
  Total Business Services   126,042,079   126,531,768   99.4
    

 

 

  

 

 

  

 

 

 

Targus Holdings, Inc. (d), (g)

 Consumer Products Common Stock  210,456   1,791,242   29,241   0.0

Targus Holdings, Inc. (d)

 Consumer Products Second Lien Term Loan A-2 15.00% PIK, 12/31/2019 $234,630   234,630   234,630   0.2

Targus Holdings, Inc. (d)

 Consumer Products Second Lien Term Loan B 15.00% PIK, 12/31/2019 $703,889   703,889   703,889   0.6
    

 

 

  

 

 

  

 

 

 
  Total Consumer Products   2,729,761   967,760   0.8
    

 

 

  

 

 

  

 

 

 

My Alarm Center, LLC

 Consumer Services Second Lien Term Loan (L+11.00%), 12.05% Cash, 7/9/2019 $9,375,000   9,359,492   7,061,250   5.6

PrePaid Legal Services, Inc. (d)

 Consumer Services First Lien Term Loan (L+5.25%), 6.50% Cash, 7/1/2019 $2,687,143   2,672,435   2,687,143   2.1

PrePaid Legal Services, Inc. (d)

 Consumer Services Second Lien Term Loan (L+9.00%), 10.25% Cash, 7/1/2020 $11,000,000   10,966,188   11,000,000   8.6
    

 

 

  

 

 

  

 

 

 
  Total Consumer Services   22,998,115   20,748,393   16.3
    

 

 

  

 

 

  

 

 

 

M/C Acquisition Corp., L.L.C. (d), (g)

 Education Class A Common Stock  544,761   30,241   —     0.0

M/C Acquisition Corp., L.L.C. (d)

 Education First Lien Term Loan 1.0% Cash, 3/31/2018 $2,321,073   1,193,790   8,087   0.0

Texas Teachers of Tomorrow, LLC (g), (h)

 Education Common Stock  750   750,000   919,680   0.7

Texas Teachers of Tomorrow, LLC

 Education Second Lien Term Loan (L+9.75%), 10.80% Cash, 6/2/2021 $10,000,000   9,918,572   10,000,000   7.9
    

 

 

  

 

 

  

 

 

 
  Total Education   11,892,603   10,927,767   8.6
    

 

 

  

 

 

  

 

 

 

TM Restaurant Group L.L.C. (g)

 Food and Beverage First Lien Term Loan (L+8.50%), 9.75% Cash, 7/17/2017 $9,358,694   9,331,446   8,422,825   6.6
    

 

 

  

 

 

  

 

 

 
  Total Food and Beverage   9,331,446   8,422,825   6.6
    

 

 

  

 

 

  

 

 

 

Censis Technologies, Inc.

 Healthcare Services First Lien Term Loan B (L+10.00%), 11.05% Cash, 7/24/2019 $11,100,000   10,977,689   10,940,160   8.6

Censis Technologies, Inc. (g), (h)

 Healthcare Services Limited Partner Interests  999   999,000   886,772   0.7

ComForCare Health Care

 Healthcare Services First Lien Term Loan (L+8.50%), 9.55% Cash, 1/31/2022 $10,500,000   10,398,957   10,395,000   8.2

Roscoe Medical, Inc. (d), (g)

 Healthcare Services Common Stock  5,081   508,077   680,823   0.5

Roscoe Medical, Inc.

 Healthcare Services Second Lien Term Loan 11.25% Cash, 9/26/2019 $4,200,000   4,155,827   4,179,000   3.3

Ohio Medical, LLC (g)

 Healthcare Services Common Stock  5,000   500,000   288,800   0.2

Ohio Medical, LLC

 Healthcare Services Senior Subordinated Note 12.00%, 7/15/2021 $7,300,000   7,238,831   6,989,750   5.5

Zest Holdings, LLC (d)

 Healthcare Services Syndicated Loan (L+4.75%), 5.80% Cash, 8/17/2020 $4,136,911   4,085,888   4,183,658   3.3
    

 

 

  

 

 

  

 

 

 
  Total Healthcare Services   38,864,269   38,543,963   30.3
    

 

 

  

 

 

  

 

 

 

HMN Holdco, LLC

 Media First Lien Term Loan 12.00% Cash, 7/8/2021 $8,462,482   8,376,876   8,462,482   6.6

HMN Holdco, LLC

 Media Delayed Draw First Lien Term Loan 12.00% Cash, 7/8/2021 $4,800,000   4,751,258   4,800,000   3.8

HMN Holdco, LLC (g)

 Media Class A Series, Expires 1/16/2025  4,264   61,647   294,770   0.2

HMN Holdco, LLC (g)

 Media Class A Warrant, Expires 1/16/2025  30,320   438,353   1,706,410   1.3

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests (Common), Expires 5/16/2024  57,872   —     2,961,310   2.3

HMN Holdco, LLC (g)

 Media Warrants to Purchase Limited Liability Company Interests (Preferred), Expires 5/16/2024  8,139   —     473,690   0.4
    

 

 

  

 

 

  

 

 

 
  Total Media   13,628,134   18,698,662   14.6
    

 

 

  

 

 

  

 

 

 

Elyria Foundry Company, L.L.C. (d), (g)

 Metals Common Stock  35,000   9,217,564   413,350   0.3

Elyria Foundry Company, L.L.C. (d)

 Metals Second Lien Term Loan 15.00% PIK, 8/10/2022 $437,500   437,500   437,500   0.4
    

 

 

  

 

 

  

 

 

 
  Total Metals   9,655,064   850,850   0.7
    

 

 

  

 

 

  

 

 

 

Mercury Network, LLC

 Real Estate First Lien Term Loan (L+9.50%), 10.55% Cash, 8/24/2021 $15,773,875   15,644,382   15,773,875   12.4

Mercury Network, LLC (g)

 Real Estate Common Stock  413,043   413,043   1,065,651   0.8
    

 

 

  

 

 

  

 

 

 
  Total Real Estate   16,057,425   16,839,526   13.2
    

 

 

  

 

 

  

 

 

 

Sub Total Non-control/Non-affiliated investments

   251,198,896   242,531,514   190.5
    

 

 

  

 

 

  

 

 

 

Control investments - 39.4% (b)

      

Easy Ice, LLC (g)

 Business Services Preferred Equity  5,080,000   8,000,000   8,000,000   6.3

Easy Ice, LLC (d), (f)

 Business Services First Lien Term Loan (L+10.25%), 11.02% Cash, 1/15/2020 $26,680,000   26,464,162   26,680,000   20.9
    

 

 

  

 

 

  

 

 

 
  Total Business Services   34,464,162   34,680,000   27.2
    

 

 

  

 

 

  

 

 

 

Saratoga Investment Corp. CLO 2013-1, Ltd. (a), (d), (e), (f)

 Structured Finance Securities Other/Structured Finance Securities 14.87%, 10/20/2025 $30,000,000   10,319,374   10,950,249   8.7

Saratoga Investment Corp. Class F Note (a), (d), (f)

 Structured Finance Securities Other/Structured Finance Securities (L+8.50%), 9.55%, 10/20/2025 $4,500,000   4,500,000   4,499,550   3.5
    

 

 

  

 

 

  

 

 

 
  Total Structured Finance Securities   14,819,374   15,449,799   12.2
    

 

 

  

 

 

  

 

 

 

Sub Total Control investments

     49,283,536   50,129,799   39.4
    

 

 

  

 

 

  

 

 

 

TOTAL INVESTMENTS - 229.9% (b)

    $300,482,432  $292,661,313   229.9
    

 

 

  

 

 

  

 

 

 
      Principal  Cost  Fair Value  % of
Net Assets
 

Cash and cash equivalents and cash and cash equivalents, reserve accounts - 17.4% (b)

    

U.S. Bank Money Market (k)

   $22,087,968  $22,087,968  $22,087,968   17.4
   

 

 

  

 

 

  

 

 

  

 

 

 

Total cash and cash equivalents and cash and cash equivalents, reserve accounts

 $22,087,968  $22,087,968  $22,087,968   17.4
   

 

 

  

 

 

  

 

 

  

 

 

 

 

(a)Represents a non-qualifying investment as defined under Section 55(a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 5.3% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b)Percentages are based on net assets of $127,294,777 as of February 28, 2017.
(c)Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors (see Note 3 to the consolidated financial statements).
(d)These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e)This investment does not have a stated interest rate that is payable thereon. As a result, the 14.87% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f)As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

 

           Sales
(Cost)
   Interest
Income
   Management
Fee Income
   Net
Realized

Gains
(Losses)
   Net Unrealized
Appreciation
(Depreciation)
 

Company

  Purchases   Redemptions           

Easy Ice, LLC

  $20,553,200   $—     $—     $217,362   $—     $—     $283,226 

Saratoga Investment Corp. CLO 2013-1, Ltd.

  $—     $—     $—     $1,941,914   $1,499,001   $—     $833,646 

Saratoga Investment Corp. Class F Note

  $4,500,000   $—     $—     $122,121   $—     $—     $(450
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(g)Non-income producing at February 28, 2017.
(h)Includes securities issued by an affiliate of the company.
(i)The investment has an unfunded commitment as of February 28, 2017 (see Note 7 to the consolidated financial statements).
(j)The entire commitment was unfunded at February 28, 2017. As such, no interest is being earned on this investment.
(k)Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s Consolidated Statements of Assets and Liabilities as of February 28, 2017.

 

6


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)

 

   For the three months ended
May 31, 2017
  For the three months ended
May 31, 2016
 

INCREASE FROM OPERATIONS:

   

Net investment income

  $3,504,449  $2,538,549 

Net realized gain from investments

   95,589   6,102,905 

Net unrealized depreciation on investments

   (2,585,951  (5,353,867
  

 

 

  

 

 

 

Net increase in net assets from operations

   1,014,087   3,287,587 
  

 

 

  

 

 

 

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:

   

Distributions declared

   (2,665,516  (2,346,311
  

 

 

  

 

 

 

Net decrease in net assets from shareholder distributions

   (2,665,516  (2,346,311
  

 

 

  

 

 

 

CAPITAL SHARE TRANSACTIONS:

   

Proceeds from issuance of common stock

   1,367,168   —   

Stock dividend distribution

   622,088   1,750,901 

Repurchases of common stock

   —     (713,184

Offering costs

   (23,951  —   
  

 

 

  

 

 

 

Net increase in net assets from capital share transactions

   1,965,305   1,037,717 
  

 

 

  

 

 

 

Total increase in net assets

   313,876   1,978,993 

Net assets at beginning of period

   127,294,777   125,149,875 
  

 

 

  

 

 

 

Net assets at end of period

  $127,608,653  $127,128,868 
  

 

 

  

 

 

 

Net asset value per common share

  $21.69  $22.11 

Common shares outstanding at end of period

   5,884,475   5,750,222 

Distribution in excess of net investment income

  $(26,898,415 $(26,025,665

See accompanying notes to consolidated financial statements.

 

7


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

 

   For the three months ended
May 31, 2017
  For the three months ended
May 31, 2016
 

Operating activities

   

NET INCREASE IN NET ASSETS FROM OPERATIONS

  $1,014,087  $3,287,587 

ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES:

   

Payment-in-kind interest income

   (261,677  (134,256

Net accretion of discount on investments

   (168,970  (136,568

Amortization of deferred debt financing costs

   236,124   262,663 

Net realized gain from investments

   (95,589  (6,102,905

Net unrealized depreciation on investments

   2,585,951   5,353,867 

Proceeds from sales and repayments of investments

   5,876,640   20,588,570 

Purchase of investments

   (44,964,990  —   

(Increase) decrease in operating assets:

   

Interest receivable

   (358,485  (246,128

Management and incentive fee receivable

   (105,378  (478

Other assets

   1,938   (9,834

Receivable from unsettled trades

   —     300,000 

Increase (decrease) in operating liabilities:

   

Base management and incentive fees payable

   (1,821,732  159,089 

Accounts payable and accrued expenses

   64,171   82,384 

Interest and debt fees payable

   (958,745  (513,146

Payable for repurchases of common stock

   —     15,930 

Directors fees payable

   —     22,500 

Due to manager

   (52,200  6,977 
  

 

 

  

 

 

 

NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

   (39,008,855  22,936,252 
  

 

 

  

 

 

 

Financing activities

   

Borrowings on debt

   46,500,000   —   

Payments of deferred debt financing costs

   (1,108,645  (313,400

Proceeds from issuance of common stock

   1,367,168   —   

Payments of offering costs

   (20,504  —   

Repurchases of common stock

   —     (713,184

Payments of cash dividends

   (2,043,428  (1,471,009
  

 

 

  

 

 

 

NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

   44,694,591   (2,497,593
  

 

 

  

 

 

 

NET INCREASE IN CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS

   5,685,736   20,438,659 

CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, BEGINNING OF PERIOD

   22,087,968   7,034,783 
  

 

 

  

 

 

 

CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, END OF PERIOD

  $27,773,704  $27,473,442 
  

 

 

  

 

 

 

Supplemental information:

   

Interest paid during the period

  $3,246,228  $2,618,539 

Cash paid for taxes

  $54,084  $140,029 

Supplemental non-cash information:

   

Payment-in-kind interest income

  $261,677  $134,256 

Net accretion of discount on investments

  $168,970  $136,568 

Amortization of deferred debt financing costs

  $236,124  $262,663 

Stock dividend distribution

  $622,088  $1,750,901 

See accompanying notes to consolidated financial statements.

 

8


Table of Contents

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

May 31, 2017

(unaudited)

Note 1. Organization

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). The Company commenced operations on March 23, 2007 as GSC Investment Corp. and completed the initial public offering (“IPO”) on March 28, 2007. The Company has elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). The Company expects to continue to qualify and to elect to be treated, for tax purposes, as a RIC. The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation from its investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in connection with the consummation of a recapitalization transaction.

The Company is externally managed and advised by the investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant to a management agreement (the “Management Agreement”). Prior to July 30, 2010, the Company was managed and advised by GSCP (NJ), L.P.

The Company has established wholly-owned subsidiaries, SIA Avionte, Inc., SIA Easy Ice, LLC, SIA GH, Inc., SIA Mercury, Inc., SIA TT Inc., and SIA Vector Inc., which are structured as Delaware entities, or tax blockers, to hold equity or equity-like investments in portfolio companies organized as limited liability companies, or LLCs (or other forms of pass through entities). Tax blockers are consolidated for accounting purposes, but are not consolidated for income tax purposes and may incur income tax expense as a result of their ownership of portfolio companies.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

On April 2, 2015, the SBA issued a “green light” letter inviting the Company to continue the application process to obtain a license to form and operate its second SBIC subsidiary. On September 27, 2016, the SBA informed us that as part of their continued review of our application for a second license, and in order to ensure that they were reviewing the most current information available, we would need to update all previously submitted materials and invited us to reapply. As a result of this request, with which we are in the process of complying, the existing “green light” letter that the SBA issued to us has expired. If approved in the future, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue up to $150.0 million of additional SBA-guaranteed debentures in addition to the $150.0 million already approved under the first license.

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with generally accepted accounting principles (“U.S. GAAP”), are stated in U.S. Dollars and include the accounts of the Company

 

9


Table of Contents

and its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC), SBIC LP, SIA Avionte, Inc., SIA Easy Ice, LLC, SIA GH, Inc., SIA Mercury, Inc., SIA TT Inc., and SIA Vector Inc. All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

The Company and SBIC LP are both considered to be investment companies for financial reporting purposes and have applied the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services — Investment Companies (“ASC 946”). There have been no changes to the Company or SBIC LP’s status as investment companies during the three months ended May 31, 2017.

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as, a money market fund if such investment would cause the Company to exceed any of the following limitations:

 

  we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

 

  we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets, except as allowed pursuant to Rule 12d1-1 of Section 12(d)(1) of the 1940 Act which is designed to permit “cash sweep” arrangements rather than investments directly in short-term instruments; or

 

  we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

As of May 31, 2017, the Company did not exceed any of these limitations.

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds, representing payments received on secured investments or other reserved amounts associated with the Company’s $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

In addition, cash and cash equivalents, reserve accounts also include amounts held in designated bank accounts, in the form of cash and short-term liquid investments in money market funds, within our wholly-owned subsidiary, SBIC LP.

In November 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”). ASU 2016-18 requires that the statements of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. Therefore, amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statements of cash flows. The new guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, and early adoption is permitted and is to be applied on a retrospective basis. The Company has adopted the provisions of ASU 2016-18 as of November 30, 2016. The adoption of the provisions of ASU 2016-18 did not materially impact the Company’s consolidated financial position or results of operations. Prior period amounts were reclassified to conform to the current period presentation.

The following table provides a reconciliation of cash and cash equivalents and cash and cash equivalents, reserve accounts reported within the consolidated statements of assets and liabilities that sum to the total of the same such amounts shown in the consolidated statements of cash flows:

 

10


Table of Contents
   May 31,
2017
   May 31,
2016
 

Cash and cash equivalents

  $ 1,246,815   $ 1,309,111 

Cash and cash equivalents, reserve accounts

   26,526,889    26,164,331 
  

 

 

   

 

 

 

Total cash and cash equivalents, and cash and cash equivalents, reserve accounts

  $27,773,704   $27,473,442 
  

 

 

   

 

 

 

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the FASB ASC Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

The Company undertakes a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

  Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

  An independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year.

In addition, all our investments are subject to the following valuation process:

 

  The audit committee of our board of directors reviews and approves each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

  Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

The Company’s investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for

 

11


Table of Contents

equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. The Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. The Company’s net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Derivative Financial Instruments

The Company accounts for derivative financial instruments in accordance with ASC Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Other Income

Other income includes dividends received, origination fees, structuring fees and advisory fees, and is recorded in the consolidated statements of operations when earned.

Payment-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility and notes are deferred and amortized using the straight line method over the life of the respective facility and debt securities. Financing costs incurred in connection with our SBA debentures are deferred and amortized using the effective yield method over the life of the debentures.

 

12


Table of Contents

ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs (“ASU 2015-03”) requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The Company has adopted the provisions of ASU 2015-03 as of February 28, 2015, by reclassifying deferred debt financing costs from within total assets to within total liabilities as a contra-liability. Prior period amounts were reclassified to conform to the current period presentation.

Contingencies

In the ordinary course of business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote. Therefore, the Company has not accrued any liabilities in connection with such indemnifications.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has filed an election to be treated for tax purposes as a RIC under the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes.

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least 98.0% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.

In accordance with certain applicable U.S. Treasury regulations and private letter rulings issued by the Internal Revenue Service (“IRS”), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

ASC 740, Income Taxes, (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense on the consolidated statements of operations. During the fiscal year ended February 28, 2017, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2014, 2015 and 2016 federal tax years for the Company remain subject to examination by the IRS. As of May 31, 2017 and February 28, 2017, there were no uncertain tax positions. The Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change significantly in the next 12 months.

 

13


Table of Contents

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations, relating to the capital gains incentive fee payable on the consolidated statements of assets and liabilities, by the Company to its investment adviser when the net realized and unrealized gain on its investments exceed all net realized and unrealized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains net of realized and unrealized losses for the period.

New Accounting Pronouncements

In October 2016, the U.S. Securities and Exchange Commission (“SEC”) adopted new rules and amended existing rules (together, “final rules”) intended to modernize the reporting and disclosure of information by registered investment companies. In part, the final rules amend Regulation S-X and require standardized, enhanced disclosures about derivatives in investment company financial statements, as well as other amendments. The compliance date for the amendments to Regulation S-X is August 1, 2017. Management is currently evaluating the impact that the adoption of the amendments to Regulation S-X will have on the Company’s consolidated financial statements and related disclosures.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which is intended to reduce the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for annual periods beginning after December 15, 2017, and interim periods therein. Early adoption is permitted. Management is currently evaluating the impact ASU 2016-15 will have on the Company’s consolidated financial statements and disclosures.

In February 2016, the FASB issued ASU 2016-02, Amendments to the Leases (“ASU Topic 842”), which will require for all operating leases the recognition of a right-of-use asset and a lease liability, in the statement of financial position. The lease cost will be allocated over the lease term on a straight-line basis. This guidance is effective for annual and interim periods beginning after December 15, 2018. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments — Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). ASU 2016-01 retains many current requirements for the classification and measurement of financial instruments; however, it significantly revises an entity’s accounting related to (1) the classification and measurement of investments in equity securities and (2) the presentation of certain fair value changes for financial liabilities measured at fair value. ASU 2016-01 also amends certain disclosure requirements associated with the fair value of financial instruments. This guidance is effective for annual and interim periods beginning after December 15, 2017, and early adoption is not permitted for public business entities. Management is currently evaluating the impact the adoption of this standard has on the Company’s consolidated financial statements and disclosures.

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In May 2016, ASU 2016-12 amended ASU 2014-09 and deferred the effective period to December 15, 2017. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

 

14


Table of Contents

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

 

  Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

  Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

 

  Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by a disclaimer would result in classification as a Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

The following table presents fair value measurements of investments, by major class, as of May 31, 2017 (dollars in thousands), according to the fair value hierarchy:

 

   Fair Value Measurements 
   Level 1   Level 2   Level 3   Total 

Syndicated loans

  $—     $—     $9,068   $9,068 

First lien term loans

   —      —      186,015    186,015 

Second lien term loans

   —      —      95,975    95,975 

Structured finance securities

   —      —      16,111    16,111 

Equity interests

   —      —      22,521    22,521 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $—     $—     $329,690   $329,690 
  

 

 

   

 

 

   

 

 

   

 

 

 

 

15


Table of Contents

The following table presents fair value measurements of investments, by major class, as of February 28, 2017 (dollars in thousands), according to the fair value hierarchy:

 

   Fair Value Measurements 
   Level 1   Level 2   Level 3   Total 

Syndicated loans

  $—     $—     $9,823   $9,823 

First lien term loans

   —      —      159,097    159,097 

Second lien term loans

   —      —      87,750    87,750 

Structured finance securities

   —      —      15,450    15,450 

Equity interests

   —      —      20,541    20,541 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $—     $—     $292,661   $292,661 
  

 

 

   

 

 

   

 

 

   

 

 

 

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended May 31, 2017 (dollars in thousands):

 

   Syndicated
loans
  First lien
term loans
  Second
lien
term loans
  Structured
finance
securities
  Equity
interests
  Total 

Balance as of February 28, 2017

  $9,823  $159,097  $87,750  $15,450  $20,541  $292,661 

Net unrealized appreciation (depreciation) on investments

   21   387   (5,855  1,460   1,401   (2,586

Purchases and other adjustments to cost

   6   43,738   1,073   —     579   45,396 

Sales and repayments

   (728  (1,440  (2,786  (799  (124  (5,877

Net realized gain (loss) from investments

   (54  7   19   —     124   96 

Restructures in

   —     —     15,774   —     —     15,774 

Restructures out

   —     (15,774  —     —     —     (15,774
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balance as of May 31, 2017

  $9,068  $186,015  $95,975  $16,111  $22,521  $329,690 
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net change in unrealized appreciation (depreciation) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:

  $21  $387  $(5,855 $1,460  $1,401  $(2,586

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and repayments represent net proceeds received from investments sold, and principal paydowns received, during the period.

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the three months ended May 31, 2016 (dollars in thousands):

 

 

16


Table of Contents
   Syndicated
loans
  First lien
term loans
  Second
lien
term loans
   Structured
finance
securities
  Equity
interests
  Total 

Balance as of February 29, 2016

  $11,868  $144,643  $88,178   $12,828  $26,479  $283,996 

Net unrealized appreciation (depreciation) on investments

   1,242   (363  1,268    583   (8,084  (5,354

Purchases and other adjustments to cost

   26   164   73    —     8   271 

Sales and redemptions

   (95  (13,078  —      (959  (6,457  (20,589

Net realized gain from investments

   1   126   —      —     5,976   6,103 
  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

  

 

 

 

Balance as of May 31, 2016

  $13,042  $131,492  $89,519   $12,452  $17,922  $264,427 
  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

  

 

 

 

Net change in unrealized appreciation (depreciation) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:

  $1,242  $(297 $1,268   $583  $(2,329 $467 
  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

  

 

 

 

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and repayments represent net proceeds received from investments sold, and principal paydowns received, during the period.

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of May 31, 2017 were as follows (dollars in thousands):

 

   Fair Value   Valuation Technique  Unobservable Input  Range

Syndicated loans

  $9,068   Market Comparables  Third-Party Bid (%)  100.5%  - 101.1%

First lien term loans

   186,015   Market Comparables  Market Yield (%)  6.4%  - 13.9%
      EBITDA Multiples (x)  3.0x  - 5.5x
      Third-Party Bid (%)  100%  - 100.5%

Second lien term loans

   95,975   Market Comparables  Market Yield (%)  9.2%  - 90.3%
      Third-Party Bid (%)  97.6%  - 99.8%

Structured finance securities

   16,111   Discounted Cash Flow  Discount Rate (%)  8.0%  - 13.0%

Equity interests

   22,521   Market Comparables  EBITDA Multiples (x)  3.7x  - 16.3x

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2017 were as follows (dollars in thousands):

 

   Fair Value   Valuation Technique  Unobservable Input  Range

Syndicated loans

  $9,823   Market Comparables  Third-Party Bid (%)  100.5% - 101.1%

First lien term loans

   159,097   Market Comparables  Market Yield (%)  6.3% - 39.0%
      EBITDA Multiples (x)  3.0x - 10.3x
      Third-Party Bid (%)  100.0% - 100.2%

Second lien term loans

   87,750   Market Comparables  Market Yield (%)  10.1% - 26.4%
      Third-Party Bid (%)  97.6% - 99.9%

Structured finance securities

   15,450   Discounted Cash Flow  Discount Rate (%)  8.5% - 13.0%

Equity interests

   20,541   Market Comparables  EBITDA Multiples (x)  3.7x - 12.0x

 

17


Table of Contents

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDA or revenue valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, in isolation, would result in a significantly lower (higher) fair value measurement. For investments utilizing a market quote in deriving a value, a significant increase (decrease) in the market quote, in isolation, would result in a significantly higher (lower) fair value measurement.

The composition of our investments as of May 31, 2017, at amortized cost and fair value was as follows (dollars in thousands):

 

   Investments at
Amortized Cost
   Amortized Cost
Percentage of

Total Portfolio
  Investments at
Fair Value
   Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

  $8,892    2.6 $9,068    2.8

First lien term loans

   187,097    55.0   186,015    56.4 

Second lien term loans

   104,605    30.8   95,975    29.1 

Structured finance securities

   14,020    4.1   16,111    4.9 

Equity interests

   25,483    7.5   22,521    6.8 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $340,097    100.0 $329,690    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

The composition of our investments as of February 28, 2017, at amortized cost and fair value was as follows (dollars in thousands):

 

   Investments at
Amortized Cost
   Amortized Cost
Percentage of
Total Portfolio
  Investments at
Fair Value
   Fair Value
Percentage of
Total Portfolio
 

Syndicated loans

  $9,669    3.2 $9,823    3.4

First lien term loans

   160,436    53.4   159,097    54.3 

Second lien term loans

   90,655    30.2   87,750    30.0 

Structured finance securities

   14,819    4.9   15,450    5.3 

Equity interests

   24,903    8.3   20,541    7.0 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $300,482    100.0 $292,661    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, we determine the fair value based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

 

18


Table of Contents

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. In connection with the refinancing of the Saratoga CLO liabilities, we ran Intex models based on assumptions about the refinanced Saratoga CLO’s structure, including capital structure, cost of liabilities and reinvestment period. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at May 31, 2017. The significant inputs at May 31, 2017 for the valuation model include:

 

  Default rates: 2.0%

 

  Recovery rates: 35-70%

 

  Discount rate: 13.0%

 

  Prepayment rate: 20.0%

 

  Reinvestment rate / price: L+350bps / $99.75.

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

On January 22, 2008, the Company invested $30.0 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by the Company that invests primarily in senior secured loans. Additionally, the Company entered into a collateral management agreement with GSC Investment Corp. CLO 2007, Ltd. pursuant to which we act as collateral manager to it. The Saratoga CLO was initially refinanced in October 2013 and its reinvestment period ended in October 2016. On November 15, 2016, the Company completed the second refinancing of the Saratoga CLO. The Saratoga CLO refinancing, among other things, extended its reinvestment period to October 2018, and extended its legal maturity date to October 2025. Following the refinancing, the Saratoga CLO portfolio remained at the same size and with a similar capital structure of approximately $300.0 million in aggregate principal amount of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we also purchased $4.5 million in aggregate principal amount of the Class F notes tranche of the Saratoga CLO at par, with a coupon of LIBOR plus 8.5%.

The Saratoga CLO remains 100.0% owned and managed by Saratoga Investment Corp. Following the refinancing, the Company receives a base management fee of 0.10% and a subordinated management fee of 0.40% of the fee basis amount at the beginning of the collection period, paid quarterly to the extent of available proceeds. The Company is also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%. For the three months ended May 31, 2017 and May 31, 2016, we accrued $0.4 million and $0.4 million in management fee income, respectively, and $0.5 million and $0.5 million in interest income, respectively, from Saratoga CLO. For the three months ended May 31, 2017, we accrued $0.1 million related to the incentive management fee from Saratoga CLO. For the three months ended May 31, 2016, we did not accrue any amounts related to the incentive management fee from Saratoga CLO as the 12.0% hurdle rate has not yet been achieved.

As of May 31, 2017, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $11.6 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. As of May 31, 2017, Saratoga CLO had investments with a principal balance of $299.3 million and a weighted average spread over LIBOR of 4.0%, and had debt with a principal balance of $282.4 million with a weighted average spread over LIBOR of 2.4%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At May 31, 2017, the present value of the projected future cash flows of the subordinated notes was approximately $11.8 million, using a 13.0% discount rate. Saratoga Investment Corp. invested $32.8 million into the CLO since January 2008, and to date has since received distributions of $50.6 million and management fees of $16.9 million.

Below is certain financial information from the separate financial statements of Saratoga CLO as of May 31, 2017 (unaudited) and February 28, 2017 and for the three months ended May 31, 2017 (unaudited) and May 31, 2016 (unaudited).

 

19


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

 

   As of 
   May 31, 2017  February 28, 2017 
   (unaudited)    

ASSETS

   

Investments

   

Fair Value Loans (amortized cost of $296,570,507 and $294,270,284, respectively)

  $294,679,202  $292,437,930 

Fair Value Other/Structured finance securities (amortized cost of $3,531,218 and
$3,531,218, respectively)

   33,902   22,718 
  

 

 

  

 

 

 

Total investments at fair value (amortized cost of $300,101,725 and $297,801,502, respectively)

   294,713,104   292,460,648 

Cash and cash equivalents

   7,039,670   13,046,555 

Receivable from open trades

   7,927,175   1,505,000 

Interest receivable

   1,337,584   1,443,865 

Other assets

   —     6,049 
  

 

 

  

 

 

 

Total assets

  $311,017,533  $308,462,117 
  

 

 

  

 

 

 

LIABILITIES

   

Interest payable

  $1,084,119  $1,031,457 

Payable from open trades

   11,603,306   9,431,552 

Accrued base management fee

   34,238   34,221 

Accrued subordinated management fee

   136,951   136,885 

Accrued incentive fee

   105,295   —   

Class A-1 Notes - SIC CLO 2013-1, Ltd.

   170,000,000   170,000,000 

Class A-2 Notes - SIC CLO 2013-1, Ltd.

   20,000,000   20,000,000 

Class B Notes - SIC CLO 2013-1, Ltd.

   44,800,000   44,800,000 

Class C Notes - SIC CLO 2013-1, Ltd.

   16,000,000   16,000,000 

Discount on Class C Notes - SIC CLO 2013-1, Ltd.

   (75,111  (77,383

Class D Notes - SIC CLO 2013-1, Ltd.

   14,000,000   14,000,000 

Discount on Class D Notes - SIC CLO 2013-1, Ltd.

   (348,703  (359,249

Class E Notes - SIC CLO 2013-1, Ltd.

   13,100,000   13,100,000 

Class F Notes - SIC CLO 2013-1, Ltd.

   4,500,000   4,500,000 

Deferred debt financing costs, SIC CLO 2013-1, Ltd. Notes

   (1,108,709  (1,161,590

Subordinated Notes

   30,000,000   30,000,000 
  

 

 

  

 

 

 

Total liabilities

  $323,831,386  $321,435,893 
  

 

 

  

 

 

 

Commitments and contingencies

   

NET ASSETS

   

Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively

  $250  $250 

Accumulated loss

   (12,974,026  (21,557,618

Net gain

   159,923   8,583,592 
  

 

 

  

 

 

 

Total net assets

   (12,813,853  (12,973,776
  

 

 

  

 

 

 

Total liabilities and net assets

  $311,017,533  $308,462,117 
  

 

 

  

 

 

 

 

20


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)

 

   For the three months ended
May 31
 
   2017  2016 

INVESTMENT INCOME

   

Interest from investments

  $3,977,871  $3,788,336 

Interest from cash and cash equivalents

   5,083   771 

Other income

   160,614   243,301 
  

 

 

  

 

 

 

Total investment income

   4,143,568   4,032,408 
  

 

 

  

 

 

 

EXPENSES

   

Interest expense

   3,623,558   3,281,015 

Professional fees

   34,551   18,482 

Miscellaneous fee expense

   10,126   8,244 

Base management fee

   75,136   186,842 

Subordinated management fee

   300,545   186,842 

Incentive fees

   105,295   —   

Trustee expenses

   36,168   26,688 

Amortization expense

   44,357   239,963 
  

 

 

  

 

 

 

Total expenses

   4,229,736   3,948,076 
  

 

 

  

 

 

 

NET INVESTMENT INCOME (LOSS)

   (86,168  84,332 
  

 

 

  

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

   

Net realized gain on investments

   293,858   55,562 

Net unrealized appreciation (depreciation) on investments

   (47,767  9,320,673 
  

 

 

  

 

 

 

Net gain on investments

   246,091   9,376,235 
  

 

 

  

 

 

 

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $159,923  $9,460,567 
  

 

 

  

 

 

 

 

21


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

May 31, 2017

(unaudited)

 

Issuer Name

 

Industry

 

Asset Name

 Asset
Type
 Spread  LIBOR
Floor
  PIK  Current
Rate
(All In)
  Maturity
Date
  Principal/
Number
of Shares
  Cost  Fair Value 

Education Management II, LLC

 Leisure Goods/Activities/Movies A-1 Preferred Shares Equity  0.00  0.00  0.00  0.00   6,692  $669,214  $13,384 

Education Management II, LLC

 Leisure Goods/Activities/Movies A-2 Preferred Shares Equity  0.00  0.00  0.00  0.00   18,975   1,897,538   76 

New Millennium Holdco, Inc.

 Healthcare & Pharmaceuticals Common Stock Equity  0.00  0.00  0.00  0.00   14,813   964,466   20,442 

24 Hour Holdings III, LLC

 Leisure Goods/Activities/Movies Term Loan Loan  3.75  1.00  0.00  4.90  5/28/2021  $486,250   483,268   483,211 

ABB Con-Cise Optical Group, LLC

 Healthcare & Pharmaceuticals Term Loan B Loan  5.00  1.00  0.00  6.10  6/15/2023  $1,990,000   1,970,291   2,007,413 

Acosta Holdco, Inc.

 Media Term Loan B1 Loan  3.25  1.00  0.00  4.29  9/26/2021  $1,940,025   1,929,835   1,806,997 

Advantage Sales & Marketing, Inc.

 Services: Business Delayed Draw Term Loan Loan  3.25  1.00  0.00  4.29  7/25/2021  $2,439,950   2,437,594   2,412,061 

Aegis Toxicology Science Corporation

 Healthcare & Pharmaceuticals Term B Loan Loan  4.50  1.00  0.00  5.66  2/24/2021  $2,457,233   2,337,953   2,440,843 

Agrofresh, Inc.

 Food Services Term Loan Loan  4.75  1.00  0.00  5.90  7/30/2021  $1,965,000   1,957,975   1,953,957 

AI MISTRAL T/L (V. GROUP)

 Utilities Term Loan Loan  3.00  1.00  0.00  4.18  3/11/2024  $500,000   500,000   499,375 

Akorn, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  4.25  1.00  0.00  5.31  4/16/2021  $398,056   397,016   402,534 

Albertson’s LLC

 Retailers (Except Food and Drugs) Term Loan B-4 Loan  3.00  0.75  0.00  4.04  8/25/2021  $2,888,953   2,873,134   2,904,120 

Alere Inc. (fka IM US Holdings, LLC)

 Healthcare & Pharmaceuticals Term Loan B Loan  3.25  1.00  0.00  4.30  6/20/2022  $915,616   913,895   919,050 

Alion Science and Technology Corporation

 High Tech Industries Term Loan B (First Lien) Loan  4.50  1.00  0.00  5.54  8/19/2021  $2,947,500   2,936,726   2,945,054 

Alliance Healthcare Services, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  3.25  1.00  0.00  4.36  6/3/2019  $981,997   978,851   979,542 

ALPHA 3 T/L B1 (ATOTECH)

 Chemicals/Plastics Term Loan B 1 Loan  3.00  1.00  0.00  4.15  1/31/2024  $250,000   249,380   251,173 

Almonde, Inc. (Misys)

 High Tech Industries Term Loan B Loan  3.50  1.00  0.00  4.50  4/26/2024  $1,000,000   995,000   1,001,920 

Anchor Glass T/L (11/16)

 Containers/Glass Products Term Loan Loan  3.25  1.00  0.00  4.25  12/7/2023  $498,750   496,452   502,047 

APCO Holdings, Inc.

 Automotive Term Loan Loan  6.00  1.00  0.00  7.00  1/31/2022  $1,896,081   1,851,847   1,848,679 

Aramark Corporation

 Food Products U.S. Term F Loan Loan  2.00  0.00  0.00  3.05  3/28/2024  $2,000,000   2,000,000   2,013,120 

Arctic Glacier U.S.A., Inc.

 Beverage, Food & Tobacco Term Loan B Loan  4.25  1.00  0.00  5.30  3/20/2024  $500,000   497,543   505,940 

Aspen Dental Management, Inc.

 Healthcare & Pharmaceuticals Term Loan Initial Loan  3.75  1.00  0.00  4.92  4/29/2022  $1,979,905   1,975,830   1,998,477 

Astoria Energy T/L B

 Utilities Term Loan Loan  4.00  1.00  0.00  5.15  12/24/2021  $1,495,307   1,480,752   1,491,569 

Asurion, LLC (fka Asurion Corporation)

 Insurance Replacement Term Loan B-2 Loan  3.25  0.75  0.00  4.29  7/8/2020  $522,122   518,066   525,495 

Asurion, LLC (fka Asurion Corporation)

 Insurance Term Loan B4 (First Lien) Loan  3.25  1.00  0.00  4.29  8/4/2022  $2,391,773   2,380,910   2,405,430 

Auction.com, LLC

 Banking, Finance, Insurance & Real Estate Term Loan Loan  5.00  1.00  0.00  6.05  5/13/2019  $2,711,717   2,711,519   2,728,665 

Avantor Performance Materials Holdings, Inc.

 Chemicals/Plastics Term Loan Loan  4.00  1.00  0.00  5.05  3/8/2024  $3,000,000   2,992,568   3,006,000 

AVOLON TLB BORROWER 1 LUXEMBOURG S.A.R.L.

 Capital Equipment Term Loan B-2 Loan  2.75  0.75  0.00  3.76  3/20/2022  $1,000,000   995,342   1,012,430 

Bass Pro Group, LLC

 Retailers (Except Food and Drugs) Term Loan Loan  3.25  0.75  0.00  4.24  6/5/2020  $1,470,000   1,468,053   1,468,163 

Belmond Interfin Ltd.

 Lodging & Casinos Term Loan Loan  3.00  1.00  0.00  4.15  3/19/2021  $2,473,003   2,476,208   2,476,094 

Blackboard T/L B4

 High Tech Industries Term Loan B4 Loan  5.00  1.00  0.00  6.16  6/30/2021  $2,985,000   2,963,237   2,990,612 

Blucora, Inc.

 High Tech Industries Term Loan B Loan  3.75  1.00  0.00  4.76  5/22/2024  $1,000,000   995,075   1,007,500 

BMC Software

 Technology Term Loan Loan  4.00  1.00  0.00  5.16  9/12/2022  $1,946,210   1,888,314   1,947,436 

BMC Software T/L US

 Technology Term Loan Loan  4.00  1.00  0.00  5.16  9/12/2022  $588,449   578,390   591,056 

Brickman Group Holdings, Inc.

 Brokers/Dealers/Investment Houses Initial Term Loan (First Lien) Loan  3.00  1.00  0.00  4.04  12/18/2020  $1,431,702   1,421,385   1,432,246 

BWAY Holding Company

 Leisure Goods/Activities/Movies Term Loan B Loan  3.25  0.00  0.00  4.25  4/3/2024  $1,000,000   995,071   998,540 

Cable One, Inc.

 Telecommunications Term Loan B Loan  2.25  1.00  0.00  3.43  5/1/2024  $500,000   499,375   503,125 

Candy Intermediate Holdings, Inc.

 Beverage, Food & Tobacco Term Loan Loan  4.50  1.00  0.00  5.65  6/15/2023  $496,250   494,152   470,197 

Capital Automotive L.P.

 Conglomerate Tranche B-1 Term Loan Facility Loan  3.00  1.00  0.00  4.03  3/25/2024  $500,000   497,547   503,905 

Caraustar Industries Inc.

 Forest Products & Paper Term Loan B Loan  5.50  1.00  0.00  6.65  3/14/2022  $500,000   498,761   501,625 

CASA SYSTEMS T/L

 Telecommunications Term Loan Loan  4.00  1.00  0.00  5.04  12/20/2023  $1,496,250   1,482,060   1,499,991 

Catalent Pharma Solutions, Inc

 Drugs Initial Term B Loan Loan  2.75  1.00  0.00  3.79  5/20/2021  $423,560   422,273   427,854 

Cengage Learning Acquisitions, Inc.

 Publishing Term Loan Loan  4.25  1.00  0.00  5.25  6/7/2023  $1,488,750   1,473,865   1,401,107 

CH HOLD (CALIBER COLLISION) T/L

 Automotive Term Loan Loan  3.00  0.00  0.00  4.04  2/1/2024  $227,273   226,761   228,789 

Charter Communications Operating, LLC

 Cable and Satellite Television Term F Loan Loan  2.00  0.00  0.00  3.05  1/3/2021  $1,605,364   1,599,826   1,614,193 

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term G Loan Loan  2.75  1.00  0.00  3.95  12/31/2019  $922,719   901,552   923,181 

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term H Loan Loan  3.00  1.00  0.00  4.20  1/27/2021  $1,697,791   1,644,603   1,697,859 

CITGO Petroleum Corporation

 Oil & Gas Term Loan B Loan  3.50  1.00  0.00  4.65  7/29/2021  $1,959,849   1,942,358   1,960,338 

Communications Sales & Leasing, Inc.

 Telecommunications Term Loan B (First Lien) Loan  3.00  1.00  0.00  4.04  10/24/2022  $1,965,137   1,954,120   1,974,609 

Concordia Healthcare Corporation

 Healthcare & Pharmaceuticals Term Loan B Loan  4.25  1.00  0.00  5.28  10/21/2021  $1,967,500   1,883,686   1,421,519 

Consolidated Aerospace Manufacturing, LLC

 Aerospace and Defense Term Loan (First Lien) Loan  3.75  1.00  0.00  4.80  8/11/2022  $1,418,750   1,413,095   1,369,094 

Consolidated Communications, Inc.

 Telecommunications Term Loan B-2 Loan  3.00  1.00  0.00  4.00  10/5/2023  $500,000   497,500   502,395 

CPI Acquisition Inc.

 Technology Term Loan B (First Lien) Loan  4.50  1.00  0.00  5.83  8/17/2022  $1,436,782   1,419,495   1,250,000 

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

 Electronics/Electric Term B Loan Loan  3.25  1.00  0.00  4.30  4/7/2021  $2,462,342   2,461,788   2,462,342 

Crosby US Acquisition Corporation

 Industrial Equipment Initial Term Loan (First Lien) Loan  3.00  1.00  0.00  4.17  11/23/2020  $725,625   725,152   661,044 

CT Technologies Intermediate Hldgs, Inc

 Healthcare & Pharmaceuticals Term Loan Loan  4.25  1.00  0.00  5.29  12/1/2021  $1,466,381   1,455,744   1,449,884 

Cypress Intermediate Holdings III, Inc.

 Services: Business Term Loan B Loan  3.00  1.00  0.00  4.04  4/29/2024  $500,000   498,776   498,500 

Culligan International Company-T/L

 Conglomerate Term Loan Loan  4.00  1.00  0.00  5.00  12/13/2023  $2,044,875   2,045,149   2,056,388 

Cumulus Media Holdings Inc.

 Broadcast Radio and Television Term Loan Loan  3.25  1.00  0.00  4.30  12/23/2020  $470,093   467,518   372,548 

DAE Aviation (StandardAero)

 Aerospace and Defense Term Loan Loan  3.75  1.00  0.00  4.79  7/7/2022  $2,470,000   2,460,059   2,488,525 

DASEKE T/L (HENNESSY CAPITAL)

 Transportation Term Loan Loan  5.50  1.00  0.00  6.54  2/27/2024  $827,143   820,224   832,313 

DCS Business Services, Inc.

 Financial Intermediaries Term B Loan Loan  7.25  1.50  0.00  8.75  3/19/2018  $1,782,727   1,778,648   1,782,727 

Delta 2 (Lux) S.a.r.l.

 Lodging & Casinos Term Loan B-3 Loan  3.25  1.00  0.00  4.57  2/1/2024  $1,000,000   996,775   1,000,680 

DELL INTERNATIONAL 1ST LIEN T/L

 High Tech Industries Term Loan (01/17) Loan  2.50  0.75  0.00  3.55  9/7/2023  $997,500   996,476   1,003,146 

Deluxe Entertainment Service Group, Inc.

 Leisure Goods/Activities/Movies Term Loan (First Lien) Loan  5.50  1.00  0.00  6.62  2/28/2020  $2,849,297   2,821,745   2,845,735 

DEX MEDIA, INC.

 Media Term Loan (07/16) Loan  10.00  1.00  0.00  11.04  7/29/2021  $35,702   35,702   36,505 

DIGITALGLOBE T/L B (12/16)

 Aerospace and Defense Term Loan B Loan  2.75  0.75  0.00  3.79  1/15/2024  $498,750   497,631   499,373 

DJO Finance, LLC

 Healthcare & Pharmaceuticals Term Loan Loan  3.25  1.00  0.00  4.25  6/8/2020  $491,250   489,802   485,601 

Dole Food Company, Inc.

 Beverage, Food & Tobacco Term Loan B Loan  3.00  1.00  0.00  4.18  4/8/2024  $500,000   497,548   501,965 

DPX Holdings B.V.

 Healthcare & Pharmaceuticals Term Loan 2015 Incr Dollar Loan  3.25  1.00  0.00  4.41  4/22/2024  $2,917,500   2,912,750   2,929,170 

Drew Marine Group, Inc.

 Chemicals/Plastics Term Loan (First Lien) Loan  3.25  1.00  0.00  4.40  11/19/2020  $2,863,470   2,839,806   2,852,731 

DTZ U.S. Borrower, LLC

 Construction & Building Term Loan B Add-on Loan  3.25  1.00  0.00  4.40  11/4/2021  $1,957,576   1,948,917   1,962,019 

DUKE FINANCE (OM GROUP/VECTRA) T/L

 Banking, Finance, Insurance & Real Estate Term Loan Loan  5.00  1.00  0.00  6.15  2/21/2024  $1,500,000   1,399,164   1,514,370 

Edelman Financial Group, Inc.

 Banking, Finance, Insurance & Real Estate Term Loan Loan  5.50  1.00  0.00  6.66  12/19/2022  $1,474,728   1,450,390   1,475,952 

Education Management II, LLC

 Leisure Goods/Activities/Movies Term Loan A Loan  4.50  1.00  0.00  5.66  7/2/2020  $501,970   489,732   221,494 

Education Management II, LLC

 Leisure Goods/Activities/Movies Term Loan B (2.00% Cash/6.50% PIK) Loan  1.00  1.00  6.50  8.66  7/2/2020  $954,307   935,402   11,929 

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (First Lien) Loan  3.50  1.00  0.00  4.54  8/1/2021  $480,602   479,081   485,009 

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (Second Lien) Loan  7.75  1.00  0.00  8.79  8/1/2022  $500,000   498,224   498,595 

Emerald 2 Limited

 Chemicals/Plastics Term Loan B1A Loan  4.00  1.00  0.00  5.15  5/14/2021  $1,000,000   993,241   948,330 

Endo International plc

 Healthcare & Pharmaceuticals Term Loan B Loan  4.25  0.75  0.00  5.31  4/29/2024  $1,000,000   995,089   1,016,880 

Engility Corporation

 Aerospace and Defense Term Loan B-1 Loan  3.25  0.00  0.00  4.29  8/12/2020  $237,500   236,554   239,222 

Equian, LLC

 Services: Business Term Loan B Loan  3.75  1.00  0.00  4.93  5/20/2024  $1,529,412   1,519,428   1,533,235 

Evergreen Acqco 1 LP

 Retailers (Except Food and Drugs) New Term Loan Loan  3.75  1.25  0.00  5.00  7/9/2019  $952,613   951,841   869,259 

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

 Industrial Equipment Term Loan (First Lien) Loan  3.75  1.00  0.00  4.90  1/15/2021  $1,942,311   1,939,288   1,949,595 

EWT Holdings III Corp.

 Capital Equipment Term Loan Loan  4.50  1.00  0.00  5.65  1/15/2021  $990,000   982,363   996,188 

Extreme Reach, Inc.

 Media Term Loan B Loan  6.25  1.00  0.00  7.30  2/7/2020  $2,831,250   2,806,680   2,873,719 

Federal-Mogul Corporation

 Automotive Tranche C Term Loan Loan  3.75  1.00  0.00  4.75  4/15/2021  $2,917,500   2,906,685   2,926,369 

First Data Corporation

 Financial Intermediaries First Data T/L Ext (2021) Loan  2.50  0.00  0.00  3.53  4/26/2024  $1,886,914   1,809,171   1,896,651 

First Eagle Investment Management

 Banking, Finance, Insurance & Real Estate Term Loan Loan  3.50  0.75  0.00  4.66  12/1/2022  $2,481,250   2,452,109   2,512,266 

Fitness International, LLC

 Leisure Goods/Activities/Movies Term Loan B Loan  4.25  1.00  0.00  5.40  7/1/2020  $1,624,755   1,604,627   1,643,716 

Gardner Denver, Inc.

 High Tech Industries Initial Dollar Term Loan Loan  3.25  1.00  0.00  4.57  7/30/2020  $2,054,505   2,051,123   2,058,614 

Gates Global LLC

 Leisure Goods/Activities/Movies Term Loan (First Lien) Loan  3.25  1.00  0.00  4.41  4/1/2024  $349,886   346,468   351,233 

General Nutrition Centers, Inc.

 Retailers (Except Food and Drugs) Amended Tranche B Term Loan Loan  2.50  0.75  0.00  3.55  3/4/2019  $2,047,169   2,044,152   1,841,715 

GLOBALLOGIC HOLDINGS INC TERM LOAN B

 Services: Business Term Loan B Loan  4.50  1.00  0.00  5.65  6/20/2022  $500,000   495,340   503,125 

Global Tel*Link Corporation

 Services: Business Term Loan (First Lien) Loan  3.75  1.25  0.00  5.00  5/26/2020  $2,641,595   2,635,582   2,640,486 

Goodyear Tire & Rubber Company, The

 Chemicals/Plastics Loan (Second Lien) Loan  2.00  0.00  0.00  3.00  4/30/2019  $1,833,333   1,822,047   1,844,792 

Grosvenor Capital Management Holdings, LP

 Brokers/Dealers/Investment Houses Initial Term Loan Loan  3.00  1.00  0.00  4.04  8/18/2023  $1,000,000   995,091   1,002,500 

GTCR Valor Companies, Inc.

 Services: Business Term Loan B Loan  6.00  1.00  0.00  7.15  6/16/2023  $1,488,751   1,434,934   1,498,800 

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

 Publishing Tranche B-4 Term Loan Loan  5.50  1.00  0.00  6.65  2/9/2022  $2,162,357   2,105,279   2,160,195 

Hargray Communications Group, Inc.

 Media Term Loan B Loan  3.00  1.00  0.00  4.03  2/9/2022  $1,000,000   997,509   1,001,500 

Helix Gen Funding, LLC

 Utilities Term Loan B Loan  3.75  1.00  0.00  4.96  5/3/2024  $479,104   476,709   479,104 

Highline Aftermarket Acquisition, LLC

 Automotive Term Loan B Loan  4.25  1.00  0.00  5.31  3/15/2024  $1,000,000   995,000   1,005,000 

Help/Systems Holdings, Inc.

 High Tech Industries Term Loan Loan  5.25  1.00  0.00  6.40  10/8/2021  $1,481,250   1,432,668   1,482,479 

Hemisphere Media Holdings, LLC

 Media Term Loan B Loan  3.50  0.00  0.00  4.54  2/14/2024  $2,493,750   2,506,145   2,496,867 

Herbalife T/L B (HLF Financing)

 Drugs Term Loan B Loan  5.50  0.75  0.00  6.54  2/15/2023  $2,000,000   1,985,640   2,010,840 

Hercules Achievement Holdings, Inc.

 Retailers (Except Food and Drugs) Term Loan B Loan  4.00  1.00  0.00  5.00  12/10/2021  $246,222   244,291   247,497 

Hoffmaster Group, Inc.

 Containers/Glass Products Term Loan Loan  4.50  1.00  0.00  5.54  11/21/2023  $997,500   1,001,241   1,008,722 

Hostess Brand, LLC

 Beverage, Food & Tobacco Term Loan B (First Lien) Loan  2.50  0.75  0.00  3.54  8/3/2022  $1,486,275   1,482,559   1,496,619 

HUB International Limited

 Banking, Finance, Insurance & Real Estate Term Loan B Loan  3.25  1.00  0.00  4.42  10/2/2022  $748,072   748,072   751,932 

Huntsman International LLC

 Chemicals/Plastics Term Loan B (First Lien) Loan  3.00  0.70  0.00  4.04  4/19/2019  $1,021,487   1,017,292   1,027,023 

Husky Injection Molding Systems Ltd.

 Services: Business Term Loan B Loan  3.25  1.00  0.00  4.29  6/30/2021  $449,208   447,231   452,690 

Hyland Software, Inc.

 High Tech Industries Term Loan B Loan  3.25  0.75  0.00  4.00  7/1/2022  $1,000,000   997,500   1,000,000 

Hyperion Refinance T/L

 Banking, Finance, Insurance & Real Estate Term Loan Loan  4.00  1.00  0.00  5.06  4/29/2022  $1,881,998   1,859,264   1,881,998 

ICSH Parent, Inc.

 Containers/Glass Products Term Loan Loan  4.00  1.00  0.00  5.18  4/29/2024  $847,059   842,847   844,941 

IG Investments Holdings, LLC

 Services: Business Term Loan Loan  4.00  1.00  0.00  5.08  10/29/2021  $3,441,142   3,425,616   3,466,950 

Imagine! Print Solutions, Inc.

 Media Term Loan B Loan  6.00  1.00  0.00  7.15  3/30/2022  $495,000   488,876   495,619 

Infor US (Lawson) T/L B-6

 Services: Business Term Loan B-6 Loan  2.75  1.00  0.00  3.90  2/1/2022  $1,609,802   1,596,120   1,605,986 

Informatica Corporation

 High Tech Industries Term Loan B Loan  3.50  1.00  0.00  4.65  8/5/2022  $485,671   484,711   485,215 

Inmar, Inc.

 Services: Business Term Loan B Loan  3.50  1.00  0.00  4.67  5/1/2024  $500,000   495,040   500,625 

ION Media T/L B

 Media Term Loan B Loan  3.50  1.00  0.00  4.50  12/18/2020  $500,000   497,761   505,000 

J. Crew Group, Inc.

 Retailers (Except Food and Drugs) Term B-1 Loan Retired 03/05/2014 Loan  3.00  1.00  0.00  4.00  3/5/2021  $943,325   943,325   642,131 

Jazz Acquisition, Inc

 Aerospace and Defense First Lien 6/14 Loan  3.50  1.00  0.00  4.65  6/19/2021  $486,667   485,937   472,067 

J.Jill Group, Inc.

 Retailers (Except Food and Drugs) Term Loan (First Lien) Loan  5.00  1.00  0.00  6.18  5/9/2022  $948,238   944,632   923,745 

Kinetic Concepts, Inc.

 Healthcare & Pharmaceuticals Term Loan F-1 Loan  3.25  1.00  0.00  4.40  2/2/2024  $2,400,000   2,389,073   2,366,256 

Koosharem, LLC

 Services: Business Term Loan Loan  6.50  1.00  0.00  7.54  5/15/2020  $2,927,613   2,911,567   2,710,969 

Kraton Polymers, LLC

 Chemicals/Plastics Term Loan (Initial) Loan  4.00  1.00  0.00  5.05  1/6/2022  $1,733,177   1,592,433   1,754,703 

Lannett Company T/L A

 Healthcare & Pharmaceuticals Term Loan A Loan  4.75  1.00  0.00  5.79  11/25/2020  $986,842   959,754   976,974 

Lannett Company, Inc.

 Healthcare & Pharmaceuticals Term Loan B Loan  5.38  1.00  0.00  6.42  11/25/2022  $1,875,000   1,820,609   1,860,938 

LEARFIELD COMMUNICATIONS INITIAL T/L (A-L PARENT)

 Healthcare & Pharmaceuticals Initial Term Loan (A-L Parent) Loan  3.25  1.00  0.00  4.30  12/1/2023  $498,750   496,523   504,361 

Lightstone Generation T/L B

 Utilities Term Loan B Loan  4.50  1.00  0.00  5.54  1/30/2024  $57,971   56,838   56,667 

Lightstone Generation T/L C

 Utilities Term Loan C Loan  4.50  1.00  0.00  5.54  1/30/2024  $939,674   921,338   918,531 

Limetree Bay Terminals T/L (01/17)

 Oil & Gas Term Loan Loan  5.00  1.00  0.00  6.00  2/15/2024  $500,000   495,258   504,375 

LPL Holdings

 Banking, Finance, Insurance & Real Estate Term Loan B (2022) Loan  2.50  0.00  0.00  3.61  3/11/2024  $1,750,000   1,745,678   1,757,665 

McGraw-Hill Global Education Holdings, LLC

 Publishing Term Loan Loan  4.00  1.00  0.00  5.04  5/4/2022  $992,500   988,527   980,878 

MHVC Acquisition Corp.

 Aerospace and Defense Term Loan Loan  5.25  1.00  0.00  6.30  4/29/2024  $2,000,000   1,990,154   2,013,760 

Michaels Stores, Inc.

 Retailers (Except Food and Drugs) Term Loan B1 Loan  2.75  1.00  0.00  3.79  1/30/2023  $1,675,147   1,669,900   1,673,053 

Micro Holding Corporation

 High Tech Industries Term Loan Loan  3.75  1.00  0.00  4.79  7/8/2021  $322,700   321,911   325,524 

Micro Holding Corporation

 High Tech Industries Term Loan Loan  3.75  1.00  0.00  4.79  7/8/2021  $979,860   976,399   988,130 

Microsemi Corporation

 Electronics/Electric Term Loan B Loan  2.25  0.00  0.00  3.33  1/17/2023  $829,180   808,580   832,173 

Midas Intermediate Holdco II, LLC

 Automotive Term Loan (Initial) Loan  2.75  1.00  0.00  3.90  8/18/2021  $243,764   242,937   244,373 

Milacron T/L B

 Capital Equipment Term Loan B Loan  3.00  0.00  0.00  4.04  9/28/2023  $997,500   994,134   999,994 

Milk Specialties Company

 Beverage, Food & Tobacco Term Loan Loan  4.00  1.00  0.00  5.15  8/16/2023  $995,000   985,645   1,002,463 

Mister Car Wash T/L

 Automotive Term Loan Loan  4.25  1.00  0.00  5.30  8/20/2021  $1,495,312   1,489,711   1,497,182 

MWI Holdings, Inc.

 Capital Equipment Term Loan (First Lien) Loan  5.50  1.00  0.00  6.65  6/29/2020  $2,977,500   2,951,521   2,999,831 

National Vision, Inc.

 Retailers (Except Food and Drugs) Term Loan (Second Lien) Loan  5.75  1.00  0.00  6.79  3/11/2022  $250,000   249,802   242,813 

New Media Holdings II T/L (NEW)

 Retailers (Except Food and Drugs) Term Loan Loan  6.25  1.00  0.00  7.29  6/4/2020  $3,160,034   3,147,716   3,136,334 

New Millennium Holdco, Inc.

 Healthcare & Pharmaceuticals Term Loan Loan  6.50  1.00  0.00  7.54  12/21/2020  $1,925,088   1,784,595   1,138,208 

Novetta Solutions

 Aerospace and Defense Term Loan (200MM) Loan  5.00  1.00  0.00  6.15  10/16/2022  $1,975,000   1,959,035   1,881,188 

Novetta Solutions

 Aerospace and Defense Term Loan (2nd Lien) Loan  8.50  1.00  0.00  9.50  10/16/2023  $1,000,000   991,479   941,250 

NPC International, Inc.

 Food Services Term Loan (2013) Loan  3.50  1.00  0.00  4.51  4/19/2024  $500,000   499,408   503,335 

NVA Holdings (National Veterinary) T/L B2

 Services: Consumer Term Loan B2 Loan  3.50  1.00  0.00  4.65  8/14/2021  $1,261,425   1,256,849   1,275,616 

NXT Capital T/L (11/16)

 Banking, Finance, Insurance & Real Estate Term Loan Loan  4.50  1.00  0.00  5.65  11/23/2022  $1,247,500   1,242,663   1,264,653 

Onex Carestream Finance LP

 Healthcare & Pharmaceuticals Term Loan (First Lien 2013) Loan  4.00  1.00  0.00  5.15  6/7/2019  $3,558,804   3,552,314   3,475,777 

OnexYork Acquisition Co

 Healthcare & Pharmaceuticals Term Loan B Loan  3.75  1.00  0.00  4.90  10/1/2021  $487,500   485,121   476,044 

OpenLink International, LLC

 Services: Business Term B Loan Loan  6.50  1.25  0.00  7.75  7/29/2019  $2,906,156   2,905,864   2,915,834 

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

 Food/Drug Retailers Term Borrowing Loan  3.25  1.00  0.00  4.54  6/24/2019  $1,413,810   1,410,322   1,403,207 

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

 Services: Business Term Loan (First Lien) Loan  4.00  1.00  0.00  5.18  10/30/2020  $967,500   964,621   945,731 

Petsmart, Inc. (Argos Merger Sub, Inc.)

 Retailers (Except Food and Drugs) Term Loan B1 Loan  3.00  1.00  0.00  4.01  3/11/2022  $980,000   975,713   940,898 

PGX Holdings, Inc.

 Financial Intermediaries Term Loan Loan  5.25  1.00  0.00  6.30  9/29/2020  $2,871,499   2,857,322   2,873,308 

Planet Fitness Holdings LLC

 Leisure Goods/Activities/Movies Term Loan Loan  3.00  0.75  0.00  4.15  3/31/2021  $2,386,345   2,379,828   2,390,831 

Polycom Term Loan (9/16)

 Telecommunications Term Loan Loan  5.25  1.00  0.00  6.25  9/27/2023  $1,804,333   1,780,636   1,821,023 

Pike Corporation

 Construction & Building Term Loan B Loan  3.75  1.00  0.00  4.80  3/8/2024  $500,000   497,661   504,375 

PrePaid Legal Services, Inc.

 Services: Business Term Loan B Loan  5.25  1.25  0.00  6.50  7/1/2019  $3,169,278   3,172,153   3,184,142 

Presidio, Inc.

 Services: Business Term Loan Loan  3.25  1.00  0.00  4.40  2/2/2022  $2,101,767   2,040,643   2,119,505 

Prestige Brands T/L B4

 Drugs Term Loan B4 Loan  2.75  0.75  0.00  3.79  1/26/2024  $477,225   476,160   481,005 

Prime Security Services (Protection One)

 Services: Business Term Loan Loan  3.25  1.00  0.00  4.29  5/2/2022  $1,980,062   1,970,177   1,995,982 

Radio Systems Corporation

 Leisure Goods/Activities/Movies Term Loan Loan  3.50  1.00  0.00  4.54  5/2/2024  $1,500,000   1,500,000   1,505,625 

Ranpak Holdings, Inc.

 Services: Business Term Loan Loan  3.25  1.00  0.00  4.29  10/1/2021  $913,716   911,432   914,858 

Ranpak Holdings, Inc.

 Services: Business Term Loan (Second Lien) Loan  7.25  1.00  0.00  8.25  10/3/2022  $311,111   310,001   309,556 

Redtop Acquisitions Limited

 Electronics/Electric Initial Dollar Term Loan (First Lien) Loan  3.50  1.00  0.00  4.67  12/3/2020  $483,778   481,891   485,592 

RGIS Services, LLC

 Services: Business Term Loan Loan  7.50  1.00  0.00  8.65  3/31/2023  $500,000   492,623   497,815 

Research Now Group, Inc

 Media Term Loan B Loan  4.50  1.00  0.00  5.65  3/18/2021  $2,004,470   1,996,990   1,979,414 

Resolute Investment Managers, Inc.

 Banking, Finance, Insurance & Real Estate Term Loan Loan  4.25  1.00  0.00  5.40  4/30/2022  $728,517   727,070   729,733 

Rexnord LLC/RBS Global, Inc.

 Industrial Equipment Term B Loan Loan  2.75  1.00  0.00  3.90  8/21/2023  $1,370,341   1,370,341   1,375,480 

Reynolds Group Holdings Inc.

 Industrial Equipment Incremental U.S. Term Loan Loan  3.00  0.00  0.00  4.04  2/3/2023  $1,756,731   1,756,731   1,765,111 

Rovi Solutions Corporation / Rovi Guides, Inc.

 Electronics/Electric Tranche B-3 Term Loan Loan  2.50  0.75  0.00  3.55  7/2/2021  $1,458,750   1,454,281   1,460,880 

Royal Adhesives and Sealants

 Chemicals/Plastics Term Loan (Second Lien) Loan  7.50  1.00  0.00  8.65  6/19/2023  $275,862   274,177   275,172 

Royal Holdings T/L (02/17)

 Chemicals/Plastics Term Loan (Second Lien) Loan  3.25  1.00  0.00  4.40  6/17/2022  $541,607   539,264   547,364 

Russell Investment Management T/L B

 Banking, Finance, Insurance & Real Estate Term Loan B Loan  5.75  1.00  0.00  6.79  6/1/2023  $2,234,372   2,123,883   2,267,887 

Sable International Finance Ltd

 Telecommunications Term Loan B2 Loan  3.50  0.00  0.00  4.54  1/31/2025  $1,500,000   1,492,500   1,505,250 

SBP Holdings LP

 Industrial Equipment Term Loan (First Lien) Loan  4.00  1.00  0.00  5.04  3/27/2021  $970,000   967,121   887,550 

Scientific Games International, Inc.

 Electronics/Electric Term Loan B2 Loan  4.00  0.75  0.00  5.01  10/1/2021  $769,549   762,015   781,092 

SCS Holdings (Sirius Computer)

 High Tech Industries Term Loan (First Lien) Loan  4.25  1.00  0.00  5.29  10/31/2022  $1,871,532   1,837,243   1,887,327 

Seadrill Operating LP

 Oil & Gas Term Loan B Loan  3.00  1.00  0.00  4.15  2/21/2021  $974,811   923,318   667,746 

Shearers Foods LLC

 Food Services Term Loan (First Lien) Loan  3.94  1.00  0.00  5.09  6/30/2021  $975,000   973,500   971,344 

SG Acquisition, Inc. (Safe Guard)

 Banking, Finance, Insurance & Real Estate Term Loan Loan  5.00  1.00  0.00  6.15  3/29/2024  $2,000,000   1,980,387   1,985,000 

Sitel Worldwide

 Telecommunications Term Loan Loan  5.50  1.00  0.00  6.69  9/18/2021  $1,970,000   1,955,355   1,962,120 

SMB Shipping Logistics T/L B (REP WWEX Acquisition)

 Transportation Term Loan B Loan  4.50  1.00  0.00  5.67  2/2/2024  $1,000,000   995,503   1,002,080 

Sonneborn, LLC

 Chemicals/Plastics Term Loan (First Lien) Loan  3.75  1.00  0.00  4.79  12/10/2020  $207,451   207,127   209,007 

Sonneborn, LLC

 Chemicals/Plastics Initial US Term Loan Loan  3.75  1.00  0.00  4.79  12/10/2020  $1,175,553   1,173,719   1,184,370 

Sophia, L.P.

 Electronics/Electric Term Loan (Closing Date) Loan  3.25  1.00  0.00  4.40  9/30/2022  $1,935,931   1,927,068   1,929,155 

SourceHOV LLC

 Services: Business Term Loan B (First Lien) Loan  6.75  1.00  0.00  7.90  10/31/2019  $1,812,500   1,782,852   1,703,750 

SRAM, LLC

 Industrial Equipment Term Loan (First Lien) Loan  3.50  1.00  0.00  4.58  3/15/2024  $2,677,652   2,655,727   2,684,346 

Steak ’n Shake Operations, Inc.

 Food Services Term Loan Loan  3.75  1.00  0.00  4.80  3/19/2021  $852,491   847,501   843,966 

Survey Sampling International

 Services: Business Term Loan B Loan  5.00  1.00  0.00  6.15  12/16/2020  $2,714,821   2,701,862   2,711,427 

Sybil Finance BV

 High Tech Industries Term Loan B Loan  3.25  1.00  0.00  4.40  9/29/2023  $987,500   983,249   1,000,091 

Syniverse Holdings, Inc.

 Telecommunications Initial Term Loan Loan  3.00  1.00  0.00  4.17  4/23/2019  $468,409   466,632   445,377 

Tennessee Merger T/L (Team Health)

 Healthcare & Pharmaceuticals Term Loan Loan  2.75  1.00  0.00  3.79  2/6/2024  $1,000,000   997,601   994,060 

Townsquare Media, Inc.

 Media Term Loan B Loan  3.00  1.00  0.00  4.04  4/1/2022  $911,712   907,481   914,374 

TPF II Power LLC and TPF II Covert Midco LLC

 Utilities Term Loan B Loan  4.00  1.00  0.00  5.04  10/2/2023  $1,413,873   1,367,114   1,403,566 

TransDigm, Inc.

 Aerospace and Defense Tranche C Term Loan Loan  3.00  0.75  0.00  4.15  2/28/2020  $4,222,175   4,227,281   4,238,219 

Travel Leaders Group, LLC

 Hotel, Gaming and Leisure Term Loan B Loan  5.25  0.00  0.00  6.29  1/25/2024  $2,000,000   1,990,390   2,018,760 

Truck Hero, Inc. (Tectum Holdings)

 Transportation Term Loan B Loan  4.00  1.00  0.00  5.16  4/22/2024  $2,000,000   1,980,000   2,000,000 

Trugreen Limited Partnership

 Services: Business Term Loan B Loan  5.50  1.00  0.00  6.50  4/13/2023  $496,250   489,897   500,592 

Twin River Management Group, Inc.

 Lodging & Casinos Term Loan B Loan  3.50  1.00  0.00  4.65  7/10/2020  $792,846   794,051   796,810 

Univar Inc.

 Chemicals/Plastics Term B Loan Loan  2.75  0.00  0.00  3.79  7/1/2022  $2,955,094   2,941,679   2,966,175 

UOS, LLC (Utility One Source)

 Capital Equipment Term Loan B Loan  5.50  1.00  0.00  6.53  4/18/2023  $500,000   495,062   509,375 

Univision Communications Inc.

 Telecommunications Replacement First-Lien Term Loan Loan  2.75  1.00  0.00  3.79  3/15/2024  $2,877,927   2,860,288   2,852,746 

Valeant Pharmaceuticals International, Inc.

 Drugs Series D2 Term Loan B Loan  4.75  0.75  0.00  5.75  4/1/2022  $1,689,182   1,689,182   1,718,743 

Verint Systems Inc.

 Services: Business Term Loan Loan  2.75  0.75  0.00  3.92  9/6/2019  $1,003,684   1,001,096   1,010,790 

Virtus Investment Partners, Inc.

 Banking, Finance, Insurance & Real Estate Term Loan B Loan  3.75  0.75  0.00  4.95  6/3/2024  $500,000   497,542   507,500 

Vistra Operations Company T/L B (12/16)

 Utilities Term Loan B Loan  3.25  0.75  0.00  4.28  12/13/2023  $498,750   497,576   498,940 

Vizient Inc.

 Healthcare & Pharmaceuticals Term Loan Loan  3.50  1.00  0.00  4.54  2/13/2023  $879,853   857,810   890,121 

Washington Inventory Service

 High Tech Industries Revolver Loan  5.50  0.00  0.00  9.50  7/14/2017  $31,390   31,390   30,919 

Washington Inventory Service

 High Tech Industries U.S. Term Loan (First Lien) Loan  0.00  0.00  5.75  7.50  12/20/2018  $1,738,077   1,745,574   1,425,223 

Western Digital Corporation

 High Tech Industries Term Loan B (USD) Loan  2.75  0.75  0.00  3.78  4/28/2023  $1,588,020   1,541,984   1,601,661 

Windstream Services, LLC

 Telecommunications Term Loan B6 Loan  4.00  0.75  0.00  5.01  3/29/2021  $996,870   987,502   998,116 

Xerox Business Services T/L B (Conduent)

 Services: Business Term Loan Loan  4.00  0.00  0.00  4.99  12/7/2023  $748,125   736,442   759,534 

ZEP, Inc.

 Chemicals/Plastics Term Loan B Loan  4.00  1.00  0.00  5.04  6/27/2022  $2,947,500   2,934,504   2,954,869 

Zest Holdings 1st Lien T/L (2014 Replacement)

 Healthcare & Pharmaceuticals Term Loan Loan  4.25  1.00  0.00  5.40  8/16/2023  $1,000,000   995,336   1,006,250 
          

 

 

  

 

 

 
          $300,101,725  $294,713,104 
          

 

 

  

 

 

 
                       Principal  Cost  Fair Value 

Cash and cash equivalents

           

U.S. Bank Money Market (a)

         $7,039,670  $7,039,670  $7,039,670 
         

 

 

  

 

 

  

 

 

 

Total cash and cash equivalents

        $7,039,670  $7,039,670  $7,039,670 
         

 

 

  

 

 

  

 

 

 

(a)    Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of May 31, 2017.

 

22


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

February 28, 2017

 

Issuer Name

 

Industry

 

Asset Name

 Asset
Type
  Spread  LIBOR
Floor
  PIK  Current
Rate
(All In)
  Maturity
Date
  Principal/
Number
of Shares
  Cost  Fair Value 

Education Management II, LLC

 Leisure Goods/Activities/Movies A-1 Preferred Shares  Equity   0.00  0.00  0.00  0.00   6,692  $669,214  $6,725 

Education Management II, LLC

 Leisure Goods/Activities/Movies A-2 Preferred Shares  Equity   0.00  0.00  0.00  0.00   18,975   1,897,538   247 

New Millennium Holdco, Inc.

 Healthcare & Pharmaceuticals Common Stock  Equity   0.00  0.00  0.00  0.00   14,813   964,466   15,746 

24 Hour Holdings III, LLC

 Leisure Goods/Activities/Movies Term Loan  Loan   3.75  1.00  0.00  4.75  5/28/2021  $487,500   484,284   476,127 

ABB Con-Cise Optical Group, LLC

 Healthcare & Pharmaceuticals Term Loan B  Loan   5.00  1.00  0.00  6.00  6/15/2023  $1,995,000   1,975,193   2,009,963 

Acosta Holdco, Inc.

 Media Term Loan B1  Loan   3.25  1.00  0.00  4.29  9/26/2021  $1,940,025   1,929,297   1,893,348 

Advantage Sales & Marketing, Inc.

 Services: Business Delayed Draw Term Loan  Loan   3.25  1.00  0.00  4.25  7/25/2021  $2,446,206   2,443,710   2,438,574 

Aegis Toxicology Science Corporation

 Healthcare & Pharmaceuticals Term B Loan  Loan   4.50  1.00  0.00  5.50  2/24/2021  $2,463,550   2,337,204   2,412,234 

Agrofresh, Inc.

 Food Services Term Loan  Loan   4.75  1.00  0.00  5.75  7/30/2021  $1,970,000   1,962,367   1,898,587 

AI MISTRAL T/L (V. GROUP)

 Utilities Term Loan  Loan   3.00  1.00  0.00  4.00  3/11/2024  $500,000   500,000   500,940 

Akorn, Inc.

 Healthcare & Pharmaceuticals Term Loan B  Loan   4.25  1.00  0.00  5.25  4/16/2021  $398,056   396,948   403,529 

Albertson’s LLC

 Retailers (Except Food and Drugs) Term Loan B-4  Loan   3.00  0.75  0.00  3.78  8/25/2021  $2,896,193   2,879,009   2,931,179 

Alere Inc. (fka IM US Holdings, LLC)

 Healthcare & Pharmaceuticals Term Loan B  Loan   3.25  1.00  0.00  4.25  6/20/2022  $917,946   916,144   919,479 

Alion Science and Technology Corporation

 High Tech Industries Term Loan B (First Lien)  Loan   4.50  1.00  0.00  5.50  8/19/2021  $2,955,000   2,943,621   2,951,306 

Alliance Healthcare Services, Inc.

 Healthcare & Pharmaceuticals Term Loan B  Loan   3.25  1.00  0.00  4.29  6/3/2019  $984,570   981,094   977,184 

ALPHA 3 T/L B1 (ATOTECH)

 Chemicals/Plastics Term Loan B 1  Loan   3.00  1.00  0.00  4.00  1/31/2024  $250,000   249,377   252,500 

Anchor Glass T/L (11/16)

 Containers/Glass Products Term Loan  Loan   3.25  1.00  0.00  4.25  12/7/2023  $500,000   497,626   505,780 

APCO Holdings, Inc.

 Automotive Term Loan  Loan   6.00  1.00  0.00  7.00  1/31/2022  $1,933,919   1,887,037   1,885,571 

Aramark Corporation

 Food Products U.S. Term F Loan  Loan   2.50  0.75  0.00  3.50  2/24/2021  $3,118,358   3,118,358   3,147,327 

Aspen Dental Management, Inc.

 Healthcare & Pharmaceuticals Term Loan Initial  Loan   4.25  1.00  0.00  5.25  4/29/2022  $1,484,941   1,481,061   1,491,446 

Astoria Energy T/L B

 Utilities Term Loan  Loan   4.00  1.00  0.00  5.00  12/24/2021  $1,495,307   1,480,354   1,499,045 

Asurion, LLC (fka Asurion Corporation)

 Insurance Replacement Term Loan B-2  Loan   3.25  0.75  0.00  4.03  7/8/2020  $531,422   526,976   537,024 

Asurion, LLC (fka Asurion Corporation)

 Insurance Term Loan B4 (First Lien)  Loan   3.25  1.00  0.00  4.25  8/4/2022  $2,434,375   2,422,950   2,463,661 

Auction.com, LLC

 Banking, Finance, Insurance & Real Estate Term Loan  Loan   5.00  1.00  0.00  6.00  5/13/2019  $2,718,634   2,718,434   2,739,024 

Avantor Performance Materials Holdings, Inc.

 Chemicals/Plastics Term Loan  Loan   5.00  1.00  0.00  6.00  6/21/2022  $2,784,429   2,760,689   2,819,234 

AVOLON TLB BORROWER 1 LUXEMBOURG S.A.R.L.

 Capital Equipment Term Loan B-2  Loan   2.75  0.75  0.00  3.50  3/20/2022  $1,000,000   995,000   1,017,300 

Bass Pro Group, LLC

 Retailers (Except Food and Drugs) Term Loan  Loan   3.25  0.75  0.00  4.02  6/5/2020  $1,473,750   1,471,637   1,411,116 

Belmond Interfin Ltd.

 Lodging & Casinos Term Loan  Loan   3.00  1.00  0.00  4.00  3/19/2021  $2,481,122   2,484,502   2,488,888 

BJ’s Wholesale Club, Inc.

 Food/Drug Retailers New 2013 (November) Replacement Loan (First Lien)  Loan   3.75  1.00  0.00  4.75  2/2/2024  $1,500,000   1,496,335   1,487,385 

Blackboard T/L B4

 High Tech Industries Term Loan B4  Loan   5.00  1.00  0.00  6.02  6/30/2021  $2,992,500   2,969,529   3,008,390 

BMC Software

 Technology Term Loan  Loan   4.00  1.00  0.00  5.00  9/10/2020  $1,959,596   1,917,256   1,965,729 

BMC Software T/L US

 Technology Term Loan  Loan   4.00  1.00  0.00  5.00  9/10/2020  $676,193   665,400   679,607 

Brickman Group Holdings, Inc.

 Brokers/Dealers/Investment Houses Initial Term Loan (First Lien)  Loan   3.00  1.00  0.00  4.00  12/18/2020  $1,461,186   1,451,382   1,467,952 

BWAY Holding Company

 Leisure Goods/Activities/Movies Term Loan B  Loan   3.25  0.00  0.00  4.75  8/14/2023  $1,189,327   1,179,242   1,189,826 

Candy Intermediate Holdings, Inc.

 Beverage, Food & Tobacco Term Loan  Loan   4.50  1.00  0.00  5.50  6/15/2023  $497,500   495,317   500,609 

Capital Automotive L.P.

 Conglomerate Tranche B-1 Term Loan Facility  Loan   3.00  1.00  0.00  4.00  4/10/2019  $1,487,353   1,489,058   1,500,829 

CASA SYSTEMS T/L

 Telecommunications Term Loan  Loan   4.00  1.00  0.00  5.00  12/20/2023  $1,500,000   1,485,318   1,500,000 

Catalent Pharma Solutions, Inc

 Drugs Initial Term B Loan  Loan   2.75  1.00  0.00  3.75  5/20/2021  $424,821   423,456   429,953 

Cengage Learning Acquisitions, Inc.

 Publishing Term Loan  Loan   4.25  1.00  0.00  5.25  6/7/2023  $1,492,500   1,477,575   1,411,965 

CH HOLD (CALIBER COLLISION) T/L

 Automotive Term Loan  Loan   3.00  0.00  0.00  4.00  2/1/2024  $227,273   226,758   229,545 

Charter Communications Operating, LLC

 Cable and Satellite Television Term F Loan  Loan   2.00  0.00  0.00  2.79  1/3/2021  $1,609,533   1,603,525   1,617,130 

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term G Loan  Loan   2.75  1.00  0.00  3.80  12/31/2019  $981,177   960,939   972,866 

CHS/Community Health Systems, Inc.

 Healthcare & Pharmaceuticals Term H Loan  Loan   3.00  1.00  0.00  4.05  1/27/2021  $1,805,352   1,763,950   1,773,940 

CITGO Petroleum Corporation

 Oil & Gas Term Loan B  Loan   3.50  1.00  0.00  4.50  7/29/2021  $1,964,874   1,946,245   1,976,172 

Communications Sales & Leasing, Inc.

 Telecommunications Term Loan B (First Lien)  Loan   3.00  1.00  0.00  4.00  10/24/2022  $1,970,062   1,958,282   1,980,405 

Concordia Healthcare Corporation

 Healthcare & Pharmaceuticals Term Loan B  Loan   4.25  1.00  0.00  5.25  10/21/2021  $1,980,000   1,891,488   1,615,522 

Consolidated Aerospace Manufacturing, LLC

 Aerospace and Defense Term Loan (First Lien)  Loan   3.75  1.00  0.00  4.75  8/11/2022  $1,418,750   1,412,839   1,365,547 

Consolidated Communications, Inc.

 Telecommunications Term Loan B-2  Loan   3.00  1.00  0.00  4.00  10/5/2023  $500,000   497,500   502,890 

CPI Acquisition Inc.

 Technology Term Loan B (First Lien)  Loan   4.50  1.00  0.00  5.83  8/17/2022  $1,436,782   1,418,783   1,289,511 

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

 Electronics/Electric Term B Loan  Loan   3.25  1.00  0.00  4.25  11/17/2017  $2,462,342   2,461,490   2,457,934 

Crosby US Acquisition Corporation

 Industrial Equipment Initial Term Loan (First Lien)  Loan   3.00  1.00  0.00  4.05  11/23/2020  $727,500   726,911   667,329 

CT Technologies Intermediate Hldgs, Inc

 Healthcare & Pharmaceuticals Term Loan  Loan   4.25  1.00  0.00  5.25  12/1/2021  $1,470,113   1,458,924   1,389,256 

Culligan International Company-T/L

 Conglomerate Term Loan  Loan   4.00  1.00  0.00  5.00  12/13/2023  $2,050,000   2,049,738   2,083,313 

Cumulus Media Holdings Inc.

 Broadcast Radio and Television Term Loan  Loan   3.25  1.00  0.00  4.25  12/23/2020  $470,093   467,345   342,580 

DAE Aviation (StandardAero)

 Aerospace and Defense Term Loan  Loan   4.25  1.00  0.00  5.25  7/7/2022  $1,975,000   1,967,190   1,987,838 

DASEKE T/L (HENNESSY CAPITAL)

 Transportation Term Loan  Loan   5.50  1.00  0.00  6.50  2/27/2024  $714,286   707,143   717,857 

DCS Business Services, Inc.

 Financial Intermediaries Term B Loan  Loan   7.25  1.50  0.00  8.75  3/19/2018  $2,101,458   2,096,045   2,101,458 

Delta 2 (Lux) S.a.r.l.

 Lodging & Casinos Term Loan B-3  Loan   3.75  1.00  0.00  5.07  7/30/2021  $1,000,000   996,568   1,002,920 

DELL INTERNATIONAL 1ST LIEN T/L

 High Tech Industries Term Loan (01/17)  Loan   2.50  0.75  0.00  3.25  9/7/2023  $1,000,000   998,850   1,006,480 

Deluxe Entertainment Service Group, Inc.

 Leisure Goods/Activities/Movies Term Loan (Incremental)  Loan   6.00  1.00  0.00  7.04  2/28/2020  $1,000,000   972,672   997,500 

Deluxe Entertainment Service Group, Inc.

 Leisure Goods/Activities/Movies Term Loan (First Lien)  Loan   5.50  1.00  0.00  6.54  2/28/2020  $1,868,084   1,869,141   1,864,199 

DEX MEDIA, INC.

 Media Term Loan (07/16)  Loan   10.00  1.00  0.00  11.00  7/29/2021  $43,444   43,444   44,041 

Diebold, Inc.

 High Tech Industries Term Loan B  Loan   4.50  0.75  0.00  5.31  11/6/2023  $398,750   395,190   404,731 

DIGITALGLOBE T/L B (12/16)

 Aerospace and Defense Term Loan B  Loan   2.75  0.75  0.00  3.53  1/15/2024  $500,000   498,815   502,030 

DJO Finance, LLC

 Healthcare & Pharmaceuticals Term Loan  Loan   3.25  1.00  0.00  4.25  6/8/2020  $492,500   490,933   483,388 

DPX Holdings B.V.

 Healthcare & Pharmaceuticals Term Loan 2015 Incr Dollar  Loan   3.25  1.00  0.00  4.25  3/11/2021  $2,925,000   2,919,916   2,937,431 

Drew Marine Group, Inc.

 Chemicals/Plastics Term Loan (First Lien)  Loan   3.25  1.00  0.00  4.25  11/19/2020  $2,950,591   2,923,591   2,928,461 

DTZ U.S. Borrower, LLC

 Construction & Building Term Loan B Add-on  Loan   3.25  1.00  0.00  4.30  11/4/2021  $1,962,557   1,954,741   1,973,703 

DUKE FINANCE (OM GROUP/VECTRA) T/L

 Banking, Finance, Insurance & Real Estate Term Loan  Loan   5.00  1.00  0.00  6.00  2/21/2024  $1,500,000   1,395,987   1,511,250 

Edelman Financial Group, Inc.

 Banking, Finance, Insurance & Real Estate Term Loan  Loan   5.50  1.00  0.00  6.51  12/19/2022  $1,485,000   1,459,535   1,487,317 

Education Management II, LLC

 Leisure Goods/Activities/Movies Term Loan A  Loan   4.50  1.00  0.00  5.51  7/2/2020  $501,970   488,778   177,446 

Education Management II, LLC

 Leisure Goods/Activities/Movies Term Loan B (2.00% Cash/6.50% PIK)  Loan   1.00  1.00  6.50  8.51  7/2/2020  $954,307   934,189   77,938 

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (First Lien)  Loan   3.50  1.00  0.00  4.50  8/1/2021  $480,756   479,151   483,308 

Emerald Performance Materials, LLC

 Chemicals/Plastics Term Loan (Second Lien)  Loan   7.75  1.00  0.00  8.75  8/1/2022  $500,000   498,153   498,595 

Emerald 2 Limited

 Chemicals/Plastics Term Loan B1A  Loan   4.00  1.00  0.00  5.00  5/14/2021  $1,000,000   994,172   950,000 

Endo International plc

 Healthcare & Pharmaceuticals Term Loan B  Loan   3.00  0.75  0.00  3.81  9/26/2022  $990,000   987,999   994,247 

EnergySolutions, LLC

 Environmental Industries Term Loan B  Loan   5.75  1.00  0.00  6.75  5/29/2020  $795,000   785,654   799,969 

Engility Corporation

 Aerospace and Defense Term Loan B-1  Loan   4.25  0.70  0.00  4.03  8/12/2020  $243,750   242,680   245,503 

Evergreen Acqco 1 LP

 Retailers (Except Food and Drugs) New Term Loan  Loan   3.75  1.25  0.00  5.00  7/9/2019  $955,106   954,175   846,224 

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

 Industrial Equipment Term Loan (First Lien)  Loan   3.75  1.00  0.00  4.75  1/15/2021  $1,947,330   1,943,904   1,954,632 

EWT Holdings III Corp.

 Capital Equipment Term Loan  Loan   4.50  1.00  0.00  5.50  1/15/2021  $992,500   984,248   997,463 

Extreme Reach, Inc.

 Media Term Loan B  Loan   6.25  1.00  0.00  7.25  2/7/2020  $2,887,500   2,860,092   2,905,547 

Federal-Mogul Corporation

 Automotive Tranche C Term Loan  Loan   3.75  1.00  0.00  4.75  4/15/2021  $2,925,000   2,915,873   2,894,434 

First Data Corporation

 Financial Intermediaries First Data T/L Ext (2021)  Loan   3.00  0.70  0.00  3.78  3/24/2021  $1,886,914   1,804,119   1,904,010 

First Eagle Investment Management

 Banking, Finance, Insurance & Real Estate Term Loan  Loan   4.00  0.75  0.00  5.00  12/1/2022  $1,485,000   1,460,081   1,493,361 

Fitness International, LLC

 Leisure Goods/Activities/Movies Term Loan B  Loan   5.00  1.00  0.00  6.00  7/1/2020  $1,929,311   1,905,661   1,947,793 

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

 Nonferrous Metals/Minerals Loan  Loan   2.75  1.00  0.00  3.75  6/28/2019  $801,502   802,865   806,279 

Garda World Security Corporation

 Services: Business Term B Delayed Draw Loan  Loan   3.00  1.00  0.00  4.00  11/6/2020  $197,083   196,509   197,822 

Garda World Security Corporation

 Services: Business Term B Loan  Loan   3.00  1.00  0.00  4.00  11/6/2020  $770,417   768,226   773,306 

Gardner Denver, Inc.

 High Tech Industries Initial Dollar Term Loan  Loan   3.25  1.00  0.00  4.57  7/30/2020  $2,426,061   2,421,316   2,420,263 

Gates Global LLC

 Leisure Goods/Activities/Movies Term Loan (First Lien)  Loan   3.25  1.00  0.00  4.25  7/5/2021  $481,656   476,839   481,478 

General Nutrition Centers, Inc.

 Retailers (Except Food and Drugs) Amended Tranche B Term Loan  Loan   2.50  0.75  0.00  3.29  3/4/2019  $2,121,102   2,117,573   1,765,817 

GLOBALLOGIC HOLDINGS INC TERM LOAN B

 Services: Business Term Loan B  Loan   4.50  1.00  0.00  5.50  6/20/2022  $500,000   495,133   501,250 

Global Tel*Link Corporation

 Services: Business Term Loan (First Lien)  Loan   3.75  1.25  0.00  5.00  5/26/2020  $2,667,633   2,661,035   2,654,962 

Goodyear Tire & Rubber Company, The

 Chemicals/Plastics Loan (Second Lien)  Loan   3.00  0.75  0.00  3.78  4/30/2019  $1,333,333   1,320,613   1,333,747 

Grosvenor Capital Management Holdings, LP

 Brokers/Dealers/Investment Houses Initial Term Loan  Loan   2.75  1.00  0.00  3.75  1/4/2021  $1,014,560   1,011,573   1,010,755 

GTCR Valor Companies, Inc.

 Services: Business Term Loan B  Loan   6.00  1.00  0.00  7.00  6/16/2023  $1,492,500   1,436,528   1,501,201 

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

 Publishing Tranche B-4 Term Loan  Loan   5.50  1.00  0.00  6.50  2/9/2022  $2,176,889   2,117,378   2,190,495 

Headwaters Incorporated

 Building & Development Term Loan  Loan   3.00  1.00  0.00  4.00  3/24/2022  $242,058   241,141   242,784 

Help/Systems Holdings, Inc.

 High Tech Industries Term Loan  Loan   5.25  1.00  0.00  6.25  10/8/2021  $1,485,000   1,433,886   1,485,000 

Hemisphere Media Holdings, LLC

 Media Term Loan B  Loan   3.50  0.00  0.00  4.27  2/14/2024  $2,500,000   2,512,500   2,493,750 

Herbalife T/L B (HLF Financing)

 Drugs Term Loan B  Loan   5.50  0.75  0.00  6.28  2/15/2023  $2,000,000   1,985,000   2,001,660 

Hercules Achievement Holdings, Inc.

 Retailers (Except Food and Drugs) Term Loan B  Loan   4.00  1.00  0.00  5.00  12/10/2021  $246,851   244,820   250,431 

Hoffmaster Group, Inc.

 Containers/Glass Products Term Loan  Loan   4.50  1.00  0.00  5.50  11/21/2023  $1,000,000   1,003,734   1,013,750 

Hostess Brand, LLC

 Beverage, Food & Tobacco Term Loan B (First Lien)  Loan   3.00  1.00  0.00  4.00  8/3/2022  $1,490,000   1,486,482   1,507,508 

Huntsman International LLC

 Chemicals/Plastics Term Loan B (First Lien)  Loan   3.00  0.70  0.00  3.78  4/19/2019  $1,518,031   1,510,811   1,525,150 

Husky Injection Molding Systems Ltd.

 Services: Business Term Loan B  Loan   3.25  1.00  0.00  4.25  6/30/2021  $469,398   467,182   472,158 

Hyperion Refinance T/L

 Banking, Finance, Insurance & Real Estate Term Loan  Loan   4.50  1.00  0.00  5.50  4/29/2022  $1,994,924   1,971,849   1,998,675 

Imagine! Print Solutions, Inc.

 Media Term Loan B  Loan   6.00  1.00  0.00  7.00  3/30/2022  $496,250   489,837   499,972 

Infor US (Lawson) T/L B-6

 Services: Business Term Loan B-6  Loan   2.75  1.00  0.00  3.75  2/1/2022  $1,609,802   1,595,316   1,610,945 

Informatica Corporation

 High Tech Industries Term Loan B  Loan   3.50  1.00  0.00  4.50  8/5/2022  $493,750   492,732   490,664 

Insight Global

 Services: Business Term Loan  Loan   5.00  1.00  0.00  6.00  10/29/2021  $3,450,126   3,434,977   3,471,690 

ION Media T/L B

 Media Term Loan B  Loan   3.50  1.00  0.00  4.50  12/18/2020  $500,000   497,615   506,875 

J. Crew Group, Inc.

 Retailers (Except Food and Drugs) Term B-1 Loan Retired 03/05/2014  Loan   3.00  1.00  0.00  4.00  3/5/2021  $945,756   945,756   540,660 

Jazz Acquisition, Inc

 Aerospace and Defense First Lien 6/14  Loan   3.50  1.00  0.00  4.50  6/19/2021  $487,879   487,106   471,208 

J.Jill Group, Inc.

 Retailers (Except Food and Drugs) Term Loan (First Lien)  Loan   5.00  1.00  0.00  6.04  5/9/2022  $950,648   946,877   935,200 

Kinetic Concepts, Inc.

 Healthcare & Pharmaceuticals Term Loan F-1  Loan   4.00  1.00  0.00  4.28  2/2/2024  $2,400,000   2,388,246   2,399,496 

Koosharem, LLC

 Services: Business Term Loan  Loan   6.50  1.00  0.00  7.50  5/15/2020  $2,935,100   2,917,778   2,730,259 

Kraton Polymers, LLC

 Chemicals/Plastics Term Loan (Initial)  Loan   5.00  1.00  0.00  5.00  1/6/2022  $2,500,000   2,286,776   2,533,825 

Lannett Company T/L A

 Healthcare & Pharmaceuticals Term Loan A  Loan   4.75  1.00  0.00  5.75  11/25/2020  $1,000,000   970,576   985,000 

Lannett Company, Inc.

 Healthcare & Pharmaceuticals Term Loan B  Loan   5.38  1.00  0.00  6.38  11/25/2022  $1,900,000   1,842,852   1,885,750 

LEARFIELD COMMUNICATIONS INITIAL T/L (A-L PARENT)

 Healthcare & Pharmaceuticals Initial Term Loan (A-L Parent)  Loan   3.25  1.00  0.00  4.25  12/1/2023  $500,000   497,713   505,625 

Lightstone Generation T/L B

 Utilities Term Loan B  Loan   5.50  1.00  0.00  6.54  1/30/2024  $913,043   894,897   925,981 

Lightstone Generation T/L C

 Utilities Term Loan C  Loan   5.50  1.00  0.00  6.54  1/30/2024  $86,957   85,236   88,189 

Limetree Bay Terminals T/L (01/17)

 Oil & Gas Term Loan  Loan   5.00  1.00  0.00  6.04  2/15/2024  $500,000   495,000   503,125 

LPL Holdings

 Banking, Finance, Insurance & Real Estate Term Loan B (2022)  Loan   4.00  0.75  0.00  4.78  11/21/2022  $1,980,000   1,963,355   2,007,225 

Mauser Holdings, Inc.

 Containers/Glass Products Term Loan  Loan   3.50  1.00  0.00  4.50  7/31/2021  $488,750   487,123   488,647 

McGraw-Hill Global Education Holdings, LLC

 Publishing Term Loan  Loan   4.00  1.00  0.00  5.00  5/4/2022  $995,000   990,840   977,468 

Michaels Stores, Inc.

 Retailers (Except Food and Drugs) Term Loan B1  Loan   2.75  1.00  0.00  3.75  1/30/2023  $1,679,779   1,674,140   1,674,673 

Micro Holding Corporation

 High Tech Industries Term Loan  Loan   3.75  1.00  0.00  4.75  7/8/2021  $982,378   978,629   985,079 

Microsemi Corporation

 Electronics/Electric Term Loan B  Loan   2.25  0.00  0.00  3.03  1/17/2023  $868,445   845,882   874,593 

Midas Intermediate Holdco II, LLC

 Automotive Term Loan (Initial)  Loan   3.50  1.00  0.00  3.75  8/18/2021  $244,375   243,499   246,005 

Milacron T/L B

 Capital Equipment Term Loan B  Loan   3.00  0.00  0.00  3.78  9/28/2023  $1,000,000   996,250   1,004,380 

Milk Specialties Company

 Beverage, Food & Tobacco Term Loan  Loan   5.00  1.00  0.00  5.00  8/16/2023  $997,500   987,646   1,004,562 

Mister Car Wash T/L

 Automotive Term Loan  Loan   4.25  1.00  0.00  5.25  8/20/2021  $831,203   825,179   832,931 

MSC Software Corporation

 Services: Business Term Loan  Loan   4.00  1.00  0.00  5.00  5/29/2020  $1,969,898   1,931,995   1,972,360 

MWI Holdings, Inc.

 Capital Equipment Term Loan (First Lien)  Loan   5.50  1.00  0.00  6.50  6/29/2020  $2,985,000   2,956,823   3,007,388 

National Veterinary Associates, Inc

 Healthcare & Pharmaceuticals Term Loan B  Loan   3.50  1.00  0.00  4.50  8/14/2021  $977,543   974,893   982,430 

National Vision, Inc.

 Retailers (Except Food and Drugs) Term Loan (Second Lien)  Loan   5.75  1.00  0.00  6.75  3/11/2022  $250,000   249,793   242,750 

New Media Holdings II T/L (NEW)

 Retailers (Except Food and Drugs) Term Loan  Loan   6.25  1.00  0.00  7.25  6/4/2020  $3,168,116   3,154,983   3,140,395 

New Millennium Holdco, Inc.

 Healthcare & Pharmaceuticals Term Loan  Loan   6.50  1.00  0.00  7.50  12/21/2020  $1,930,106   1,777,976   980,494 

Novetta Solutions

 Aerospace and Defense Term Loan (200MM)  Loan   5.00  1.00  0.00  6.00  10/16/2022  $1,980,000   1,963,361   1,890,900 

Novetta Solutions

 Aerospace and Defense Term Loan (2nd Lien)  Loan   8.50  1.00  0.00  9.50  10/16/2023  $1,000,000   991,237   930,000 

NPC International, Inc.

 Food Services Term Loan (2013)  Loan   3.75  1.00  0.00  4.75  12/28/2018  $476,250   476,250   477,241 

NVA Holdings (National Veterinary) T/L B2

 Services: Consumer Term Loan B2  Loan   3.50  1.00  0.00  4.50  8/14/2021  $129,601   129,601   130,897 

NVA Holdings, Inc.

 Services: Consumer Term Loan B1  Loan   3.50  1.00  0.00  4.50  8/14/2021  $157,443   157,108   158,034 

NXT Capital T/L (11/16)

 Banking, Finance, Insurance & Real Estate Term Loan  Loan   4.50  1.00  0.00  5.50  11/23/2022  $1,000,000   995,240   1,013,750 

ON Semiconductor Corporation

 High Tech Industries Term Loan B  Loan   3.25  0.70  0.00  4.03  3/31/2023  $498,750   491,370   503,204 

Onex Carestream Finance LP

 Healthcare & Pharmaceuticals Term Loan (First Lien 2013)  Loan   4.00  1.00  0.00  5.00  6/7/2019  $3,613,555   3,606,228   3,490,297 

OnexYork Acquisition Co

 Healthcare & Pharmaceuticals Term Loan B  Loan   3.75  1.00  0.00  4.75  10/1/2021  $488,750   486,195   475,554 

OpenLink International, LLC

 Services: Business Term B Loan  Loan   6.50  1.25  0.00  7.75  7/29/2019  $2,913,824   2,913,362   2,938,096 

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

 Food/Drug Retailers Term Borrowing  Loan   3.25  1.00  0.00  4.54  6/24/2019  $1,417,598   1,413,680   1,389,245 

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

 Services: Business Term Loan (First Lien)  Loan   4.00  1.00  0.00  5.25  10/30/2020  $970,000   966,928   933,625 

Petsmart, Inc. (Argos Merger Sub, Inc.)

 Retailers (Except Food and Drugs) Term Loan B1  Loan   3.00  1.00  0.00  4.00  3/11/2022  $982,500   977,998   967,183 

PGX Holdings, Inc.

 Financial Intermediaries Term Loan  Loan   5.25  1.00  0.00  6.25  9/29/2020  $2,891,464   2,876,188   2,889,671 

Planet Fitness Holdings LLC

 Leisure Goods/Activities/Movies Term Loan  Loan   3.50  0.75  0.00  4.28  3/31/2021  $2,392,341   2,385,223   2,407,293 

Polycom Term Loan (9/16)

 Telecommunications Term Loan  Loan   5.25  1.00  0.00  6.25  9/27/2023  $1,894,167   1,868,863   1,907,426 

PrePaid Legal Services, Inc.

 Services: Business Term Loan B  Loan   5.25  1.25  0.00  6.50  7/1/2019  $3,328,536   3,330,285   3,335,825 

Presidio, Inc.

 Services: Business Term Loan  Loan   3.50  1.00  0.00  4.50  2/2/2022  $2,297,698   2,248,964   2,314,930 

Prestige Brands T/L B4

 Drugs Term Loan B4  Loan   2.75  0.75  0.00  3.53  1/26/2024  $500,000   498,779   506,040 

Prime Security Services (Protection One)

 Services: Business Term Loan  Loan   3.25  1.00  0.00  4.25  5/2/2022  $1,985,025   1,975,632   2,003,645 

Ranpak Holdings, Inc.

 Services: Business Term Loan  Loan   3.25  1.00  0.00  4.25  10/1/2021  $916,047   913,757   918,337 

Ranpak Holdings, Inc.

 Services: Business Term Loan (Second Lien)  Loan   7.25  1.00  0.00  8.25  10/3/2022  $500,000   498,149   475,000 

Redtop Acquisitions Limited

 Electronics/Electric Initial Dollar Term Loan (First Lien)  Loan   3.50  1.00  0.00  4.54  12/3/2020  $485,019   483,001   486,634 

Regal Cinemas Corporation

 Services: Consumer Term Loan  Loan   2.50  0.75  0.00  3.28  4/1/2022  $495,009   493,772   499,573 

Research Now Group, Inc

 Media Term Loan B  Loan   4.50  1.00  0.00  5.50  3/18/2021  $2,037,705   2,029,696   2,002,045 

Resolute Investment Managers, Inc.

 Banking, Finance, Insurance & Real Estate Term Loan  Loan   4.25  1.00  0.00  5.25  4/30/2022  $240,815   239,883   241,518 

Rexnord LLC/RBS Global, Inc.

 Industrial Equipment Term B Loan  Loan   2.75  1.00  0.00  3.75  8/21/2023  $732,374   732,374   736,497 

Rexnord LLC/RBS Global, Inc.

 Industrial Equipment Term B Loan  Loan   2.75  1.00  0.00  3.75  8/21/2023  $641,402   641,402   645,013 

Reynolds Group Holdings Inc.

 Industrial Equipment Incremental U.S. Term Loan  Loan   3.00  0.00  0.00  3.78  2/3/2023  $1,761,134   1,761,134   1,773,603 

Rovi Solutions Corporation / Rovi Guides, Inc.

 Electronics/Electric Tranche B-3 Term Loan  Loan   2.50  0.75  0.00  3.29  7/2/2021  $1,462,500   1,457,765   1,467,984 

Royal Adhesives and Sealants

 Chemicals/Plastics Term Loan (Second Lien)  Loan   7.50  1.00  0.00  8.50  6/19/2023  $275,862   274,109   276,552 

Royal Holdings T/L (02/17)

 Chemicals/Plastics Term Loan (Second Lien)  Loan   3.25  1.00  0.00  4.25  6/17/2022  $541,607   539,167   544,992 

RPI Finance Trust

 Financial Intermediaries Term B-4 Term Loan  Loan   2.50  0.00  0.00  3.50  10/14/2022  $2,554,764   2,554,764   2,580,848 

Russell Investment Management T/L B

 Banking, Finance, Insurance & Real Estate Term Loan B  Loan   5.75  1.00  0.00  6.75  6/1/2023  $2,240,000   2,127,043   2,259,600 

Sable International Finance Ltd

 Telecommunications Term Loan B2  Loan   4.75  0.75  0.00  5.53  12/30/2022  $1,500,000   1,470,825   1,521,570 

SBP Holdings LP

 Industrial Equipment Term Loan (First Lien)  Loan   4.00  1.00  0.00  5.00  3/27/2021  $972,500   969,442   870,388 

Scientific Games International, Inc.

 Electronics/Electric Term Loan B2  Loan   4.00  0.75  0.00  4.85  10/1/2021  $769,549   762,102   781,416 

SCS Holdings (Sirius Computer)

 High Tech Industries Term Loan (First Lien)  Loan   4.25  1.00  0.00  5.25  10/31/2022  $1,972,528   1,934,960   1,991,030 

Seadrill Operating LP

 Oil & Gas Term Loan B  Loan   3.00  1.00  0.00  4.00  2/21/2021  $977,330   922,444   729,635 

Shearers Foods LLC

 Food Services Term Loan (First Lien)  Loan   3.94  1.00  0.00  4.94  6/30/2021  $977,500   975,832   979,944 

Sitel Worldwide

 Telecommunications Term Loan  Loan   5.50  1.00  0.00  6.56  9/18/2021  $1,975,000   1,959,274   1,961,432 

SMB Shipping Logistics T/L B (REP WWEX Acquisition)

 Transportation Term Loan B  Loan   4.50  1.00  0.00  5.53  2/2/2024  $1,000,000   995,095   1,008,330 

Sonneborn, LLC

 Chemicals/Plastics Term Loan (First Lien)  Loan   3.75  1.00  0.00  4.75  12/10/2020  $207,981   207,633   208,501 

Sonneborn, LLC

 Chemicals/Plastics Initial US Term Loan  Loan   3.75  1.00  0.00  4.75  12/10/2020  $1,178,561   1,176,588   1,181,508 

Sophia, L.P.

 Electronics/Electric Term Loan (Closing Date)  Loan   3.25  1.00  0.00  4.25  9/30/2022  $1,960,897   1,951,404   1,967,761 

SourceHOV LLC

 Services: Business Term Loan B (First Lien)  Loan   6.75  1.00  0.00  7.75  10/31/2019  $1,837,500   1,804,647   1,808,412 

SRAM, LLC

 Industrial Equipment Term Loan (First Lien)  Loan   3.00  1.00  0.00  4.00  4/10/2020  $2,725,103   2,719,454   2,718,289 

Steak ‘n Shake Operations, Inc.

 Food Services Term Loan  Loan   3.75  1.00  0.00  4.75  3/19/2021  $923,173   917,444   930,097 

Survey Sampling International

 Services: Business Term Loan B  Loan   5.00  1.00  0.00  6.00  12/16/2020  $2,721,749   2,707,531   2,721,749 

Sybil Finance BV

 High Tech Industries Term Loan B  Loan   4.00  1.00  0.00  5.00  9/30/2022  $987,500   982,957   1,002,006 

Syniverse Holdings, Inc.

 Telecommunications Initial Term Loan  Loan   3.00  1.00  0.00  4.04  4/23/2019  $468,977   466,972   427,473 

TaxACT, Inc.

 Services: Business Term Loan B  Loan   6.00  1.00  0.00  7.00  1/3/2023  $1,200,000   1,168,727   1,206,000 

Tectum Holdings, Inc.

 Transportation Delayed Draw Term Loan (Initial)  Loan   4.75  1.00  0.00  5.80  8/24/2023  $997,500   988,185   1,004,981 

Tennessee Merger T/L (Team Health)

 Healthcare & Pharmaceuticals Term Loan  Loan   2.75  1.00  0.00  3.75  2/6/2024  $1,000,000   997,518   996,880 

TGI Friday’s, Inc.

 Food Services Term Loan B  Loan   4.25  1.00  0.00  5.25  7/15/2020  $1,651,817   1,648,856   1,646,316 

Townsquare Media, Inc.

 Media Term Loan B  Loan   3.00  1.00  0.00  4.00  4/1/2022  $932,522   927,933   937,185 

TPF II Power LLC and TPF II Covert Midco LLC

 Utilities Term Loan B  Loan   4.00  1.00  0.00  5.00  10/2/2021  $1,413,873   1,364,619   1,426,683 

TransDigm, Inc.

 Aerospace and Defense Tranche C Term Loan  Loan   3.00  0.75  0.00  3.78  2/28/2020  $4,233,198   4,238,155   4,249,920 

Travel Leaders Group, LLC

 Hotel, Gaming and Leisure Term Loan B  Loan   5.25  0.00  0.00  6.03  1/25/2024  $2,000,000   1,990,095   2,025,000 

Trugreen Limited Partnership

 Services: Business Term Loan B  Loan   5.50  1.00  0.00  6.50  4/13/2023  $497,500   490,931   503,719 

Twin River Management Group, Inc.

 Lodging & Casinos Term Loan B  Loan   3.50  1.00  0.00  4.50  7/10/2020  $809,438   810,684   819,556 

Univar Inc.

 Chemicals/Plastics Term B Loan  Loan   2.75  0.00  0.00  3.61  7/1/2022  $2,962,500   2,948,361   2,971,565 

Univision Communications Inc.

 Telecommunications Replacement First-Lien Term Loan  Loan   3.00  1.00  0.00  4.00  3/1/2020  $2,885,666   2,876,319   2,896,949 

Valeant Pharmaceuticals International, Inc.

 Drugs Series D2 Term Loan B  Loan   4.25  0.75  0.00  5.03  2/13/2019  $2,445,056   2,437,788   2,456,890 

Verint Systems Inc.

 Services: Business Term Loan  Loan   2.75  0.75  0.00  3.53  9/6/2019  $1,006,278   1,003,396   1,010,554 

Vistra Operations Company T/L B (12/16)

 Utilities Term Loan B  Loan   3.25  0.75  0.00  4.02  12/13/2023  $500,000   498,784   502,970 

Vizient Inc.

 Healthcare & Pharmaceuticals Term Loan  Loan   4.00  1.00  0.00  5.00  2/13/2023  $879,853   856,884   891,405 

Vouvray US Finance

 Industrial Equipment Term Loan  Loan   3.75  1.00  0.00  4.75  6/27/2021  $487,500   485,889   486,891 

Washington Inventory Service

 Services: Business U.S. Term Loan (First Lien)  Loan   0.00  0.00  5.75  5.75  12/20/2018  $1,735,292   1,743,798   1,418,601 

Western Digital Corporation

 High Tech Industries Term Loan B (USD)  Loan   3.75  0.75  0.00  4.53  5/1/2023  $1,592,000   1,547,312   1,602,396 

Windstream Services, LLC

 Telecommunications Term Loan B6  Loan   4.00  0.75  0.00  4.78  3/29/2021  $999,375   989,489   1,006,121 

Xerox Business Services T/L B (Conduent)

 Services: Business Term Loan  Loan   5.50  0.75  0.00  6.28  12/7/2023  $750,000   737,850   761,955 

Zekelman Industries (JMC Steel) T/L (01/17)

 Nonferrous Metals/Minerals Term Loan  Loan   3.75  1.00  0.00  4.75  6/14/2021  $500,000   501,250   506,040 

ZEP, Inc.

 Chemicals/Plastics Term Loan B  Loan   4.00  1.00  0.00  5.00  6/27/2022  $2,955,000   2,941,390   2,984,550 

Zest Holdings 1st Lien T/L (2014 Replacement)

 Healthcare & Pharmaceuticals Term Loan  Loan   4.75  1.00  0.00  5.75  8/17/2020  $1,000,000   995,523   1,012,500 
          

 

 

  

 

 

 
        $297,801,502  $292,460,648 
          

 

 

  

 

 

 
                   Principal  Cost  Fair Value 

Cash and cash equivalents

          

U.S. Bank Money Market (a)

       $13,046,555  $13,046,555  $13,046,555 
         

 

 

  

 

 

  

 

 

 

Total cash and cash equivalents

       $13,046,555  $13,046,555  $13,046,555 
         

 

 

  

 

 

  

 

 

 

(a)    Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of February 28, 2017.

 

23


Table of Contents

Note 5. Agreements and Related Party Transactions

On July 30, 2010, the Company entered into the Management Agreement with our Manager. The initial term of the Management Agreement was two years, with automatic, one-year renewals at the end of each year, subject to certain approvals by our board of directors and/or the Company’s stockholders. On July 11, 2017, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive fee.

The base management fee of 1.75% is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters.

The incentive fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20.0% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter. There is no accumulation of amounts on the hurdle rate from quarter to quarter, and accordingly there is no claw back of amounts previously paid if subsequent quarters are below the quarterly hurdle rate, and there is no delay of payment if prior quarters are below the quarterly hurdle rate.

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the fiscal year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the three months ended May 31, 2017 and May 31, 2016, the Company incurred $1.4 million and $1.2 million in base management fees, respectively. For the three months ended May 31, 2017 and May 31, 2016, the Company incurred $0.7 million and $0.6 million in incentive fees related to pre-incentive fee net investment income, respectively. For the three months ended May 31, 2017, there was a reduction of $0.5 million in incentive fees related to capital gains. For the three months ended May 31, 2016, the Company accrued $0.1 million in incentive fees related to capital gains. The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of May 31, 2017, the base management fees accrual was $1.4 million and the incentive fees accrual was $2.6 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2017, the base management fees accrual was $1.2 million and the incentive fees accrual was $4.6 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement was two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company was capped at $1.0 million for the initial two year term of the

 

24


Table of Contents

Administration Agreement and subsequent renewals. On July 8, 2015, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company thereunder, which had not been increased since the inception of the agreement, to $1.3 million. On October 5, 2016, our board of directors determined to increase the cap on the payment or reimbursement of expenses by the Company under the Administration Agreement, from $1.3 million to $1.5 million, effective November 1, 2016. On July 11, 2017, our board of directors approved the renewal of the Administration Agreement for an additional one-year term, and determined to increase the cap on the payment or reimbursement of expenses by the Company from $1.5 million to $1.75 million, effective August 1, 2017.

For the three months ended May 31, 2017 and May 31, 2016, we recognized $0.4 million and $0.3 million, in administrator expenses, respectively, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses. As of May 31, 2017, $0.3 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. As of February 28, 2017, $0.4 million of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities. For the three months ended May 31, 2017 and May 31, 2016, the Company neither bought nor sold any investments from the Saratoga CLO.

Note 6. Borrowings

Credit Facility

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral were used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

In March 2009, we amended the Revolving Facility to increase the portion of the portfolio that could be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization. As a result of these transactions, we expected to have additional cushion under our borrowing base under the Revolving Facility that would allow us to better manage our capital in times of declining asset prices and market dislocation.

On July 30, 2009, we exceeded the permissible borrowing limit under the Revolving Facility for 30 consecutive days, resulting in an event of default under the Revolving Facility. As a result of this event of default, our lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. Acceleration of the outstanding indebtedness and/or liquidation of the collateral could have had a material adverse effect on our liquidity, financial condition and operations.

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility (the “Credit Facility”) with Madison Capital Funding LLC, in each case, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Credit Facility to secure our obligations thereunder.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

25


Table of Contents
  expand the borrowing capacity under the Credit Facility from $40.0 million to $45.0 million;

 

  extend the period during which we may make and repay borrowings under the Credit Facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may, upon the occurrence of an event of default, by action of the lenders or automatically, be terminated. All borrowings and other amounts payable under the Credit Facility are due and payable five years after the end of the Revolving Period; and

 

  remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

On September 17, 2014, we entered into a second amendment to the Credit Facility with Madison Capital Funding LLC to, among other things:

 

  extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

  extend the maturity date of the Credit Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

  reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

  reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

On May 18, 2017, we entered into a third amendment to the Credit Facility with Madison Capital Funding LLC to, among other things:

 

  extend the commitment termination date from September 17, 2017 to September 17, 2020;

 

  extend the final maturity date of the Credit Facility from September 17, 2022 to September 17, 2025 (unless terminated sooner upon certain events);

 

  reduce the floor on base rate borrowings from 2.25% to 2.0%;

 

  reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and

 

  reduce the commitment fee rate from 0.75% to 0.50% for any period during which the ratio of advances outstanding to aggregate commitments, expressed as a percentage, is greater than or equal to 50%.

As of May 31, 2017 and February 28, 2017, there was $24.5 million and $0.0, respectively, of outstanding borrowings under the Credit Facility and the Company was in compliance with all of the limitations and requirements of the Credit Facility. Financing costs of $3.1 million related to the Credit Facility have been capitalized and are being amortized over the term of the facility. For the three months ended May 31, 2017 and May 31, 2016, we recorded $0.1 million and $0.1 million of interest expense, respectively. For the three months ended May 31, 2017 and May 31, 2016, we recorded $0.02 million and $0.02 million of amortization of deferred financing costs related to the Credit Facility and Revolving Facility, respectively. The interest rate during the three months ended May 31, 2017 on the outstanding borrowings under the Credit Facility was 5.83%. During the three months ended May 31, 2017 and May 31, 2016, the average dollar amount of outstanding borrowings under the Credit Facility was $0.5 million and $0.0, respectively.

The Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight year term, consisting of a three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing LIBOR rate and 1.00%, plus an applicable margin of 4.75%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 2.00%, and the applicable margin over such alternative base rate is 3.75%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Credit Facility for the duration of the Revolving Period.

 

26


Table of Contents

Our borrowing base under the Credit Facility was $45.0 million subject to the Credit Facility cap of $45.0 million at May 31, 2017. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the May 31, 2017 borrowing base relies upon the valuations set forth in the Annual Report on Form 10-K for the year ended February 28, 2017. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

SBA Debentures

SBIC LP is able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. As of May 31, 2017, we have funded SBIC LP with $75.0 million of equity capital, and have $134.7 million of SBA-guaranteed debentures outstanding. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP may borrow to a maximum of $150.0 million, which is up to twice its potential regulatory capital.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $19.5 million and have average annual fully taxed net income not exceeding $6.5 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to ‘‘smaller’’ concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

SBIC LP is subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC LP will receive SBA-guaranteed debenture funding, which is dependent upon SBIC LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP’s assets over our stockholders and debtholders in the event we liquidate SBIC LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP upon an event of default.

The Company received exemptive relief from the SEC to permit it to exclude the debt of SBIC LP guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows the Company increased flexibility under the 200.0% asset coverage test by permitting it to borrow up to $150.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of May 31, 2017 and February 28, 2017, there was $134.7 million and $112.7 million outstanding of SBA debentures, respectively. The carrying amount of the amount outstanding of SBA debentures approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage, $4.6 million, of financing costs related to the SBA debentures, have been capitalized and are being amortized over the term of the commitment and drawdown. For the three months ended May 31, 2017 and May 31, 2016, we recorded $0.9 million and $0.8 million of interest expense related to the SBA debentures, respectively. For the three months ended May 31, 2017 and May 31, 2016, we recorded $0.1 million and $0.1 million of amortization of deferred financing costs related to the SBA debentures, respectively. The weighted average interest rate during the three months ended May 31, 2017 and May 31, 2016 on the outstanding borrowings of the SBA debentures was 3.18% and 3.09%, respectively. During the three months ended May 31, 2017 and May 31, 2016, the average dollar amount of SBA debentures outstanding was $114.2 million and $103.7 million, respectively.

In December 2015, the 2016 omnibus spending bill approved by Congress and signed into law by the President increased the amount of SBA-guaranteed debentures that affiliated SBIC funds can have outstanding from $225.0 million to $350.0 million, subject to SBA approval. SBA regulations currently limit the amount of SBA-guaranteed debentures that an SBIC may issue to $150.0 million when it has at least $75.0 million in regulatory capital. Affiliated SBICs are permitted to issue up to a combined maximum amount of $350.0 million in SBA-guaranteed debentures when they have at least $175.0 million in combined regulatory capital.

 

27


Table of Contents

On April 2, 2015, the SBA issued a “green light” letter inviting the Company to continue the application process to obtain a license to form and operate its second SBIC subsidiary. On September 27, 2016, the SBA informed us that as part of their continued review of our application for a second license, and in order to ensure that they were reviewing the most current information available, we would need to update all previously submitted materials and invited us to reapply. As a result of this request, with which we are in the process of complying, the existing “green light” letter that the SBA issued to us has expired. If approved in the future, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue up to $150.0 million of additional SBA-guaranteed debentures in addition to the $150.0 million already approved under the first license.

Notes

On May 10, 2013, the Company issued $42.0 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “2020 Notes”). The 2020 Notes will mature on May 31, 2020, and since May 31, 2016, may be redeemed in whole or in part at any time or from time to time at the Company’s option. Interest will be payable quarterly beginning August 15, 2013.

On May 17, 2013, the Company closed an additional $6.3 million in aggregate principal amount of the 2020 Notes, pursuant to the full exercise of the underwriters’ option to purchase additional 2020 Notes. On May 29, 2015, the Company entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which the Company may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market (“ATM”) offering. As of May 31, 2017, the Company sold 539,725 bonds with a principal of $13,493,125 at an average price of $25.31 for aggregate net proceeds of $13,385,766 (net of transaction costs).

On December 21, 2016, the Company issued $74.5 million in aggregate principal amount of our 6.75% fixed-rate notes due 2023 (the “2023 Notes”) for net proceeds of $71.7 million after deducting underwriting commissions of approximately $2.3 million and offering costs of approximately $0.5 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. Interest on the 2023 Notes is paid quarterly in arrears on March 15, June 15, September 15 and December 15, at a rate of 6.75% per year, beginning March 30, 2017. The 2023 Notes mature on December 30, 2023, and commencing December 21, 2019, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used to repay all of the outstanding indebtedness under the 2020 Notes, which amounted to $61.8 million, and for general corporate purposes in accordance with our investment objective and strategies. The 2023 Notes are listed on the NYSE under the trading symbol “SAB” with a par value of $25.00 per share. The remaining unamortized deferred debt financing costs of $1.5 million (including underwriting commissions and net of issuance premiums), was recorded within loss on debt extinguishment in the consolidated statements of operations in the fourth quarter of the fiscal year ended February 28, 2017, when the related 2020 Notes were extinguished. As of May 31, 2017, $2.8 million of financing costs related to the 2023 Notes have been capitalized and are being amortized over the term of the 2023 Notes.

As of May 31, 2017, the carrying amount and fair value of the 2023 Notes was $74.5 million and $78.1 million, respectively. The fair value of the 2023 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. For the three months ended May 31, 2017, we recorded $1.3 million of interest expense and $0.1 million of amortization of deferred financing costs related to the 2023 Notes. As of February 28, 2017, the carrying amount and fair value of the 2023 Notes was $74.5 million and $77.1 million, respectively. For the three months ended May 31, 2016, we recorded $1.2 million of interest expense and $0.1 million of amortization of deferred financing costs related to the 2020 Notes. During the three months ended May 31, 2017, the average dollar amount of 2023 Notes outstanding was $74.5 million. During the three months ended May 31, 2016, the average dollar amount of 2020 Notes outstanding was $61.8 million.

Note 7. Commitments and contingencies

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at May 31, 2017:

 

       Payment Due by Period 
   Total   Less Than
1 Year
   1 - 3
Years
   3 - 5
Years
   More Than
5 Years
 
   ($ in thousands) 

Long-Term Debt Obligations

  $233,611   $—    $—    $—     $233,611 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

28


Table of Contents

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $7.0 million and $2.0 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of May 31, 2017 and February 28, 2017, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.

A summary of the composition of the unfunded commitments as of May 31, 2017 and February 28, 2017 is shown in the table below (dollars in thousands):

 

  As of 
  May 31, 2017  February 28, 2017 

CLEO Communications Holding, LLC

 $5,000  $—   

GreyHeller LLC

  2,000   2,000 

TM Restaurant Group L.L.C.

  17  —   
 

 

 

  

 

 

 

Total

 $7,017  $2,000 
 

 

 

  

 

 

 

Note 8. Directors Fees

The independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of- pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of- pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the three months ended May 31, 2017 and May 31, 2016, we incurred $0.05 million and $0.07 million for directors’ fees and expenses, respectively. As of May 31, 2017 and February 28, 2017, $0.05 million and $0.05 million in directors’ fees and expenses were accrued and unpaid, respectively. As of May 31, 2017, we had not issued any common stock to our directors as compensation for their services.

Note 9. Stockholders’ Equity

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

 

29


Table of Contents

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock.

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock.

On April 9, 2015, the Company declared a dividend of $0.27 per share payable on May 29, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock.

On May 14, 2015, the Company declared a special dividend of $1.00 per share payable on June 5, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock.

On July 8, 2015, the Company declared a dividend of $0.33 per share payable on August 31, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock.

On October 7, 2015, the Company declared a dividend of $0.36 per share payable on November 30, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock.

On January 12, 2016, the Company declared a dividend of $0.40 per share payable on February 29, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock.

 

30


Table of Contents

On March 31, 2016, the Company declared a dividend of $0.41 per share payable on April 27, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock.

On July 7, 2016, the Company declared a dividend of $0.43 per share payable on August 9, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock.

On August 8, 2016, the Company declared a special dividend of $0.20 per share payable on September 5, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock.

On October 5, 2016, the Company declared a dividend of $0.44 per share payable on November 9, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock.

On January 12, 2017, the Company declared a dividend of $0.45 per share payable on February 9, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock.

On February 28, 2017, the Company declared a dividend of $0.46 per share payable on March 28, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock.

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements. On October 7, 2015, the Company’s board of directors extended the open market share repurchase plan for another year and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 400,000 shares of its common stock. On October 5, 2016, the Company’s board of directors extended the open market share repurchase plan for another year to October 15, 2017 and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of its common stock. As of May 31, 2017, the Company purchased 218,491 shares of common stock, at the average price of $16.87 for approximately $3.7 million pursuant to this repurchase plan.

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. As of May 31, 2017, the Company sold 60,779 shares for gross proceeds of $1.4 million at an average price of $22.49 for aggregate net proceeds of $1.3 million (net of transaction costs).

Note 10. Summarized Financial Information of Our Unconsolidated Subsidiary

In accordance with SEC Regulation S-X Rules 3-09 and 4-08(g), the Company must determine which of its unconsolidated controlled portfolio companies, if any, are considered “significant subsidiaries.” After performing this analysis, the Company determined that one of its portfolio companies, Easy Ice, LLC (“Easy Ice”) is not a significant subsidiary for the three months ended May 31, 2017 under at least one of the significance conditions of Rule 4-08(g) of SEC Regulation S-X, but was a significant subsidiary for the year ended February 28, 2017. Accordingly, audited financial information for the year ended December 31, 2016 and as of December 31, 2016 has been included as follows (in thousands):

 

31


Table of Contents
   As of 

Balance Sheet – Easy Ice, LLC

  December 31, 2016 

Current assets

  $1,058 

Noncurrent assets

  $18,245 

Current liabilities

  $3,473 

Noncurrent liabilities

  $23,113 

Total deficit

  $(7,283

 

   For the year ended 

Statement of Operations – Easy Ice, LLC

  December 31, 2016 

Rental income

  $14,463 

Rental expenses

  $8,463 

Gross margin

  $6,000 

Operating expenses

  $5,123 

Income from operations

  $877 

Net loss

  $(1,356

Note 11. Earnings Per Share

In accordance with the provisions of FASB ASC 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations for the three months ended May 31, 2017 and May 31, 2016 (dollars in thousands except share and per share amounts):

 

   For the three months ended 

Basic and diluted

  May 31,
2017
   May 31,
2016
 

Net increase in net assets from operations

  $1,014   $3,288 

Weighted average common shares outstanding

   5,861,654    5,737,496 

Weighted average earnings per common share

  $0.17   $0.57 

Note 12. Dividend

On February 28, 2017, the Company declared a dividend of $0.46 per share which was paid on March 28, 2017, to common stockholders of record as of March 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to our DRIP.

Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.

The following table summarizes dividends declared for the three months ended May 31, 2017 (dollars in thousands except per share amounts):

 

32


Table of Contents

Date Declared

  Record Date   Payment Date   Amount
Per Share*
   Total
Amount
 

February 28, 2017

   March 15, 2017    March 28, 2017   $0.46   $2,666 
      

 

 

   

 

 

 

Total dividends declared

      $0.46   $2,666 
      

 

 

   

 

 

 

 

*Amount per share is calculated based on the number of shares outstanding at the date of declaration.

The following table summarizes dividends declared for the three months ended May 31, 2016 (dollars in thousands except per share amounts):

 

Date Declared

  Record Date   Payment Date   Amount
Per Share*
   Total
Amount
 

March 31, 2016

   April 15, 2016    April 27, 2016   $0.41   $2,346 
      

 

 

   

 

 

 

Total dividends declared

      $0.41   $2,346 
      

 

 

   

 

 

 

 

*Amount per share is calculated based on the number of shares outstanding at the date of declaration.

Note 13. Financial Highlights

The following is a schedule of financial highlights for the three months ended May 31, 2017 and May 31, 2016:

 

   May 31, 2017  May 31, 2016 

Per share data:

  

Net asset value at beginning of period

  $21.97  $22.06 

Net investment income(1)

   0.60   0.44 

Net realized and unrealized gains and losses on investments

   (0.43  0.13 
  

 

 

  

 

 

 

Net increase in net assets from operations

   0.17   0.57 

Distributions declared from net investment income

   (0.46  (0.41
  

 

 

  

 

 

 

Total distributions to stockholders

   (0.46  (0.41

Dilution(4)

   0.01   (0.11

Net asset value at end of period

  $21.69  $22.11 

Net assets at end of period

  $127,608,653  $127,128,868 

Shares outstanding at end of period

   5,884,475   5,750,222 

Per share market value at end of period

  $22.13  $16.39 

Total return based on market value(2)

   (0.59)%   19.71

Total return based on net asset value(3)

   0.85  4.10

Ratio/Supplemental data:

  

Ratio of net investment income to average net assets(8)

   11.29  7.98

Ratio of operating expenses to average net assets(7)

   7.77  7.15

Ratio of incentive management fees to average
net assets(6)

   0.14  0.58

Ratio of interest and debt financing expenses to average net assets(7)

   7.84  7.44

Ratio of total expenses to average net assets(8)

   15.75  15.17

Portfolio turnover rate(5)

   2.00  N/A 

Asset coverage ratio per unit(6)

   2,290   3,057 

Average market value per unit:

  

Credit Facility(9)

   N/A   N/A 

SBA Debentures(9)

   N/A   N/A 

2020 Notes

   N/A   25.02 

2023 Notes

   26.04   N/A 

 

 

33


Table of Contents
(1)Net investment income per share is calculated using the weighted average shares outstanding during the period.
(2)Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.
(3)Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s DRIP. Total investment return does not reflect brokerage commissions.
(4)Represents the dilutive effect of issuing common stock below net asset value per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement. See Note 12, Dividend.
(5)Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.
(6)Ratios are not annualized.
(7)Ratios are annualized.
(8)Ratios are annualized. Incentive management fees included within the ratio are not annualized.
(9)The Credit Facility and SBA Debentures are not registered for public trading.

Note 14. Subsequent Events

The Company has evaluated subsequent events through the filing of this Form 10-Q and determined that there have been no events that have occurred that would require adjustments to the Company’s disclosures in the consolidated financial statements except for the following:

On May 30, 2017, the Company declared a dividend of $0.47 per share payable on June 27, 2017, to common stockholders of record on June 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.

 

34


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under Part I. Item 1A in our Annual Report on Form 10-K for the fiscal year ended February 28, 2017.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

 

  our future operating results;

 

  our business prospects and the prospects of our portfolio companies;

 

  the impact of investments that we expect to make;

 

  our contractual arrangements and relationships with third parties;

 

  the dependence of our future success on the general economy and its impact on the industries in which we invest;

 

  the ability of our portfolio companies to achieve their objectives;

 

  our expected financings and investments;

 

  our regulatory structure and tax treatment, including our ability to operate as a business development company (“BDC”), or to operate our small business investment company (“SBIC”) subsidiary, and to continue to qualify to be taxed as a regulated investment company (“RIC”);

 

  the adequacy of our cash resources and working capital;

 

  the timing of cash flows, if any, from the operations of our portfolio companies; and

 

  the ability of our investment adviser to locate suitable investments for us and to monitor and effectively administer our investments.

You should not place undue reliance on these forward-looking statements. The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q.

OVERVIEW

We are a Maryland corporation that has elected to be treated as a BDC under the Investment Company Act of 1940 (the“1940 Act”). Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We invest primarily in leveraged loans and mezzanine debt issued by private U.S. middle market companies, which we define as companies having EBITDA of between $2 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to

 

35


Table of Contents

stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of “investment company” under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, which includes private equity funds, to no more than 15.0% of its net assets. We have elected and qualified to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Corporate History and Recent Developments

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors (“SIA”) to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

As a result of the event of default under a revolving securitized credit facility with Deutsche Bank we previously had in place, in December 2008 we engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us. On April 14, 2010, GSC Investment Corp. entered into a stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates and an assignment, assumption and novation agreement with Saratoga Investment Advisors, pursuant to which GSC Investment Corp. assumed certain rights and obligations of Saratoga Investment Advisors under a debt commitment letter Saratoga Investment Advisors received from Madison Capital Funding LLC, which indicated Madison Capital Funding’s willingness to provide GSC Investment Corp. with a $40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, GSC Investment Corp. and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

On July 30, 2010, the transactions contemplated by the stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates were completed, the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates closed, the Company entered into the Credit Facility, and the Company began doing business as Saratoga Investment Corp.

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

In January 2011, we registered for public resale of the 986,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received an SBIC license from the Small Business Administration (“SBA”).

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 (the “2020 Notes”) for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these 2020 Notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The 2020 Notes mature on May 31, 2020 and since May 31, 2016, may be redeemed in whole or in part at any time or from time to time at our option. The 2020 Notes were listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share. The 2020 Notes were redeemed in full on January 13, 2017.

 

36


Table of Contents

On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which we may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market (“ATM”) offering. As of May 31, 2017, the Company sold 539,725 bonds with a principal of $13,493,125 at an average price of $25.31 for aggregate net proceeds of $13,385,766 (net of transaction costs).

On December 21, 2016, we issued $74.5 million in aggregate principal amount of our 6.75% fixed-rate notes due 2023 (the “2023 Notes”) for net proceeds of $72.1 million after deducting underwriting commissions of approximately $2.0 million and offering costs of approximately $0.5 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. Interest on the 2023 Notes is paid quarterly in arrears on March 15, June 15, September 15 and December 15, at a rate of 6.75% per year, beginning March 30, 2017. The 2023 Notes mature on December 20, 2023, and commencing December 21, 2019, may be redeemed in whole or in part at any time or from time to time at our option. The 2023 Notes are listed on the NYSE under the trading symbol “SAB” with a par value of $25.00 per share.

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. As of May 31, 2017, the Company sold 60,779 shares for gross proceeds of $1.4 million at an average price of $22.49 for aggregate net proceeds of $1.3 million (net of transaction costs).

Critical Accounting Policies

Basis of Presentation

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in the Company’s consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisers, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

 

  Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

 

37


Table of Contents
  An independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year.

In addition, all our investments are subject to the following valuation process:

 

  The audit committee of our board of directors reviews and approves each preliminary valuation and Saratoga Investment Advisors and an independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

 

  Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by SIA and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Revenue Recognition

Income Recognition

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Payment-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

 

38


Table of Contents

Capital Gains Incentive Fee

The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

Revenues

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt investments may provide for a portion of the interest to be PIK. To the extent interest is paid-in-kind, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity securities that pay dividends on a current basis.

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 and its reinvestment period ended in October 2016. On November 15, 2016, we completed the second refinancing of the Saratoga CLO. The Saratoga CLO refinancing, among other things, extended its reinvestment period to October 2018, and extended its legal maturity date to October 2025. Following the refinancing, the Saratoga CLO portfolio remained at the same size and with a similar capital structure of approximately $300.0 million in aggregate principal amount of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we also purchased $4.5 million in aggregate principal amount of the Class F notes tranche of the Saratoga CLO at par, with a coupon of LIBOR plus 8.5%.

The Saratoga CLO remains effectively 100% owned and managed by Saratoga Investment Corp. Following the refinancing, we receive a base management fee of 0.10% and a subordinated management fee of 0.40% of the fee basis amount at the beginning of the collection period, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

We recognize interest income on our investment in the subordinated notes of Saratoga CLO using the effective interest method, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Expenses

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our investment adviser for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

 

  organization;

 

  calculating our net asset value (including the cost and expenses of any independent valuation firm);

 

  expenses incurred by our investment adviser payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

 

  expenses incurred by our investment adviser payable for travel and due diligence on our prospective portfolio companies;

 

39


Table of Contents
  interest payable on debt, if any, incurred to finance our investments;

 

  offerings of our common stock and other securities;

 

  investment advisory and management fees;

 

  fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

 

  transfer agent and custodial fees;

 

  federal and state registration fees;

 

  all costs of registration and listing our common stock on any securities exchange;

 

  federal, state and local taxes;

 

  independent directors’ fees and expenses;

 

  costs of preparing and filing reports or other documents required by governmental bodies (including the Securities and Exchange Commission (“SEC”) and the SBA);

 

  costs of any reports, proxy statements or other notices to common stockholders including printing costs;

 

  our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

 

  direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

 

  administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters and an incentive fee.

The incentive fee had two parts:

 

  A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

 

  A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis, less the aggregate amount of capital gains incentive fees paid to the investment adviser through such date.

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007, and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Quarterly Report.

 

40


Table of Contents

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

 

  The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

 

  Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

 

  We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

To the extent that any of our leveraged loans are denominated in a currency other than U.S. Dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of interest rate caps, futures, options and forward contracts. Costs incurred in entering into or settling such contracts will be borne by us.

New Accounting Pronouncements

In October 2016, the SEC adopted new rules and amended existing rules (together, “final rules”) intended to modernize the reporting and disclosure of information by registered investment companies. In part, the final rules amend Regulation S-X and require standardized, enhanced disclosures about derivatives in investment company financial statements, as well as other amendments. The compliance date for the amendments to Regulation S-X is August 1, 2017. Management is currently evaluating the impact that the adoption of the amendments to Regulation S-X will have on the Company’s consolidated financial statements and related disclosures.

In August 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which is intended to reduce the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The guidance is effective for annual periods beginning after December 15, 2017, and interim periods therein. Early adoption is permitted. Management is currently evaluating the impact ASU 2016-15 will have on the Company’s consolidated financial statements and disclosures.

In February 2016, the FASB issued ASU 2016-02, Amendments to the Leases (“ASU Topic 842”), which will require for all operating leases the recognition of a right-of-use asset and a lease liability, in the statement of financial position. The lease cost will be allocated over the lease term on a straight-line basis. This guidance is effective for annual and interim periods beginning after December 15, 2018. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments — Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”). ASU 2016-01 retains many current requirements for the classification and measurement of financial instruments; however, it significantly revises an entity’s accounting related to (1) the classification and measurement of investments in equity securities and (2) the presentation of certain fair value changes for financial liabilities measured at fair value. ASU 2016-01 also amends certain disclosure requirements associated with the fair value of financial instruments. This guidance is effective for annual and interim periods beginning after December 15, 2017, and early adoption is not permitted for public business entities. Management is currently evaluating the impact the adoption of this standard has on our consolidated financial statements and disclosures.

 

41


Table of Contents

In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Revenue Recognition (Topic 605). Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In May 2016, ASU 2016-12 amended ASU 2014-09 and deferred the effective period to December 15, 2017. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statements and disclosures.

Portfolio and investment activity

Corporate Debt Portfolio Overview

 

   At May 31,
2017
   At February 28,
2017
 
   ($ in millions)   ($ in millions) 

Number of investments(1)

   57    52 

Number of portfolio companies(3)

   31    28 

Average investment size(1)

  $5.6   $5.4 

Weighted average maturity(1)

   3.7 yrs    3.8 yrs 

Number of industries(3)

   9    9 

Average investment per portfolio company(1)

  $9.9   $9.7 

Non-performing or delinquent investments

  $11.3   $8.4 

Fixed rate debt (% of interest bearing portfolio)(2)

  $44.0(14.9%)   $44.2(16.9%) 

Weighted average current coupon(2)

   11.9%    11.4% 

Floating rate debt (% of interest bearing portfolio)(2)

  $  252.2(85.1%)   $  217.6(83.1%) 

Weighted average current spread over LIBOR(2)(4)

   9.3%    9.3% 

 

(1)Excludes our investment in the subordinated notes of Saratoga CLO.
(2)Excludes our investment in the subordinated notes of Saratoga CLO and equity interests.
(3)Excludes our investment in the subordinated notes of Saratoga CLO and Class F notes tranche of Saratoga CLO.
(4)Calculation uses either 1-month or 3-month LIBOR, depending on the contractual turns, and after factoring in any existing LIBOR floors.

During the three months ended May 31, 2017, we invested $45.0 million in new or existing portfolio companies and had $5.9 million in aggregate amount of exits and repayments resulting in net investments of $39.1 million for the period. During the three months ended May 31, 2016, we did not invest in any new or existing portfolio companies and had $20.6 million in aggregate amount of exits and repayments resulting in net repayments of $20.6 million for the period.

Our portfolio composition at May 31, 2017 and February 28, 2017 at fair value was as follows:

Portfolio composition

 

   At May 31, 2017  At February 28, 2017 
   Percentage
of Total
Portfolio
  Weighted
Average
Current
Yield
  Percentage
of Total
Portfolio
  Weighted
Average
Current
Yield
 

Syndicated loans

   2.8  5.3  3.4  5.3

First lien term loans

   56.4   10.8   54.3   10.5 

Second lien term loans

   29.1   12.5   30.0   11.7 

Structured finance securities

   4.9   16.0   5.3   12.7 

Equity interests

   6.8   4.0   7.0   0.4 
  

 

 

  

 

 

  

 

 

  

 

 

 

Total

   100.0  11.4  100.0  10.9
  

 

 

  

 

 

  

 

 

  

 

 

 

Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at May 31, 2017 and February 28, 2017 was composed of $299.3 million and $297.1 million, respectively, in aggregate principal amount of

 

42


Table of Contents

predominantly senior secured first lien term loans. This investment is subject to unique risks. (See “Risk Factors—Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility” in our Annual Report on Form 10-K for the fiscal year ended February 28, 2017). We do not consolidate the Saratoga CLO portfolio in our consolidated financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at May 31, 2017, $290.2 million or 98.5% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and there was one Saratoga CLO portfolio investment in default with a fair value of $1.4 million. At February 28, 2017, $288.5 million or 98.7% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and one Saratoga CLO portfolio investment was in default with a fair value of $1.4 million.

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—performing credit; (Yellow)—underperforming credit; (Red)—in payment default and/or risk of principal recovery.

The CMR distribution of our investments at May 31, 2017 and February 28, 2017 was as follows:

Portfolio CMR distribution

 

   At May 31, 2017  At February 28, 2017 

Color Score

  Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Green

  $284,624    86.3 $245,678    83.9

Yellow

   8,280    2.5   8,423    2.9 

Red

   2,702    0.8   7,069    2.4 

N/A(1)

   34,084    10.4   31,491    10.8 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $329,690    100.0 $292,661    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

The change in reserve from $0.2 million as of February 28, 2017 to $0.8 million as of May 31, 2017 primarily related to the increase in reserve for the quarter on two non-performing and delinquent investments, TM Restaurant Group L.L.C and My Alarm Center, LLC.

The CMR distribution of Saratoga CLO investments at May 31, 2017 and February 28, 2017 was as follows:

Portfolio CMR distribution

 

   At May 31, 2017  At February 28, 2017 

Color Score

  Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Green

  $270,009    91.6 $266,449    91.1

Yellow

   20,194    6.9   22,064    7.6 

Red

   4,476    1.5   3,925    1.3 

N/A(1)

   34    0.0   23    0.0 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $294,713    100.0 $292,461    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of Saratoga CLO’s equity interests.

 

43


Table of Contents

Portfolio composition by industry grouping at fair value

The following table shows our portfolio composition by industry grouping at fair value at May 31, 2017 and February 28, 2017:

 

   At May 31, 2017  At February 28, 2017 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Business Services

  $187,407    56.8 $161,212    55.1

Healthcare Services

   37,836    11.5   38,544    13.2 

Education

   26,725    8.1   10,928    3.7 

Media

   18,106    5.5   18,698    6.4 

Consumer Services

   16,217    4.9   20,748    7.1 

Structured Finance Securities(1)

   16,111    4.9   15,450    5.3 

Real Estate

   15,749    4.8   16,839    5.7 

Food and Beverage

   8,646    2.6   8,423    2.9 

Metals

   1,896    0.6   851    0.3 

Consumer Products

   997    0.3   968    0.3 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $329,690    100.0 $292,661    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of our investment in the subordinated notes and Class F Note of Saratoga CLO.

 

44


Table of Contents

The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at May 31, 2017 and February 28, 2017:

 

   At May 31, 2017  At February 28, 2017 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Services: Business

  $37,393    12.7 $40,675    13.9

Healthcare & Pharmaceuticals

   32,381    11.0   33,002    11.3 

High Tech Industries

   21,233    7.2   17,851    6.1 

Chemicals/Plastics

   20,805    7.1   21,492    7.4 

Banking, Finance, Insurance & Real Estate

   19,378    6.6   14,752    5.0 

Retailers (Except Food and Drugs)

   14,890    5.1   14,706    5.0 

Aerospace and Defense

   14,143    4.8   11,643    4.0 

Telecommunications

   14,065    4.8   13,704    4.7 

Media

   12,110    4.1   11,283    3.9 

Leisure Goods/Activities/Movies

   10,466    3.6   9,627    3.3 

Industrial Equipment

   9,323    3.2   9,853    3.4 

Electronics/Electric

   7,951    2.7   8,036    2.7 

Automotive

   7,750    2.6   6,088    2.1 

Financial Intermediaries

   6,553    2.2   9,476    3.2 

Capital Equipment

   6,518    2.2   6,026    2.1 

Utilities

   5,348    1.8   4,944    1.7 

Drugs

   4,638    1.6   5,394    1.8 

Publishing

   4,542    1.5   4,580    1.6 

Lodging and Casinos

   4,274    1.4   4,311    1.5 

Food Services

   4,273    1.4   5,932    2.0 

Beverage, Food & Tobacco

   3,977    1.3   3,013    1.0 

Transportation

   3,834    1.3   2,731    0.9 

Technology

   3,788    1.3   3,935    1.3 

Oil & Gas

   3,132    1.1   3,209    1.1 

Insurance

   2,931    1.0   3,001    1.0 

Conglomerate

   2,560    0.9   3,584    1.2 

Construction & Building

   2,466    0.8   1,974    0.7 

Brokers/Dealers/Investment Houses

   2,435    0.8   2,479    0.8 

Containers/Glass Products

   2,356    0.8   2,008    0.7 

Hotel, Gaming and Leisure

   2,019    0.7   2,025    0.7 

Food Products

   2,013    0.7   3,147    1.1 

Cable and Satellite Television

   1,614    0.5   1,617    0.6 

Food/Drug Retailers

   1,403    0.5   2,877    1.0 

Services: Consumer

   1,276    0.4   788    0.3 

Forest Products & Paper

   502    0.2   —      —   

Broadcast Radio and Television

   373    0.1   343    0.1 

Nonferrous Metals/Minerals

   —      —     1,312    0.4 

Environmental Industries

   —      —     800    0.3 

Building and Development

   —      —     243    0.1 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $294,713    100.0 $292,461    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

45


Table of Contents

Portfolio composition by geographic location at fair value

The following table shows our portfolio composition by geographic location at fair value at May 31, 2017 and February 28, 2017. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

 

   At May 31, 2017  At February 28, 2017 
   Investments
at
Fair Value
   Percentage
of Total
Portfolio
  Investments
at
Fair Value
   Percentage
of Total
Portfolio
 
   ($ in thousands) 

Southeast

  $144,013    43.7 $116,186    39.7

Midwest

   88,586    26.9   75,154    25.7 

Southwest

   34,018    10.3   34,060    11.6 

Northeast

   33,952    10.3   38,880    13.3 

Other(1)

   16,111    4.9   15,450    5.3 

Northwest

   7,850    2.4   7,780    2.6 

West

   5,160    1.5   5,151    1.8 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $329,690    100.0 $292,661    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

 

(1)Comprised of our investment in the subordinated notes and Class F Note of Saratoga CLO.

Results of operations

Operating results for the three months ended May 31, 2017 and May 31, 2016 were as follows:

 

   For the three months ended 
   May 31,
2017
   May 31,
2016
 
   ($ in thousands) 

Total investment income

  $8,707   $7,908 

Total expenses

   5,203    5,369 
  

 

 

   

 

 

 

Net investment income

   3,504    2,539 

Net realized gains from investments

   96    6,103 

Net unrealized depreciation on investments

   (2,586   (5,354
  

 

 

   

 

 

 

Net increase in net assets resulting from operations

  $1,014   $3,288 
  

 

 

   

 

 

 

Investment income

The composition of our investment income for the three months ended May 31, 2017 and May 31, 2016 was as follows:

 

   For the three months ended 
   May 31,
2017
   May 31,
2016
 
   ($ in thousands) 

Interest from investments

  $7,741   $7,281 

Management fee income

   376    374 

Incentive fee income

   105    —   

Interest from cash and cash equivalents and other income

   485    253 
  

 

 

   

 

 

 

Total

  $8,707   $7,908 
  

 

 

   

 

 

 

For the three months ended May 31, 2017, total investment income of $8.7 million increased $0.8 million, or 10.1% compared to $7.9 million for the three months ended May 31, 2016. Interest income from investments increased $0.4 million, or 6.3%, to $7.7 million for the three months ended May 31, 2017 from $7.3 million for the three months ended May 31, 2016. This reflects an

 

46


Table of Contents

increase of 24.7% in total investments to $329.7 million at May 31, 2017 from $264.4 million at May 31, 2016, with some of the new investments being towards the end of the period. The increase was offset by the weighted average current coupon decreasing from 11.5% to 11.4%.

For the three months ended May 31, 2017 and May 31, 2016, total PIK income was $0.5 million and $0.1 million, respectively.

For the three months ended May 31, 2017, incentive fee income of $0.1 million was recognized related to Saratoga CLO, reflecting the 12.0% hurdle rate that has been achieved.

Operating expenses

The composition of our operating expenses for the three months ended May 31, 2017 and May 31, 2016 was as follows:

Operating Expenses

 

   For the three months ended 
   May 31,
2017
   May 31,
2016
 
   ($ in thousands) 

Interest and debt financing expenses

  $2,524   $2,368 

Base management fees

   1,391    1,227 

Professional fees

   384    359 

Administrator expenses

   375    325 

Incentive management fees

   176    728 

Insurance

   66    71 

Directors fees and expenses

   51    66 

General and administrative and other expenses

   236    225 
  

 

 

   

 

 

 

Total expenses

  $5,203   $5,369 
  

 

 

   

 

 

 

For the three months ended May 31, 2017, total operating expenses decreased $0.2 million, or 3.1% compared to the three months ended May 31, 2016.

For the three months ended May 31, 2017 and May 31, 2016, the increase in interest and debt financing expenses is primarily attributable to an increase in outstanding debt as compared to the prior year, with increased levels of outstanding SBA debentures, as well as additional notes being issued. Our SBA debentures increased from $103.7 million at May 31, 2016 to $134.7 million at May 31, 2017, while the 2020 Notes were repaid and the 2023 Notes issued, increasing the notes payable from $61.8 million outstanding to $74.5 million outstanding for these same periods. For the three months ended May 31, 2017, the weighted average interest rate on our outstanding indebtedness was 4.59% compared to 4.74% for the three months ended May 31, 2016. This decrease was primarily driven by an increase in SBA debentures that carry a lower interest rate as well as the notes payable interest rate decreasing from 7.50% to 6.75% following the refinancing of the 2020 Notes. SBA debentures decreased from 62.7% of overall debt as of May 31, 2016 to 57.6% as of May 31, 2017, primarily due to $24.5 million outstanding on the Credit Facility, which was drawn towards the end of the quarter.

For the three months ended May 31, 2017, base management fees increased $0.2 million, or 13.4% compared to the three months ended May 31, 2016. The increase in base management fees results from the 13.4% increase in the average value of our total assets, less cash and cash equivalents, from $278.2 million as of May 31, 2016 to $315.4 million as of May 31, 2017.

For the three months ended May 31, 2017, professional fees increased $0.03 million, or 7.0%, compared to the three months ended May 31, 2016.

For the three months ended May 31, 2017, incentive management fees decreased $0.6 million, or 75.8%, compared to the three months ended May 31, 2016. The first part of the incentive management fees increased this year from $0.65 million to $0.74 million as higher average total assets of 13.4% has led to increased net investment income above the hurdle rate pursuant to the investment advisory and management agreement. However, for the three months ended May 31, 2017, incentive management fees in total decreased $0.6 million as the incentive management fees related to capital gains decreased from incentive fees of $0.1 million for the three months ended May 31, 2016 to a reduction in incentive fees of $0.6 million, reflecting the $2.5 million net loss on investments for the three months ended May 31, 2017.

 

47


Table of Contents

As discussed above, the increase in interest and debt financing expenses for the three months ended May 31, 2017 as compared to the three months ended May 31, 2016 is primarily attributable to an increase in the amount of outstanding debt. For the three months ended May 31, 2017, there was also $24.5 million of outstanding borrowings under the Credit Facility. For the three months ended May 31, 2016, there were no outstanding borrowings under the Credit Facility. For the three months ended May 31, 2017 and May 31, 2016, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.18% and 3.09%, respectively.

Net realized gains (losses) on sales of investments

For the three months ended May 31, 2017, the Company had $5.9 million of sales, repayments, exits or restructurings resulting in $0.1 million of net realized gains. The most significant realized gains during the three months ended May 31, 2017 were as follows (dollars in thousands):

Three Months ended May 31, 2017

 

Issuer

  Asset Type   Gross
Proceeds
   Cost   Net
Realized
Gain
 

Take 5 Oil Change, L.L.C

   Common Stock   $124   $—     $124 

Mercury Funding

   Second Lien Term Loan    2,786    2,767    19 

For the three months ended May 31, 2016, the Company had $20.6 million of sales, repayments, exits or restructurings resulting in $6.1 million of net realized gains. The most significant realized gains during the three months ended May 31, 2016 were as follows (dollars in thousands):

Three Months ended May 31, 2016

 

Issuer

  Asset Type   Gross
Proceeds
   Cost   Net
Realized
Gain
 

Take 5 Oil Change, L.L.C

   Common Stock   $6,457   $481   $5,976 

Advanced Air & Heat of Florida, LLC

   First Lien Term Loan    7,100    7,037    63 

The $6.0 million of realized gain on our investment in Take 5 Oil Change, L.L.C. was due to the completion of a sales transaction with a strategic acquirer.

Net unrealized appreciation (depreciation) on investments

For the three months ended May 31, 2017, our investments had net unrealized depreciation of $2.6 million versus net unrealized depreciation of $5.4 million for the three months ended May 31, 2016. The most significant cumulative changes in unrealized appreciation and depreciation for the three months ended May 31, 2017, were the following (dollars in thousands):

 

48


Table of Contents

Three Months ended May 31, 2017

 

Issuer

 Asset Type  Cost  Fair
Value
  Total
Unrealized
Appreciation
(Depreciation)
  YTD Change
in Unrealized
Appreciation
(Depreciation)
 

Saratoga Investment Corp. CLO 2013-1, Ltd

  Structured Finance Securities  $9,520  $11,563  $2,043  $1,412 

Mercury Network, LLC

  Common Stock   858  2,631  1,773   1,120 

Elyria Foundry Company, L.L.C.

  Common Stock   9,218   1,458  (7,760  1,044 

Ohio Medical, LLC

  Second Lien Term Loan   7,241   6,396   (846  (597

My Alarm Center, LLC

  Second Lien Term Loan   10,330   2,696   (7,634  (5,336

The $1.1 million of change in unrealized appreciation in our investment in Mercury Network, LLC was driven by the completion of a sales transaction with a strategic acquirer.

The $1.0 million of change in unrealized appreciation in our investment in Elyria Foundry Company, L.L.C. was driven by an increase in oil and gas end markets since year-end, positively impacting the Company’s performance.

The $5.3 million of change in unrealized depreciation in our investment in My Alarm Center, LLC was driven by increasing leverage levels combined with declining market conditions in the sector.

The most significant cumulative changes in unrealized appreciation and depreciation for the three months ended May 31, 2016, were the following (dollars in thousands):

Three Months ended May 31, 2016

 

Issuer

 Asset Type Cost  Fair
Value
  Total
Unrealized
Appreciation
(Depreciation)
   YTD Change
in Unrealized
Appreciation
(Depreciation)
 

Take 5 Oil Change, L.L.C

 Common Stock $—   $—   $—    $(5,755

Elyria Foundry Company, L.L.C

 Common Stock  9,218   583   (8,635   (1,443

Prime Security Services, LLC

 Second Lien Term Loan  11,835   12,092   257    1,106 

The $5.8 million of change in unrealized depreciation in our investment in Take 5 Oil Change, L.L.C. was driven by the completion of a sales transaction with a strategic acquirer. In realizing this gain as a result of the sale, unrealized appreciation was adjusted to zero, which resulted in a $5.8 million change in unrealized depreciation for the quarter.

The $1.4 million of change in unrealized depreciation in our investment in Elyria Foundry Company, L.L.C. was driven by a continued decline in oil and gas end markets since quarter end, negatively impacting the company’s performance.

The $1.1 million of change in unrealized appreciation in our investment in Prime Security Services, LLC was driven by a narrowing of credit spreads since quarter end.

Changes in net assets resulting from operations

For the three months ended May 31, 2017 and May 31, 2016, we recorded a net increase in net assets resulting from operations of $1.0 million and $3.3 million, respectively. Based on 5,861,654 weighted average common shares outstanding as of May 31, 2017, our per share net increase in net assets resulting from operations was $0.17 for the three months ended May 31, 2017. This compares to a per share net increase in net assets resulting from operations of $0.57 for the three months ended May 31, 2016 based on 5,737,496 weighted average common shares outstanding as of May 31, 2016.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities.

 

49


Table of Contents

Although we expect to fund the growth of our investment portfolio through the net proceeds from SBA debenture drawdowns and future equity offerings, including our dividend reinvestment plan (“DRIP”), and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital.

In addition, we intend to distribute to our stockholders substantially all of our taxable income in order to satisfy the distribution requirement applicable to RICs under the Code. In satisfying this distribution requirement, we have in the past relied on Internal Revenue Service (“IRS”) issued private letter rulings concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. We may rely on these IRS private letter rulings in future periods to satisfy our RIC distribution requirement.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200.0%. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 229.0% as of May 31, 2017 and 271.0% as of February 28, 2017. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Madison revolving credit facility

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Madison Capital Funding LLC (the “Credit Facility”) on June 30, 2010.

Availability. The Company can draw up to the lesser of (i) $40.0 million (the “Facility Amount”) and (ii) the product of the applicable advance rate (which varies from 50.0% to 75.0% depending on the type of loan asset) and the value, determined in accordance with the Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”), in each case less (a) the amount of any undrawn funding commitments the Company has under any loan asset and which are not covered by amounts in the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”) and outstanding borrowings. Each loan asset held by the Company as of the date on which the Credit Facility was closed was valued as of that date and each loan asset that the Company acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, the Company may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

Collateral. The Credit Facility is secured by substantially all of the assets of the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and the Company’s rights under the CLO Management Agreement (as defined below).

Interest Rate and Fees. Under the Credit Facility, funds are borrowed from or through certain lenders at the greater of the

 

50


Table of Contents

prevailing LIBOR rate and 1.00%, plus an applicable margin of 4.75%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 2.00%, and the applicable margin over such alternative base rate is 3.75%. In addition, the Company pays the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. The Company was also obligated to pay certain other fees to the lenders in connection with the closing of the Credit Facility.

Revolving Period and Maturity Date. The Company may make and repay borrowings under the Credit Facility for a period of three years following the closing of the Credit Facility (the “Revolving Period”). The Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Credit Facility are due and payable in full five years after the end of the Revolving Period.

Collateral Tests. It is a condition precedent to any borrowing under the Credit Facility that the principal amount outstanding under the Credit Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

 

  Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Credit Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Credit Facility for the last 6 payment periods must equal at least 175.0%.

 

  Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

 

  Weighted Average FMV Test. The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72.0% and 80.0% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85.0% at all times thereafter.

The Credit Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon the Company’s breach of its representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.

Priority of Payments. During the Revolving Period, the priority of payments provisions of the Credit Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.

Reserve Account. The Credit Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.

Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the “Unfunded Exposure Account”) 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Credit Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.

 

51


Table of Contents

Operating Expenses. The priority of payments provision of the Credit Facility provides for the payment of certain operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company’s assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Credit Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.

Events of Default. The Credit Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Credit Facility does not contain grace periods for breach by the Company of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and separate legal entity status of the Company covenants and certain other customary covenants. Other events of default under the Credit Facility include, among other things, the following:

 

  an Interest Coverage Ratio of less than 150.0%;

 

  an Overcollateralization Ratio of less than 175.0%;

 

  the filing of certain ERISA or tax liens;

 

  the occurrence of certain “Manager Events” such as:

 

  failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5.0 million at any time prior to the third anniversary of the closing date;

 

  failure of the Management Agreement between Saratoga Investment Advisors and the Company to be in full force and effect;

 

  indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;

 

  resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

 

  occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.

Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with Saratoga Investment Advisors’ policies, personnel and processes relating to the loan assets.

Fees and Expenses. The Company paid certain fees and reimbursed Madison Capital Funding LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital Funding LLC in connection with the Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates. These amounts totaled $2.0 million.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

 

  expand the borrowing capacity under the Credit Facility from $40.0 million to $45.0 million;

 

52


Table of Contents
  extend the period during which we may make and repay borrowings under the Credit Facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may, upon the occurrence of an event of default, by action of the lenders or automatically, be terminated. All borrowings and other amounts payable under the Credit Facility are due and payable five years after the end of the Revolving Period; and

 

  remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

 

  extend the commitment termination date from February 24, 2015 to September 17, 2017;

 

  extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

 

  reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

 

  reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

On May 18, 2017, we entered into a third amendment to the Credit Facility with Madison Capital Funding LLC to, among other things:

 

  extend the commitment termination date from September 17, 2017 to September 17, 2020;

 

  extend the final maturity date of the Credit Facility from September 17, 2022 to September 17, 2025;

 

  reduce the floor on base rate borrowings from 2.25% to 2.0%;

 

  reduce the floor on LIBOR borrowings from 1.25% to 1.00%; and

 

  reduce the commitment fee rate from 0.75% to 0.50% for any period during which the ratio of advances outstanding to aggregate commitments, expressed as a percentage, is greater than or equal to 50%.

As of May 31, 2017, we had $24.5 million of outstanding borrowings under the Credit Facility and $134.7 million of SBA-guaranteed debentures outstanding (which are discussed below). As of February 28, 2017, we had no outstanding borrowings under the Credit Facility and $112.7 million SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at May 31, 2017 and February 28, 2017 was $45.0 million and $24.7 million, respectively.

Our asset coverage ratio, as defined in the 1940 Act, was 229.0% as of May 31, 2017 and 271.0% as of February 28, 2017.

SBA-guaranteed debentures

In addition, we, through a wholly-owned subsidiary, sought and obtained a license from the SBA to operate an SBIC. In this regard, on March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received a license from the SBA to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses.

The SBIC license allows our SBIC subsidiary to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

SBA regulations currently limit the amount that our SBIC subsidiary may borrow to a maximum of $150.0 million when it has at least $75.0 million in regulatory capital, receives a capital commitment from the SBA and has been through an examination by the SBA subsequent to licensing. As of May 31, 2017, our SBIC subsidiary had $75.0 million in regulatory capital and $134.7 million SBA-guaranteed debentures outstanding.

We received exemptive relief from the SEC to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA

 

53


Table of Contents

from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows us increased flexibility under the 200.0% asset coverage test by permitting us to borrow up to $150.0 million more than we would otherwise be able to absent the receipt of this exemptive relief.

On April 2, 2015, the SBA issued a “green light” letter inviting the Company to continue our application process to obtain a license to form and operate its second SBIC subsidiary. On September 27, 2016, the SBA informed us that as part of their continued review of our application for a second license, and in order to ensure that they were reviewing the most current information available, we would need to update all previously submitted materials and invited us to reapply. As a result of this request, with which we are in the process of complying, the existing “green light” letter that the SBA issued to us has expired. If approved in the future, a second SBIC license would provide us an incremental source of long-term capital by permitting us to issue up to $150.0 million of additional SBA-guaranteed debentures in addition to the $150.0 million already approved under the first license.

Unsecured notes

In May 2013, we issued $48.3 million in aggregate principal amount of our 2020 Notes for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these 2020 Notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The 2020 Notes mature on May 31, 2020 and since May 31, 2016, may be redeemed in whole or in part at any time or from time to time at our option. In connection with the issuance of the 2020 Notes, we agreed to the following covenants for the period of time during which the 2020 Notes are outstanding:

 

  we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200.0% after such borrowings.

 

  we will not violate (regardless of whether we are subject to) Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) no-action relief granted by the SEC to another BDC (or to the Company if it determines to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a) (1)(B) as modified by Section 61(a)(1) of the 1940 Act in order to maintain the BDC’s status as a regulated investment company under the Code. Currently these provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200.0% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.

The 2020 Notes were redeemed in full on January 13, 2017 and are no longer listed on the NYSE.

On May 29, 2015, we entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. through which we may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an ATM offering. As of May 31, 2017, the Company sold 539,725 bonds with a principal of $13,493,125 at an average price of $25.31 for aggregate net proceeds of $13,385,766 (net of transaction costs).

On December 21, 2016, we issued $74.5 million in aggregate principal amount of our 2023 Notes for net proceeds of $71.7 million after deducting underwriting commissions of approximately $2.3 million and offering costs of approximately $0.5 million. The issuance included the exercise of substantially all of the underwriters’ option to purchase an additional $9.8 million aggregate principal amount of 2023 Notes within 30 days. Interest on the 2023 Notes is paid quarterly in arrears on March 15, June 15, September 15 and December 15, at a rate of 6.75% per year, beginning March 30, 2017. The 2023 Notes mature on December 30, 2023, and commencing December 21, 2019, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used to repay all of the outstanding indebtedness under the 2020 Notes on January 13, 2017, which amounts to $61.8 million, and for general corporate purposes in accordance with our investment objective and strategies. The 2020 Notes were redeemed in full on January 13, 2017. The 2023 Notes are listed on the NYSE under the trading symbol “SAB” with a par value of $25.00 per share. In connection with the issuance of the 2023 Notes, we agreed to the following covenants for the period of time during which the notes are outstanding:

 

  

we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940

 

54


Table of Contents
 

Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings.

 

  if, at any time, we are not subject to the reporting requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, or the Exchange Act, to file any periodic reports with the SEC, we agree to furnish to holders of the 2023 Notes and the Trustee, for the period of time during which the 2023 Notes are outstanding, our audited annual consolidated financial statements, within 90 days of our fiscal year end, and unaudited interim consolidated financial statements, within 45 days of our fiscal quarter end (other than our fourth fiscal quarter). All such financial statements will be prepared, in all material respects, in accordance with applicable United States generally accepted accounting principles.

At May 31, 2017 and February 28, 2017, the fair value of investments, cash and cash equivalents and cash and cash equivalents, reserve accounts were as follows:

 

   At May 31, 2017  At February 28, 2017 
   Fair Value   Percentage
of
Total
  Fair Value   Percentage
of
Total
 
   ($ in thousands) 

Cash and cash equivalents

  $1,247    0.4 $9,307    3.0

Cash and cash equivalents, reserve accounts

   26,527    7.4   12,781    4.1 

Syndicated loans

   9,068    2.5   9,823    3.1 

First lien term loans

   186,015    52.0   159,097    50.5 

Second lien term loans

   95,975    26.9   87,750    27.9 

Structured finance securities

   16,111    4.5   15,450    4.9 

Equity interests

   22,521    6.3   20,541    6.5 
  

 

 

   

 

 

  

 

 

   

 

 

 

Total

  $357,464    100.0 $314,749    100.0
  

 

 

   

 

 

  

 

 

   

 

 

 

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. As of May 31, 2017, the Company sold 60,779 shares for gross proceeds of $1.4 million at an average price of $22.49 for aggregate net proceeds of $1.3 million (net of transaction costs).

On September 24, 2014, we announced the approval of an open market share repurchase plan that allows it to repurchase up to 200,000 shares of our common stock at prices below our NAV as reported in its then most recently published consolidated financial statements, which was subsequently increased to 400,000 shares of our common stock. On October 5, 2016, our board of directors extended the open market share repurchase plan for another year to October 15, 2017 and increased the number of shares we are permitted to repurchase at prices below our NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of our common stock. As of May 31, 2017, we purchased 218,491 shares of common stock, at the average price of $16.87 for approximately $3.7 million pursuant to this repurchase plan.

On May 30, 2017, we declared a dividend of $0.47 per share payable on June 27, 2017, to common stockholders of record on June 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to our DRIP. Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.

On February 28, 2017, our board of directors declared a dividend of $0.46 per share, which was paid on March 28, 2017, to common stockholders of record as of March 15, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.

 

55


Table of Contents

On January 12, 2017, our board of directors declared a dividend of $0.45 per share, which was paid on February 9, 2017, to common stockholders of record as of January 31, 2017. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.25 per share, which equaled the volume weighted average trading price per share of the common stock on January 27, 30, 31 and February 1, 2, 3, 6, 7, 8 and 9, 2017.

On October 5, 2016, our board of directors declared a dividend of $0.44 per share, which was paid on November 9, 2016, to common stockholders of record as of October 31, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.

On August 8, 2016, our board of directors declared a special dividend of $0.20 per share, which was paid on September 5, 2016, to common stockholders of record as of August 24, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.

On July 7, 2016, our board of directors declared a dividend of $0.43 per share, which was paid on August 9, 2016, to common stockholders of record as of July 29, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.

On March 31, 2016, our board of directors declared a dividend of $0.41 per share, which was paid on April 27, 2016, to common stockholders of record as of April 15, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.

On January 12, 2016, our board of directors declared a dividend of $0.40 per share, which was paid on February 29, 2016, to common stockholders of record as of February 1, 2016. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.11 per share, which equaled the volume weighted average trading price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24, 25, 26 and 29, 2016.

On October 7, 2015, our board of directors declared a dividend of $0.36 per share, which was paid on November 30, 2015, to common stockholders of record as of November 2, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.53 per share, which equaled the volume weighted average trading price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24, 25, 27 and 30, 2015.

On July 8, 2015, our board of directors declared a dividend of $0.33 per share, which was paid on August 31, 2015, to common stockholders of record as of August 3, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares

 

56


Table of Contents

of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.28 per share, which equaled the volume weighted average trading price per share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and 31, 2015.

On May 14, 2015, our board of directors declared a special dividend of $1.00 per share, which was paid on June 5, 2015, to common stockholders of record on as of May 26, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.47 per share, which equaled the volume weighted average trading price per share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4, and 5, 2015.

On April 9, 2015, our board of directors declared a dividend of $0.27 per share, which was paid on May 29, 2015, to common stockholders of record as of May 4, 2015. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.78 per share, which equaled the volume weighted average trading price per share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29, 2015.

On September 24, 2014, our board of directors declared a dividend of $0.22 per share, which was paid on February 27, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.

Also on September 24, 2014, our board of directors declared a dividend of $0.18 per share, which was paid on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

On October 30, 2013, our board of directors declared a dividend of $2.65 per share, which was paid on December 27, 2013, to common stockholders of record as of November 13, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.

On November 9, 2012, our board of directors declared a dividend of $4.25 per share, which was paid on December 31, 2012, to common stockholders of record as of November 20, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.

Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash

 

57


Table of Contents

limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.

On November 15, 2011, our board of directors declared a dividend of $3.00 per share, which was paid on December 30, 2011, to common stockholders of record as of November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share.

Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

On November 12, 2010, our board of directors declared a dividend of $4.40 per share to shareholders payable in cash or shares of our common stock, in accordance with the provisions of the IRS Revenue Procedure 2010-12, which allows a publicly-traded regulated investment company to satisfy its distribution requirements with a distribution paid partly in common stock provided that at least 10.0% of the distribution is payable in cash. The dividend was paid on December 29, 2010 to common shareholders of record on November 19, 2010.

Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

On November 13, 2009, our board of directors declared a dividend of $18.25 per share, which was paid on December 31, 2009, to common stockholders of record as of November 25, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $0.25 per share.

Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at May 31, 2017:

 

       Payment Due by Period 
   Total   Less Than
1 Year
   1 - 3
Years
   3 - 5
Years
   More Than
5 Years
 
   ($ in thousands) 

Long-Term Debt Obligations

  $233,611   $—     $—     $—     $233,611 
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

58


Table of Contents

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $7.0 million and $2.0 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of May 31, 2017 and February 28, 2017, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.

A summary of the composition of the unfunded commitments as of May 31, 2017 and February 28, 2017 is shown in the table below (dollars in thousands):

 

   As of 
   May 31, 2017   February 28, 2017 

CLEO Communications Holding, LLC

  $5,000   $—   

GreyHeller LLC

   2,000    2,000 

TM Restaurant Group L.L.C.

   17   —   
  

 

 

   

 

 

 

Total

  $7,017   $2,000 
  

 

 

   

 

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our business activities contain elements of market risk. We consider our principal market risk to be the fluctuation in interest rates. Managing this risk is essential to our business. Accordingly, we have systems and procedures designed to identify and analyze our risks, to establish appropriate policies and thresholds and to continually monitor this risk and thresholds by means of administrative and information technology systems and other policies and processes.

Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, including relative changes in different interest rates, variability of spread relationships, the difference in re-pricing intervals between our assets and liabilities and the effect that interest rates may have on our cash flows. Changes in the general level of interest rates can affect our net interest income, which is the difference between the interest income earned on interest earning assets and our interest expense incurred in connection with our interest bearing debt and liabilities. Changes in interest rates can also affect, among other things, our ability to acquire leveraged loans, high yield bonds and other debt investments and the value of our investment portfolio.

Our investment income is affected by fluctuations in various interest rates, including LIBOR and the prime rate. A large portion of our portfolio is, and we expect will continue to be, comprised of floating rate investments that utilize LIBOR. Our interest expense is affected by fluctuations in LIBOR only on our revolving credit facility. At May 31, 2017, we had $233.6 million of borrowings outstanding, of which $24.5 million was outstanding on the revolving credit facility.

We have analyzed the potential impact of changes in interest rates on interest income from investments. Assuming that our investments as of May 31, 2017 were to remain constant for a full fiscal year and no actions were taken to alter the existing interest rate terms, a hypothetical change of 1.0% in interest rates would cause a corresponding increase of approximately $2.5 million to our interest income.

Although management believes that this measure is indicative of our sensitivity to interest rate changes, it does not adjust for potential changes in credit quality, size and composition of the assets on the statements of assets and liabilities and other business developments that could magnify or diminish our sensitivity to interest rate changes, nor does it account for divergences in LIBOR and the commercial paper rate, which have historically moved in tandem but, in times of unusual credit dislocations, have experienced periods of divergence. Accordingly no assurances can be given that actual results would not materially differ from the potential outcome simulated by this estimate.

 

59


Table of Contents

ITEM 4. CONTROLS AND PROCEDURES

 

(a)As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934.

 

(b)There have been no changes in our internal control over financial reporting that occurred during the quarter ended May 31, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

60


Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Neither we nor our wholly-owned subsidiaries, Saratoga Investment Funding LLC and Saratoga Investment Corp. SBIC LP, are currently subject to any material legal proceedings.

Item 1A. Risk Factors

In addition to information set forth in this report, you should carefully consider the “Risk Factors” discussed in our Annual Report on Form 10-K for the year ended February 28, 2017, which could materially affect our business, financial condition and/or operating results. Additional risks or uncertainties not currently known to us or that we currently deem to be immaterial also may materially affect our business, financial condition and/or operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

 

61


Table of Contents

ITEM 6. EXHIBITS

Listed below are the exhibits which are filed as part of this report (according to the number assigned to them in Item 601 of Regulation S-K):

 

Exhibit

Number

 

Description of Document

3.1(a) Articles of Incorporation of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Form 10-Q for the quarterly period ended May 31, 2007, File No. 001-33376).
3.1(b) Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed August 3, 2010).
3.1(c) Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed August 13, 2010).
3.2 Amended and Restated Bylaws of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on March 5, 2008).
4.1 Specimen certificate of Saratoga Investment Corp.’s common stock, par value $0.001 per share. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-169135, filed on September 1, 2010).
4.2 Registration Rights Agreement dated July 30, 2010 between GSC Investment Corp., GSC CDO III L.L.C., and the investors party thereto (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
4.3 Dividend Reinvestment Plan (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 24, 2014).
4.4 Form of Indenture by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Saratoga Investment Corp.’s Pre-Effective Amendment No. 1 to the Registration Statement on Form N-2, File No. 333-186323 filed April 30, 2013).
4.5 Form of First Supplemental Indenture between the Company and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Pre-Effective Amendment No. 1 to the Registration Statement on Form N-2, File No. 333-186323 filed April 30, 2013).
4.6 Form of Note (incorporated by reference to Exhibit 4.5 hereto, and Exhibit A therein).
4.7 Form of Second Supplemental Indenture between the Company and U.S. Bank National Association (incorporated by reference to Amendment No. 2 to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-214182, filed on December 12, 2016).
4.8 Form of Global Note (incorporated by reference to Exhibit 4.7 hereto, and Exhibit A therein).
4.9 Form of Articles Supplementary Establishing and Fixing the Rights and Preferences of Preferred Stock (incorporated by reference to Saratoga Investment Corp.’s registration statement on Form N-2 Pre-Effective Amendment No. 1, File No. 333-196526, filed on December 5, 2014).
10.1 Investment Advisory and Management Agreement dated July 30, 2010 between GSC Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.2 Custodian Agreement dated March 21, 2007 between GSC Investment LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Form 10-Q for the quarterly period ended May 31, 2007).
10.3 Administration Agreement dated July 30, 2010 between GSC Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.4 Trademark License Agreement dated July 30, 2010 between Saratoga Investment Advisors, LLC and GSC Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
10.5 Credit, Security and Management Agreement dated July 30, 2010 by and among GSC Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).

 

62


Table of Contents
10.6  Form of Indemnification Agreement between Saratoga Investment Corp. and each officer and director of Saratoga Investment Corp. (incorporated by reference to Amendment No. 2 to Saratoga Investment Corp.’s Registration Statement on Form N-2 filed on January 12, 2007).
10.7  Amendment No. 1 to Credit, Security and Management Agreement dated February 24, 2012 by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on February 29, 2012).
10.8  Indenture, dated as of January 22, 2008, among GSC Investment Corp. CLO 2007, Ltd., GSC Investment Corp. CLO 2007, Inc. and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-186323, filed on April 30, 2013).
10.9  Indenture, dated as of October 17, 2013, among Saratoga Investment Corp. CLO 2013-1, Ltd., Saratoga Investment Corp. CLO 2013-1, Inc. and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-196526, filed on December 5, 2014).
10.10  Amended and Restated Indenture, dated as of November 15, 2016, among Saratoga Investment Corp. CLO 2013-1, Ltd., Saratoga Investment Corp. CLO 2013-1, Inc. and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-216344, filed on February 28, 2017).
10.11  Amended and Restated Collateral Management Agreement, dated October 17, 2013, by and between Saratoga Investment Corp. and Saratoga Investment Corp. CLO 2013-1, Ltd. (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-196526, filed on December 5, 2014).
10.12  Investment Advisory and Management Agreement dated July 30, 2010 between Saratoga Investment Corp. and Saratoga Investment Advisors, LLC (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-196526, filed on December 5, 2014).
10.13  Amendment No. 2 to Credit, Security and Management Agreement dated September 17, 2014 by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 18, 2014).
10.14  Amendment No. 3 to Credit, Security and Management Agreement, dated May 18, 2017, by and among Saratoga Investment Funding LLC, Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Madison Capital Funding LLC and U.S. Bank National Association (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on May 18, 2017).
10.15  Equity Distribution Agreement dated March 16, 2017, by and among Saratoga Investment Corp., Saratoga Investment Advisors, LLC, Ladenburg Thalmann and Co. Inc. and BB&T Capital Markets, a division of BB&T Securities, LLC (incorporated by reference to Saratoga Investment Corp.’s Post-Effective Amendment No. 1 to the Registration Statement on Form N-2, File No. 333-216344, filed on March 16, 2017).
11  Computation of Per Share Earnings (included in Note 12 to the consolidated financial statements contained in this report).
14  Code of Ethics of the Company adopted under Rule 17j-1 (incorporated by reference to Amendment No.7 to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-138051, filed on March 22, 2007).
21.1  List of Subsidiaries and jurisdiction of incorporation/organization: Saratoga Investment Funding LLC—Delaware; Saratoga Investment Corp. SBIC, LP—Delaware; and Saratoga Investment Corp. GP, LLC—Delaware.
31.1*  Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
31.2*  Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
32.1*  Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
32.2*  Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

 

*Submitted herewith.

 

63


Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SARATOGA INVESTMENT CORP.
Date: July 12, 2017  By: 

/s/ CHRISTIAN L. OBERBECK

   Christian L. Oberbeck
   Chief Executive Officer
  By: 

/s/ HENRI J. STEENKAMP

   Henri J. Steenkamp
   Chief Financial Officer and Chief Compliance Officer

 

64